SESSION 1 SCHEDULE
Tuesday
SESSION 1: PROGRESS IN CORONARY ARTERY STENTING, TRANSCATHETER VALVE REPLACEMENT, AND TREATMENT OF ASCENDING AORTIC DISEASE
x
6:45 AM - 6:50 AM Opening Remarks
  Presenter(s):Frank J. Veith, MD  
CORONARY STENTS
6:50 AM - 6:55 AM What Is New In Coronary Artery Stenting: Will There Be A Role For Absorbable Stents
  Presenter(s):Martin B. Leon, MD  
6:56 AM - 7:01 AM What Is New With Treatment Outcomes For Left Main Coronary Artery Disease: Advantages And Limitations Of PCI And CABG: Which Has Better Long-Term Survival
  Presenter(s):Gregg W. Stone, MD  
TRANSCATHETER HEART VALVES
7:02 AM - 7:07 AM Update On The Status Of Transcatheter Mitral And Tricuspid Valve Replacement/Repair
  Presenter(s):Roxana Mehran, MD  
7:08 AM - 7:13 AM DEBATE: Update On The Current Status Of Transcatheter Aortic Valve Replacement (TAVR): A Cardiac Surgeon’s View
  Presenter(s):Ali B. Khoynezhad, MD, PhD  
7:14 AM - 7:19 AM DEBATE: What Is New With Transcatheter Aortic Valve Replacement (TAVR): What Are Its Limitations: A Cardiologist’s View
  Presenter(s):Martin B. Leon, MD  
THE ASCENDING AORTA AND ARCH
7:20 AM - 7:25 AM Novel Tri-Branch Endograft For Repair Of Ascending Aorta And Arch Aneurysms And Dissections: What Makes It Different And Initial Clinical Results
  Presenter(s):Qingsheng Lu, MD  
7:26 AM - 7:31 AM Progress In Endovascular Treatment Of Type A Aortic Dissections (TAADs) In 2024: What Is Here And What Is Coming: Experience With Ascending Aortic Endografting Including The Gore Device In The ARISE II Trial
  Presenter(s):Eric E. Roselli, MD / Ali Azizzadeh, MD  
7:32 AM - 7:37 AM Current Status Of Endo-Bentall Procedures In Patients: Review Of Early Clinical Experiences: How Can It Be Done Without Left Ventricular Access
  Presenter(s):Stephan Haulon, MD  
7:38 AM - 7:43 AM Endovascular Graft Repair Of Ascending Aortic Dissections Including Endo-Bentall Procedures And Physician Modified Double Fenestrated Endografts (PMEGs) With Captiva From Medtronic: When Is It Possible And Results
  Presenter(s):Ludovic Canaud, MD, PhD  
7:44 AM - 7:50 AM Panel Discussion
END OF SESSION 1
 
SESSION 2 SCHEDULE
Tuesday
SESSION 2: PROGRESS IN THE TREATMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS
x
7:50 AM - 7:55 AM Primary And Redo Open Aortic Arch Repair: When Will They And Will They Not Be Replaced By Endo And Hybrid Techniques
  Presenter(s):Anthony L. Estrera, MD  
7:56 AM - 8:01 AM Current Status Of Hybrid Repair Of Aortic Arch And Thoracic Aortic Aneurysms Using ThoraFlex (Hybrid) And Relay Devices For Frozen Elephant Trunk (FET) And TEVAR: Indications And Results
  Presenter(s):Joseph S. Coselli, MD  
8:02 AM - 8:07 AM Endovascular Arch Repair With Cook 2 Or 3 Branched Devices For Lesions Involving The Whole Aortic Arch: When Are They Indicated; When Contradicted And Tips For Making Them Work
  Presenter(s):Mark A. Farber, MD  
8:08 AM - 8:13 AM Comparative Late Results With 2-Branched Endograft (Relay – Terumo) And A Single Branched Device (Nexus – Endospan) Versus Debranching For Treatment Of Zone 0 Arch Lesions
  Presenter(s):Toru Kuratani, MD, PhD  
8:14 AM - 8:19 AM Current Status And Results Of The Terumo Relay Branched Endograft Device For Aortic Arch Lesion Repairs: Unique Features And When Will It Be available In The US
  Presenter(s):Vicente Riambau, MD, PhD / Ciro Ferrer, MD, PhD / Martin Czerny, MD  
8:20 AM - 8:25 AM Update On Total And Partial Aortic Arch Lesion Repairs With The Gore TAG Single Branch Endograft: An Off-The-Shelf (OTS) Device For Revascularizing Arch Branches: Experience To Date, Advantages And Limitations
  Presenter(s):Michael D. Dake, MD / Himanshu Patel, MD / Joseph E. Bavaria, MD  
8:26 AM - 8:31 AM Physician Modified Endografts (PMEGs) For Treating Aortic Arch Lesions: When Are They Superior Options And Technical Tips
  Presenter(s):Sukgu Han, MD  
8:32 AM - 8:37 AM How Best To Treat Aortic Dissections (Type A Or Type B) Extending Into The Arch, Its Branches Or Ascending Aorta; When Open, When Endo, When Hybrid: More Updated Meta-Analysis Comparison Between Medical, Surgical And Endovascular Treatment In 2024
  Presenter(s):I-Hui Wu, MD, PhD  
8:38 AM - 8:43 AM How Best To Treat Aortic Arch Lesions: Is There Still Ever An Indication For Chimney Endografting With OTS Devices For Aortic Arch Lesions, And How To Make Them Work Without Gutter Endoleaks: What Are Other Options For Emergent Patients
  Presenter(s):Nicola Mangialardi, MD  
8:44 AM - 8:49 AM Comparison Of Indication And Results For Treatment Of Aortic Arch Lesions With Branched Endografts, Fenestrated Endografts, Parallel Stent Grafts, Hybrid Repairs, Or Open Repairs
  Presenter(s):Chang Shu, MD  
8:50 AM - 8:55 AM Techniques For Cerebral Protection During Ascending Aortic Arch Repairs – Endo And Open: The Value Of CO2 Device Flushing
  Presenter(s):Tilo Koelbel, MD, PhD  
8:56 AM - 9:02 AM Panel Discussion
END OF SESSION 2
 
SESSION 3 SCHEDULE
Tuesday
SESSION 3: PROGRESS IN THE ENDOVASCULAR TREATMENT OF THE ASCENDING AORTA, AORTIC ARCH, AORTIC DISSECTIONS, REPORTING STANDARDS AND CLASSIFICATION SYSTEMS, STABILISE, GUIDELINES AND MORE
x
9:02 AM - 9:07 AM Current Status of The Relay Ascending Aortic Endograft From Terumo: What Makes It Different
  Presenter(s):Adam Beck, MD  
9:08 AM - 9:13 AM How And Why The Aortic Arch Is An Unhospitable Location For Endovascular Graft Treatments
  Presenter(s):Piotr M. Kasprzak, MD  
9:14 AM - 9:19 AM The SVS-STS Aortic Dissection Reporting Standards And Classification System: What Is It; What Are Its Advantages; How Widely Is It Being Adopted
  Presenter(s):Joseph V. Lombardi, MD, MBA  
9:20 AM - 9:25 AM What Is The STABILISE Concept For Treating Acute And Chronic TBADs By Disrupting The Intimal Flap By Overdilating The Distal Bare Stent: Current Results, And When Should It Be The Treatment Of Choice
  Presenter(s):Jean-Marc Alsac, MD, PhD  
9:26 AM - 9:31 AM New Developments With The STABILISE Technique For Acute And Subacute TBADs: How Is The STABILISE Registry Helping: Technical Tips, And Precautions (First Author Germano C.G. Melissano, MD)
  Presenter(s):Andrea Kahlberg, MD / Germano C.G. Melissano, MD / Roberto L.V. Chiesa, MD  
9:32 AM - 9:37 AM Dual Lumen Interventions To Promote False Lumen Thrombosis In Chronic Aortic Dissections: The FLIRT Procedure: What Is It; When Is It Useful; How To Do It
  Presenter(s):Christoph A. Nienaber, MD, PhD  
9:38 AM - 9:43 AM When Is Open Repair For Post-Dissection TAAAs The Best Treatment Option Especially For Preventing SCI: Will There Be Surgeons Trained To Do It
  Presenter(s):Hazim J. Safi, MD  
9:44 AM - 9:49 AM Advances In Endograft Repair Of The Ascending Aorta Without And With Involvement Of The Aortic Valve (Endo-Bentall): What Lesions Are Or Will Be Suitable: World Clinical Experience With Endo-Bentall To Date
  Presenter(s):Ali B. Khoynezhad, MD, PhD / Shahab Toursavadkohi, MD  
9:50 AM - 9:55 AM Distal Stent-Graft Induced New Entry Tears (SINEs): Do They Prevent Aortic Remodeling After TBAD Treatment: How To Prevent And Treat Them
  Presenter(s):Chun Che Shih, MD, PhD  
9:56 AM - 10:01 AM High Risk Features Of TEVAR For TBAD: Did The AHA Guidelines Get Them Right: TEVAR Outcomes For TBAD Are Worse Than For Degenerative Aneurysms
  Presenter(s):James H. Black, III, MD  
10:02 AM - 10:07 AM Multicenter International Study Shows That There Is A Role For Endovascular Treatment Of Complex Aortic Diseases From Marfans, Loeys-Dietz And Ehlers-Danlos Syndromes: What Is This Role
  Presenter(s):Anders Wanhainen, MD, PhD  
10:08 AM - 10:14 AM Panel Discussion
10:14 AM - 10:24 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 3
 
SESSION 4 SCHEDULE
Tuesday
SESSION 4: MORE NEW DEVELOPMENTS IN THE TREATMENT OF TBADs, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAs)
x
10:24 AM - 10:29 AM When Should Hybrid Treatment (Endograft Proximal + Open Distal) Be The Preferred Treatment For TAAA Repair: Advantages And Technical Tips
  Presenter(s):Gilbert R. Upchurch, MD  
10:30 AM - 10:35 AM New Strategies And Indications For Open TAAA Repair Including Failed EVAR And F/B/EVAR: Technical Tips And Results
  Presenter(s):Andrea Kahlberg, MD / Germano C.G. Melissano, MD / Roberto L.V. Chiesa, MD  
10:36 AM - 10:41 AM Open Repair Of TAAAs Following TEVAR Treatment Of TBAD: Technical Tips: Will This Procedure Survive The Endovascular Revolution
  Presenter(s):Michael J. Jacobs, MD  
10:42 AM - 10:47 AM Retrograde Inner Branched Devices (From Cook) To Treat Aortic Arch Lesions: Indications, Value, Technical Tips And Initial Experience
  Presenter(s):Marcelo Ferreira, MD  
10:48 AM - 10:53 AM Endovascular Treatment Of Ascending Aortic Diseases; What Can Be Done Currently: What Cannot And What Does The Future Hold: From A Systematic Review
  Presenter(s):Santi Trimarchi, MD, PhD  
10:54 AM - 10:59 AM Update On F/B/EVAR For Degenerative And Post TBAD TAAAs: The Value Of Inner Branched Devices: Value Of The BeBack Catheter (Bentley) To Cross The Dissection Flap And For Other Purposes
  Presenter(s):Eric L.G. Verhoeven, MD, PhD / Athanasios Katsargyris, MD  
11:00 AM - 11:05 AM The Present Status Of Endovascular Treatment For Lesions Of The Aortic Arch: What Can Be Done, What Can't Be Done: What Has Changed In The Last Decade
  Presenter(s):Gustavo S. Oderich, MD, FACS  
11:06 AM - 11:12 AM Panel Discussion
11:12 AM - 11:17 AM Endovascular Procedures After Open Surgical Type A Aortic Dissection (TAAD) Repair Are Essential For Long-Term Success: Why And What Procedures Are Necessary
  Presenter(s):Götz M. Richter, MD, PhD  
11:18 AM - 11:23 AM The Anatomical And Hemodynamic Bases Of Obstruction In Branch Arteries And The True Lumen With Aortic Dissections: How They Can Be Treated Before And After Closure Of The Primary Tear: What Is The Value Of Fenestration Or Septotomy
  Presenter(s):David M. Williams, MD  
11:24 AM - 11:29 AM Endovascular Thermal Septotomy Of The Dissection Flap With An Electrocautery Activated Guidewire To Treat Chronic TBADs: When And How Does It Work: Complications And When It Should Be Avoided: Technical Tips And How To Avoid Pitfalls
  Presenter(s):Carlos H. Timaran, MD / Gustavo S. Oderich, MD, FACS  
11:30 AM - 11:35 AM Update On The Current Status Of A Catheter Aortic Septotomy Device For Treating Aortic Dissections By Cutting The Septum From Below: Yes, There Is A Downside To Other Septotomies That Cut The Septum From Above
  Presenter(s):Ramon Berguer, MD, PhD  
11:36 AM - 11:41 AM In Situ Fenestration (Septotomy) Versus Multiple Chimneys For Urgent Endovascular Treatment Of Aortic Arch Pathologies: Technical Tips
  Presenter(s):Ivo Petrov, MD, PhD  
11:42 AM - 11:47 AM Update On Laser Fenestrated Endografts For Aortic Emergencies: Technical Tips And Long-Term Results
  Presenter(s):Jean M. Panneton, MD  
11:48 AM - 11:53 AM The Endopatch: A Promising Solution For Endovascular Repairs For Aortic Dissections: What Is It And How Does It Work: Clinical Experience
  Presenter(s):Wei Guo, MD  
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – Rhinelander Gallery, 2nd Floor
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 4
 
SESSION 5 SCHEDULE
Tuesday
SESSION 5: NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY, DETECTION, TREATMENT AND EVAR
x
1:00 PM - 1:05 PM Unexpected Small Bowel Necrosis When Performing EVAR In Patients With Visceral Artery (SMA) Occlusive Disease: How To Predict It And How To Avoid It
  Presenter(s):Karan Garg, MD / Neal S. Cayne, MD / Carlos H. Timaran, MD / Frank J. Veith, MD  
1:06 PM - 1:11 PM New Medical Therapies For AAA Disease And An Update On The Metformin Trials For Slowing Aneurysm Growth
  Presenter(s):Ronald L. Dalman, MD  
1:12 PM - 1:17 PM DEBATE: The Safe-AAA Study Emphasizes The Importance Of Ongoing Surveillance And Continuing EVAR Device Risk: Some EVAR Endografts Have Been Found To Have More Late Risks Than Others
  Presenter(s):Philip P. Goodney, MD, MS / Eric A. Secemsky, MD, MSc  
1:18 PM - 1:23 PM DEBATE: Patient Survival After EVAR Was NOT Improved By Compliance With Surveillance Protocols: The EVAR Surveillance Paradox: From A Systematic Meta-Analysis: What Is The Explanation
  Presenter(s):George A. Antoniou, MD, PhD, MSc, FEBVS  
1:24 PM - 1:29 PM Computer Analysis Of CT Factors Determining AAA Wall Weakness/Strength Of Areas In AAAs Predicts Rupture Risk Independent Of Size And Post EVAR Neck Behavior: The ViTAA System
  Presenter(s):Randy D. Moore, MD  
1:30 PM - 1:35 PM Value Of Properly Performed Ch/EVAR For Juxtarenal AAAs: Results From A Single Center With The Longest Available Follow-Up Confirm Long-Term Safety And Effectiveness: Technique Is Vital
  Presenter(s):Joost van Herwaarden, MD, PhD  
1:36 PM - 1:41 PM Panel Discussion
1:42 PM - 1:47 PM Update On An Interesting New Endovascular Technology (Nectero – Intra-Sac Drug After AAA Balloon Isolation) To Slow AAA Growth: Updated Clinical Results Of The First-In-Human Trial
  Presenter(s):Andrew Holden, MBChB / Daniel G. Clair, MD / Venkatesh G. Ramaiah, MD  
1:48 PM - 1:53 PM Short And Long-Term Results For Endovascular Therapy For Infected Aortic Aneurysms At Various Levels: An 18-Year, >163-Case Experience: EVAR Can Work
  Presenter(s):Boonprasit Kritpracha, MD  
1:54 PM - 1:59 PM Size Thresholds For Repair Of AAAs Are Wrong On The Low Side: Data From Medicare And The VQI Indicate That Rupture Risk Only Increases With AAAs Over 6-6.9 cm
  Presenter(s):David H. Stone, MD / Sal Scali, MD / Bjoern D. Suckow, MD  
2:00 PM - 2:05 PM Update On Long-Term Results From The Dream RCT Comparing EVAR With Open Repair For AAAs Suitable For Both: Adverse Neck Anatomy (Short, Wide, Angulated) Was Associated With Increased Reintervention And Mortality Rates Equally After Open And Endo Repairs: Neck Dilatation Only Occurs After Open Repair And In EVARs With Self-Expanding Endografts: How Should This Influence Today’s Treatment
  Presenter(s):Jan D. Blankensteijn, MD  
2:06 PM - 2:11 PM DEBATE: Mortality 30 Days And 3-5 Years After Endo Repair Of Juxtarenal And Complex AAAs In The UK Compass Trial (Real World) Is Double That Of Open Repairs: Why Is This So And Why Is This Different Than Results From US Single Centers And The ARC Registry
  Presenter(s):S. Rao Vallabhaneni, MD, FRCS / Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS  
2:12 PM - 2:17 PM DEBATE: Mortality Early And 3-5 Years After Endo Repair Of Juxtarenal And Complex AAAs In The US Aortic Research Consortium (ARC) Registry Is Less Than That Reported For Comparable Open Repairs
  Presenter(s):Andres Schanzer, MD  
2:18 PM - 2:23 PM Why EVAR Should Be Preferred Over Open Repair In Young Patients With Suitable Anatomy: From A Meta-Analysis Of >50,000 Patients
  Presenter(s):George A. Antoniou, MD, PhD, MSc, FEBVS  
2:24 PM - 2:30 PM Panel Discussion
2:30 PM - 2:40 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 5
 
SESSION 6 SCHEDULE
Tuesday
SESSION 6: MORE ABOUT TBADs, AAAs AND EVAR, STANDARD AND COMPLEX: UPDATES ON PHYSICIAN MODIFIED ENDOGRAFTS (PMEGs) AND GUIDELINES
x
2:40 PM - 2:45 PM Initial Experience With A Uniquely Designed Device (The Chinese Fabulous Stent) Designed To Treat TBADs: What Makes It Different And How Does It Work
  Presenter(s):Weiguo Fu, MD  
2:46 PM - 2:51 PM Why The NICE AAA Guidelines Favoring Open Repair Over EVAR Are The Way They Are: Bias Has Played A Role As It Does In Many Things: Randomized Controlled Trials (RCTs) Can Be Misleading
  Presenter(s):Frans L. Moll, MD, PhD  
2:52 PM - 2:57 PM Cancer Is Associated With AAAs: It’s A Chicken And Egg Paradox; Which Came First, The Aneurysm Or The Cancer: Is It Related To Diagnostic And Therapeutic Radiation
  Presenter(s):Natzi Sakalihasan, MD, PhD  
2:58 PM - 3:03 PM The Link Between Elevated Cancer Risk And EVARs: Evidence From Biological Studies And A Large Population Based Data Analysis
  Presenter(s):Bijan Modarai, PhD, FRCS  
3:04 PM - 3:09 PM What Do The New ESVS Guidelines For Elective And Emergent AAA Treatment Add To Vascular Practice In 2024: Big Changes Are Coming
  Presenter(s):Ian Loftus, MD  
3:10 PM - 3:15 PM The SVS/ESVS/NICE/ACC/AHA Guidelines On AAA: Agreements, Conflicting Recommendations, And Omissions
  Presenter(s):Peter Gloviczki, MD  
3:16 PM - 3:21 PM Evolving Role For Physician Modified Endografts (PMEGs) For Complex AAA Repair: Why Are Poor Results Underreported And When Are They Justified
  Presenter(s):Javairiah Fatima, MD  
3:22 PM - 3:27 PM Hospitals Without Investigational Device Exemptions Have Worse Outcomes After PMEGs: These Are Often Unreported
  Presenter(s):Caitlin W. Hicks, MD, MS  
3:28 PM - 3:33 PM PMEGs For Juxta-And Para-Renal Aneurysms Come Out Of The Shadows And Are Now Mainstream: When Should They NOT Be Done
  Presenter(s):Benjamin W. Starnes, MD  
3:34 PM - 3:39 PM DEBATE: Population Screening With Ultrasound For Early Detection Of AAA Is Recommended For Women Age >65 Years, With A History Of Smoking Or A Family History Of AAA, And For Women Age >75 Years, With A History Of Smoking If They Are Otherwise In Good Health
  Presenter(s):Marc L. Schermerhorn, MD  
3:40 PM - 3:45 PM DEBATE: Population Screening With Ultrasound For Early Detection Of AAA Is NOT Recommended For Women Age >65 Years, Even If They Are Former Or Current Smokers Or Have Cardiovascular Disease
  Presenter(s):Janet T. Powell, MD, PhD  
3:46 PM - 3:56 PM Panel Discussion
END OF SESSION 6
 
SESSION 7 SCHEDULE
Tuesday
SESSION 7: MORE NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC AORTIC PATHOLOGY
x
3:56 PM - 4:01 PM Use Of TEVARs For TBAD In Patients With Connective Tissue Disease: When Should They Be Done: How Durable Are They And When Are Open Repairs Better
  Presenter(s):Martin R. Back, MD  
4:02 PM - 4:07 PM How To Treat Aortic Dissections With Entry Tears In The Aortic Arch: Can They Be Treated Endovascularly: Technical Tips
  Presenter(s):Santi Trimarchi, MD, PhD  
4:08 PM - 4:13 PM With Aortic Dissections, How Can Pressures In The True And False Lumens Be Measured And How Should They Influence Treatment Decisions
  Presenter(s):David M. Williams, MD  
4:14 PM - 4:19 PM Chronic False Lumen Expansion In Aortic Dissection Requires Complete Flow And Pressure Exclusion: How To Do It With CT Guided Interventions Including Embolization With Polymer Plugs (From Shape Memory) Or Other Methods
  Presenter(s):Götz M. Richter, MD, PhD  
4:20 PM - 4:25 PM How To Classify Acute Aortic Intramural Hematomas (IMHs): How And When To Treat Them Safely By TEVAR: When And Why Are They So Dangerous
  Presenter(s):Jean M. Panneton, MD  
4:26 PM - 4:31 PM Causes And Management Of Retrograde Aortic Dissection After TEVAR For TBAD
  Presenter(s):Boonprasit Kritpracha, MD  
4:32 PM - 4:37 PM A Novel Off-The-Shelf (OTS) Endograft For All Aortic Arch Pathologies: What Makes It Unique And Promising: Early Clinical Results
  Presenter(s):Wayne W. Zhang, MD  
4:38 PM - 4:43 PM Long-Term (>5 Years) Good Results Of The Medtronic Valiant Captiva Endografts For TEVAR In TBAD Patients: Advantages And Disadvantages
  Presenter(s):Nimesh Desai, MD, PhD / Joseph E. Bavaria, MD  
4:44 PM - 4:49 PM Motor Evoked Potentials (MEPs) Provide Highly Reliable Information On Spinal Cord Function During Open Thoracoabdominal Aortic Aneurysm (TAAA) Repair: Advantages, Requirements And Why It Hasn't Worked For Some Groups
  Presenter(s):Michael J. Jacobs, MD  
4:50 PM - 4:56 PM Panel Discussion
END OF SESSION 7
 
SESSION 8 SCHEDULE
Tuesday
SESSION 8: MORE NEW DEVELOPMENTS REGARDING TBADs AND TEVAR: NEED FOR AND TIMING OF TEVAR FOR ACUTE UNCOMPLICATED TYPE B AORTIC DISSECTION (uTBADs) (FOR IMPORTANT RELATED TALKS SEE SESSION 8 IN OUR 2023 PROGRAM ON OUR WEBSITE VEITHsymposium.org)
x
4:56 PM - 5:01 PM DEBATE ROUND 2: With Uncomplicated TBADs, The Case For Early TEVAR With Extensive Aortic Coverage In Most Patients: New Data
  Presenter(s):William D. Jordan Jr., MD  
5:02 PM - 5:07 PM DEBATE ROUND 2: With Uncomplicated Acute TBADs, The Case For Waiting 2-6 Weeks From Onset For TEVAR And Then Limiting Aortic Coverage: New Data
  Presenter(s):Mark A. Farber, MD  
DO WE NEED AN RCT COMPARING TEVAR VERSUS MEDICAL TREATMENT FOR uTBADs
5:08 PM - 5:13 PM Fate Of Medically Managed Acute TBADs: A Plea For Early Repair In Most Patients-Including Those Who Appear Uncomplicated
  Presenter(s):Fabio Verzini, MD, PhD, FEBVS  
5:14 PM - 5:19 PM TEVAR For Acute TBAD Significantly Reduces All-Cause Mortality At 3-Years Compared To Best Medical Management: New Data On Outcomes Of All Dissections In England: We Really Don't Need A Randomized Trial
  Presenter(s):Jonathan R. Boyle, MD, MA (Cantab) FRCS  
5:20 PM - 5:25 PM TEVAR To Treat Uncomplicated Acute/Subacute Type B Aortic Dissections (uTBADs) Must Still Be Justified By An RCT: Is An Appropriate One Possible Or Not
  Presenter(s):Colin D. Bicknell, MD, FRCS  
5:26 PM - 5:31 PM Scandinavian (SUNDAY) RCT Comparing TEVAR Versus Medical Therapy In uTBAD: Justification, Rationale And Current Status
  Presenter(s):Jacob Budtz-Lilly, MD, PhD  
5:32 PM - 5:37 PM Status Of The Multicenter RCT (IMPROVE-AD) To Evaluate The Value Of TEVAR Versus Medical Therapy In Acute And Subacute uTBADs: Rationale And Recruitment To Date
  Presenter(s):Firas F. Mussa, MD / Panos Kougias, MD, MSc  
5:38 PM - 5:43 PM Advances In The Endovascular Repair Of Complex Aortic Dissections: Timing Of Interventions, Adjunctive Techniques And Outcomes
  Presenter(s):Rami Tadros, MD  
5:44 PM - 5:49 PM What Does Endovascular Aortic Repair Do To Cardiac And Coronary Artery Function: Does The Position Of The Graft In The Aorta Make A Difference: Do We Need A Compliant Endograft
  Presenter(s):Rachel E. Clough, PhD, FRCS  
5:50 PM - 5:55 PM Re-Entry Specific Endovascular Therapy (RESET), i.e. TEVAR Plus Dealing With Re-Entry Tears: It Promotes False Lumen Thrombosis, Aortic Remodeling And Improves Outcomes: How To Do It
  Presenter(s):Jean M. Panneton, MD  
5:56 PM - 6:02 PM Panel Discussion
End of Program A

END OF SESSION 8
 
SESSION 9 SCHEDULE
Tuesday
SESSION 9: PROGRESS IN WEARABLE VASCULAR ROBOTICS, LAPAROSCOPY, GUIDANCE SYSTEMS AND SIMULATION
x
6:47 AM - 6:50 AM Opening Remarks
  Presenter(s):Enrico Ascher, MD  
WEARABLE REMOTE VASCULAR MONITORING SYSTEMS
6:50 AM - 6:55 AM Vascular Research And Innovation Priorities In The UK Should Be Applied Everywhere: They Include Wearable Sensors, And Telehealth Systems
  Presenter(s):Celia Riga, MD, FRCS  
6:56 AM - 7:01 AM Remote Measurement Of Blood Flow In Any Artery Or Graft Using An Implantable Ultrasonic Sensor With Transmission To The Internet (From IntelVasc): How Does It Work, And Experimental Data
  Presenter(s):Jean Bismuth, MD  
7:02 AM - 7:07 AM Inside Out: Next Generation Technology That Transmits Physical Intelligence And Parameters Continuously From Within The Patient: How Will It Help In Vascular Treatment
  Presenter(s):Barry T. Katzen, MD  
7:08 AM - 7:13 AM Integrating Robotic Systems Back Into Vascular Surgery: Do Not Abandon Them Yet: We Must Be Involved
  Presenter(s):Alan B. Lumsden, MD, FACS  
7:14 AM - 7:19 AM Robotic And Laparoscopic Vascular Surgery: Where Do They Stand And Why Bother Continuing To Consider Them
  Presenter(s):Willem Wisselink, MD  
RADIATION REDUCING IMAGING GUIDANCE TECHNIQUES
7:20 AM - 7:25 AM Updated Experience With The Fiberoptic RealShape (FORS From Philips) System: Results From The Completed Multicenter LEARN Registry: What Are Its Limitations And Can FORS Work With Very Complex Anatomy
  Presenter(s):Joost van Herwaarden, MD, PhD  
7:26 AM - 7:31 AM Improved Fiberoptic Based Imaging With The FORS Lumiguide System (Philips): Fiberoptic Sensors Within A Guidewire And A Special 3D Hub Allow Imaging Guidance With Any Catheter: How Does It Work And Experience
  Presenter(s):Carlos H. Timaran, MD  
7:32 AM - 7:37 AM Update On The 3D Radiation Free Electromagnetic Intraoperative Positioning System (IOPS) From Centerline For Endovascular Guidance: Advantages And Limitations
  Presenter(s):Matthew J. Eagleton, MD / Francis Caputo, MD  
7:38 AM - 7:43 AM Cydar Technology And Its AI Modifications Enhance The Accuracy Of Fusion For F/B/EVAR For Complex AAA Treatment: How Does It Work And Reduce Radiation: Advantages And Limitations
  Presenter(s):Murray L. Shames, MD / Ross Milner, MD  
7:44 AM - 7:50 AM Panel Discussion
END OF SESSION 9
 
SESSION 10 SCHEDULE
Tuesday
SESSION 10: NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; DIFFERING VIEWS ON TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND CAROTID SCREENING
x
7:50 AM - 7:55 AM A Data-Driven Look At Interventions For Carotid Disease: Do They Represent Exuberant Enthusiasm, Financial Opportunity For Industry, Doctors And Institutions, Or A Path To Excessive Risk
  Presenter(s):Colin P. Derdeyn, MD  
CORONARY DISEASE IN CAROTID STENOSIS (CS) PATIENTS
7:56 AM - 8:01 AM Ten-Year Results Of A Multicenter RCT Showing The Long-Term Benefit In CS Patients Of Pre CEA Coronary Angiography And Treatment In Preventing Late MIs And Death
  Presenter(s):Jean-Baptiste Ricco, MD, PhD  
8:02 AM - 8:07 AM Asymptomatic Coronary Artery Disease Is Deadly In Patients With Carotid Stenosis (CS) Whether The CS Is Treated Invasively Or Not: An RCT Shows How The Coronary Artery Disease Can Be Quantified And Treated To Reduce Myocardial Infarction And Improve Long-Term Survival
  Presenter(s):Dainis K. Krievins, MD / Christopher K. Zarins, MD  
8:08 AM - 8:13 AM Practice Patterns (CAS, CEA, Medical Treatment, TCAR) For Treatment Of CS Are Changing Dramatically From Those In Previous RCTs: Evidence From A Population Based Analysis
  Presenter(s):Christian A. Behrendt, MD  
VALUE OF CAROTID SCREENING
8:14 AM - 8:19 AM

Power Point Presentation with Synched Audio
The Case Against Screening For ACS (Like Lifeline): Who Profits: It May Lead To Unnecessary And Possibly Harmful Invasive Treatments
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
8:20 AM - 8:25 AM Screening For ACS: Its Main Value Is In Guiding Lipid Treatment: How Low Should LDL-Cholesterol (LDL-C) Be Pushed And What Will It Do To Carotid Plaques
  Presenter(s):Stavros K. Kakkos, MD, PhD / Andrew N. Nicolaides, MS, FRCS  
8:26 AM - 8:32 AM Panel Discussion
DIFFERING VIEWS ON TREATMENT OF ACS AND REIMBURSEMENT POLICY
8:32 AM - 8:37 AM Plaque Progression In Asymptomatic Carotid Stenosis (ACS) Patients On Best Medical Therapy (BMT): Does It Mandate Invasive Therapy Or Continued BMT
  Presenter(s):Gianluca Faggioli, MD  
8:38 AM - 8:43 AM

Power Point Presentation with Synched Audio
DEBATE: All ACS Patients Are Best Treated Medically: Invasive Treatment Causes More Harm Than Good And Should Not Have Been Widely Reimbursed By CMS
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
8:44 AM - 8:49 AM DEBATE: Not So: About 25% Of ACS Patients Can Benefit From CEA Or CAS And Should Be So Treated And Reimbursed Accordingly
  Presenter(s):Bruce A. Perler, MD, MBA  
8:50 AM - 8:55 AM DEBATE: Both Views Are Wrong: Severe ACS Has Declined As A Cause Of Ischemic Stroke To <1% Per Year: So Only <5% Of ACS Patients Should Be Treated Invasively And Reimbursed Accordingly: Can Computer Analysis Of Plaque CT Imaging Help
  Presenter(s):Robert W. Chang, MD  
8:56 AM - 9:01 AM CMS Expansion Of Reimbursement For CAS For Asymptomatic Disease: An Expensive And Potentially Harmful Decision: How Could CMS Disregard The Evidence, And Why Couldn't They Wait For CREST 2 Results
  Presenter(s):Joseph L. Mills, MD  
9:02 AM - 9:07 AM Is Transfemoral CAS Being Overused One Year After CMS Increased Reimbursement For Treating Asymptomatic Carotid Stenosis
  Presenter(s):Sean P. Lyden, MD  
9:08 AM - 9:14 AM Panel Discussion
9:15 AM - 9:30 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 10
 
SESSION 11 SCHEDULE
Tuesday
SESSION 11: MORE ABOUT CAROTID DISEASE: UPDATE ON INVASIVE TREATMENT FOR ACUTE STROKES
x
9:28 AM - 9:33 AM A System For Performing TCAR Percutaneously: How Does It Achieve Flow Reversal And How Can It Be Done Safely
  Presenter(s):Wayne W. Zhang, MD  
9:34 AM - 9:39 AM Acute Stroke Management: How Can A Vascular Surgeon Lead A Team That Provides Optimal Care And What Are Its Advanced Features
  Presenter(s):Laura Capoccia, MD  
9:40 AM - 9:45 AM The Current Status Of Intracranial Stroke Thrombectomy: What’s New With Devices And Indications: Technical Tips
  Presenter(s):Allan L. Brook, MD  
9:46 AM - 9:51 AM With Acute Strokes, What Is New With Endovascular Intracranial Techniques And Indications For Arterial Clot Removal: How Can Improved Imaging, A Dedicated System With Artificial Intelligence (AI) And Intraarterial Thrombolysis With Alteplase (Genentech) Help: The Importance Of Keeping Stroke Patients Flat
  Presenter(s):Adnan H. Siddiqui, MD, PhD / L. Nelson Hopkins, MD  
9:52 AM - 9:57 AM Current Optimal Treatment When Carotid Stenosis In The Neck Coexists With Intracranial Disease Or Clot
  Presenter(s):Klaus D. Mathias, MD  
9:58 AM - 10:03 AM How Best To Treat An ICA Occlusion With Distal Embolization: Sequence And Timing Of Treatment: Site Of Treatment (OR Versus Angio Suite Versus Hybrid Room): Technical Tips
  Presenter(s):Adnan H. Siddiqui, MD, PhD / L. Nelson Hopkins, MD  
10:04 AM - 10:09 AM With Tandem Carotid Lesions In The Neck And Supra-Aortic Trunks, How Should Acutely Symptomatic Patients Be Managed: What About Asymptomatic Patients With Such Lesions
  Presenter(s):Francesco Speziale, MD / W. Darrin Clouse, MD  
10:10 AM - 10:15 AM Current Optimal Treatment Of Carotid Artery Dissections: When Anticoagulation And Antiplatelet Drugs; When CAS And When Open Surgery: Technical Tips
  Presenter(s):Klaus D. Mathias, MD  
10:16 AM - 10:21 AM How Should Acute Stroke Severity (NIHSS) Influence Timing To Therapeutic Intervention: For TPA Use; For CEA And CAS; For Intracranial Arterial Clot Removal: It Matters To Neurologic Outcomes
  Presenter(s):Hernan A. Bazan, MD, DFSVS, FACS  
10:22 AM - 10:30 AM Panel Discussion
END OF SESSION 11
 
SESSION 12 SCHEDULE
Tuesday
SESSION 12: PROGRESS IN THE TREATMENT OF AORTIC AND AORTOILIAC OCCLUSIVE DISEASE;HYPOGASTRIC REVASCULARIZATION
x
10:30 AM - 10:35 AM The VORTEC Technique For Aortofemoral Bypass: What Is It And How To Do It: Why Is It Especially Valuable For Heavily Calcified And Scarred Aortas
  Presenter(s):Mario L. Lachat, MD  
10:36 AM - 10:41 AM What Is New In The Treatment Of External Iliac Artery Endofibrosis In Committed Cyclists: Is There A Role For Endovascular Treatment
  Presenter(s):Margaret Tracci, MD, JD  
10:42 AM - 10:47 AM Iliac Endofibrosis In Elite Cyclists: What Are Its Symptoms Despite Normal Pulses: Diagnosis Is Difficult: Diagnostic Workup: Surgical Treatment And Prognosis
  Presenter(s):Jason T. Lee, MD  
10:48 AM - 10:53 AM DEBATE: How To Treat Chronic Flush Juxtarenal Aortic Occlusions Endovascularly With Safety: Endo Is The Way To Go: How To Do It And What Is The Role Of Lysis
  Presenter(s):David J. Minion, MD  
10:54 AM - 10:59 AM DEBATE: Not So: Open Or Hybrid Repairs Are Best For Complex Juxtarenal Aortoiliac Occlusive Disease: Technical Tips
  Presenter(s):Yamume Tshomba, MD  
11:00 AM - 11:05 AM Value Of Shockwave Intravascular Lithotripsy (IVL) For Calcified Aortoiliac Occlusive Disease Treatment And For Facilitating Large Bore Access With Narrowed Calcified Iliac Arteries
  Presenter(s):Daniel G. Clair, MD  
11:06 AM - 11:12 AM Panel Discussion
COVERED ENDOVASCULAR RECONSTRUCTION OF THE AORTIC BIFURCATION (CERAB) PROCEDURE
11:12 AM - 11:17 AM Long-Term Outcomes Of The CERAB Technique In Patients With Aortoiliac Occlusive Disease: Advantages, Limitations, And Stent-Graft Choice: How Can CERAB Be Used To Treat Juxtarenal Occlusions
  Presenter(s):Michel Reijnen, MD, PhD / Peter C.J. Goverde, MD  
11:18 AM - 11:23 AM The CERAB Technique: From A Niche Procedure To A Better General Solution For Complex AortoIliac Occlusive Disease Based On The Updated Results Of The Physician Initiated Multicenter BeGlory Registry: Technical Tips And Precautions
  Presenter(s):Maria A. Ruffino, MD, EBIR, FCIRSE  
11:24 AM - 11:29 AM Impact Of Female Gender And Smaller Arteries On Outcomes Of Endovascular Treatment Of Aortoiliac Occlusive Disease: When Is Open Repair Indicated
  Presenter(s):Franco Grego, MD  
11:30 AM - 11:35 AM Treatment Of Isolated Infrarenal And Pararenal Aortic Stenosis: Why Results Are Worse In Women: When Stents; When Stent-Grafts; When Open Bypasses
  Presenter(s):Sigrid Nikol, MD  
11:36 AM - 11:41 AM Radiation Free CERAB Procedures Are Possible Using FORS Technology (Philips) With Its 3-D Hub: How Is It Done And Technical Tips: Clinical Experience In Over 20 Patients
  Presenter(s):Barend M.E. Mees, MD, PhD, FEBVS  
11:42 AM - 11:47 AM Can Mesh Covered Stents Replace Stent-Grafts For The Treatment Of Complex Iliac Occlusive Lesions: Advantages And Disadvantages
  Presenter(s):Piotr Myrcha, MD  
11:48 AM - 11:53 AM How Can The VORTEC Technique Be Used To Simplify Hypogastric Revascularization With Open Repair Of Difficult Iliac Aneurysms: How To Do It
  Presenter(s):Zoran Rancic, MD, PhD, EMBA HSG  
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – Rhinelander Gallery, 2nd Floor
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 12
 
SESSION 13 SCHEDULE
Tuesday
SESSION 13: NEW CONCEPTS; MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE (AI); TO DECREASE RADIATION (SEE ALSO SESSIONS 9 AND 90)
x
1:00 PM - 1:05 PM Revolutionizing Vascular Surgery: Navigating The AI And Multiomics Frontiers For Precision Care: Advantages And Limitations
  Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS  
1:06 PM - 1:11 PM Why RCTs In Vascular Surgery In The Era Of AI Are Unnecessary, Useless And Possibly Unethical
  Presenter(s):Willem Wisselink, MD  
1:12 PM - 1:17 PM What Is The VASCUL-AID Platform Which Uses AI To Predict Cardiovascular Disease Progression In AAA And Lower Extremity Lesion Patients (PAD): Interesting Findings To Date
  Presenter(s):Kak Khee Yeung, MD, PhD  
1:18 PM - 1:23 PM

Power Point Presentation with Synched Audio
Focus On Radiation Protection During Simulation-Based Training Improves Both Correct Behavior And Procedural Performance: Proven By A Randomized Comparison
  Presenter(s):Lars B. Lonn, MD, PhD  
1:24 PM - 1:29 PM How Can AI Markedly Reduce Radiation, Contrast Usage And Complications For Complex TAAA Repair With PMEGs
  Presenter(s):Mahmoud B. Malas, MD, MHS  
1:30 PM - 1:35 PM Use Of Virtual Reality 3-D Visualization With A Headset For Preoperative Optimization For Treatment Of Visceral Artery Aneurysms
  Presenter(s):Dominique Fabre, MD, PhD  
1:36 PM - 1:41 PM Benefit Of AI And AAA Volume Measurements After EVAR And F/B/EVAR: How Do They Improve Care
  Presenter(s):Stephan Haulon, MD  
1:42 PM - 1:47 PM Is Image Fusion Advanced Guidance For Complex And Simple Aortic Procedures Really Worthwhile And Cost Effective: Why Is It A Question And Do We Need A Trial
  Presenter(s):Rachel E. Clough, PhD, FRCS  
1:48 PM - 1:53 PM Update On Siemens I-Flow: A New Intelligent Technology To Improve The Endo Treatment Of Lower Extremity Occlusive Disease And Predicting Stroke Risk With Carotid Disease; How Does It Work And How Reliable Is It
  Presenter(s):Ravi K. Veeraswamy, MD  
1:54 PM - 1:59 PM Update On How An AI Based Prediction Of Rupture Risk Is Better Than Size Based Predictions
  Presenter(s):Jes S. Lindholt, MD  
2:00 PM - 2:05 PM Remote Endovascular Proctoring And Mentoring Using An Augmented Reality Virtual Platform: How Does It Work And Experience
  Presenter(s):Cherrie Z. Abraham, MD  
2:06 PM - 2:12 PM Panel Discussion
END OF SESSION 13
 
SESSION 14 SCHEDULE
Tuesday
SESSION 14: ISSUES IMPORTANT TO VASCULAR SURGERY’S INDEPENDENCE, IDENTITY AND TRAINING; SHOULD WE GET A COVID-19 VACCINATION
x
2:12 PM - 2:17 PM Why Vascular Surgery Needs To Have An Independent Board And What Is The SVS Doing To Pursue This Goal
  Presenter(s):Joseph L. Mills, MD  
2:18 PM - 2:23 PM What Is The ABVS Doing To Pursue An Independent Board And Why Hasn't It Done More
  Presenter(s):Timur P. Sarac, MD / Jeffrey H. Hsu, MD / Sean P. Lyden, MD / Alan M. Dietzek, MD, RPVI, DFSVS  
2:24 PM - 2:29 PM Why An Independent Board Of Vascular Surgery Was So Helpful In France To Patients And To Vascular Surgeons After It Was Created In 1974: What Organizations Resisted It And How Was The Resistance Overcome
  Presenter(s):Jean Pierre Becquemin, MD, FRCS  
2:30 PM - 2:35 PM Five Issues Affecting Vascular Surgeons' Bargaining Power: Would An Independent Vascular Board Help
  Presenter(s):Margaret Tracci, MD, JD  
2:36 PM - 2:41 PM Status Of Cardiology’s Independent Board For Cardiovascular Medicine: What Will Be Its Impact On Vascular Surgery And How Would An Independent Vascular Surgery Board Counteract This
  Presenter(s):Alan M. Dietzek, MD, RPVI, DFSVS  
2:42 PM - 2:47 PM The SVS Public Marketing Initiative: Why It Will Help Overcome Vascular Surgery’s Clouded Identity: In View Of Cardiology’s Initiative To Obtain An Independent Board, Shouldn’t Vascular Surgery Get One Too
  Presenter(s):Matthew J. Eagleton, MD / Keith D. Calligaro, MD / Joseph L. Mills, MD  
2:48 PM - 2:53 PM The Importance Of Mentorship In Vascular Surgery: How Best To Achieve It
  Presenter(s):Malachi Sheahan, MD  
2:54 PM - 2:59 PM How To Handle Bad Clinical Outcomes And Other Professional And Personal Adversity: It Really Matters For A Vascular Surgeon/Specialist
  Presenter(s):John F. Eidt, MD  
3:00 PM - 3:05 PM Evolution And Current Status Of Integrated Vascular Surgery Residency (0+5) Training: Advantages And Limitations: A View From One Of The First Such Trainees
  Presenter(s):Daniel K. Han, MD  
3:06 PM - 3:11 PM Important Developments In Vascular Surgery Training Programs: Changes In Numbers And Quality Of 0+5 And 5+2 Trainees; Why We Need More Qualified Vascular Surgeons And How Are We Going To Get Them
  Presenter(s):Dawn M. Coleman, MD, FACS  
3:12 PM - 3:17 PM How Safe And Effective Are Current COVID-19 Drugs For Vaccination: When And How Often Should Vascular Surgeons/Specialists Get Them If They Are <50, >50, >65 Or >75
  Presenter(s):Clayton J. Brinster, MD  
3:18 PM - 3:24 PM Panel Discussion
3:25 PM - 3:36 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 14
 
SESSION 15 SCHEDULE
Tuesday
SESSION 15: PROGRESS IN THE TREATMENT OF VISCERAL AND RENAL ARTERY DISEASE (FOR IMPORTANT RELATED TALKS SEE SESSION 15 IN OUR 2023 PROGRAM ON OUR WEBSITE VEITHsymposium.org)
x
3:36 PM - 3:41 PM Natural History Of Untreated Visceral And Renal Artery Aneurysms (Renal, Splenic, Celiac, Etc.): From Large Series With Mid-To Long-Term Follow Up
  Presenter(s):Caron B. Rockman, MD  
3:42 PM - 3:47 PM Multidisciplinary Consensus Statement On The Management Of Pediatric Renovascular Hypertension, Renal Artery Stenosis And Midaortic Syndrome: Optimal Conduits, Techniques And Results
  Presenter(s):Dawn M. Coleman, MD, FACS / James C. Stanley, MD  
3:48 PM - 3:53 PM Treatment Of Visceral And Renal Artery Aneurysms: Technical Tips And When To Use Coils, Covered Stents Or Uncovered Stents: How To Maintain Critical Arterial Flow
  Presenter(s):Paulo E. Ocke Reis, MD, PhD  
3:54 PM - 3:59 PM Why Is Open Repair Always Indicated To Treat Long Complex SMA Occlusions: Technical Tips
  Presenter(s):Armando Mansilha, MD, PhD, FEBVS  
4:00 PM - 4:05 PM Endovascular Mesenteric Artery Revascularization: Has It Improved Outcomes Of Acute Mesenteric Ischemia: Stents Versus Covered Stents
  Presenter(s):Manju Kalra, MBBS  
4:06 PM - 4:11 PM When Should SMA Endovascular Embolectomy Be The Standard Of Care: How To Do It
  Presenter(s):Loay S. Kabbani, MD, MHSA  
4:12 PM - 4:17 PM Visceral Artery Aneurysms: When To Treat Invasively, At What Size: When Endo, When Open
  Presenter(s):Rabih A. Chaer, MD  
4:18 PM - 4:23 PM Open Versus Endovascular Treatment For Visceral Artery Aneurysms And Acute Mesenteric Ischemia: When Is Open Surgery Mandatory
  Presenter(s):Timur P. Sarac, MD  
4:24 PM - 4:29 PM Gastroduodenal Aneurysms Associated With Celiac Artery Occlusion – Patterns, Treatment (Endo Versus Open); Technical Tips To Maintain Flow Through The Gastroduodenal And Results
  Presenter(s):Keith D. Calligaro, MD / Samy S. Nitecki, MD  
4:30 PM - 4:36 PM Panel Discussion
END OF SESSION 15
 
SESSION 16 SCHEDULE
Tuesday
SESSION 16: UPDATE ON OPEN VASCULAR SURGICAL PROCEDURES; PROGRESS IN THE TREATMENT OF AORTIC COARCTATIONS (FOR IMPORTANT RELATED TALKS SEE SESSION 16 IN OUR 2023 PROGRAM ON OUR WEBSITE VEITHsymposium.org)
x
OPEN VASCULAR SURGERY
4:36 PM - 4:41 PM What Are The Symptoms And What Is Current Open Surgical Treatment For Arterial Nutcracker Syndrome (Compression Of The Duodenum By The SMA)
  Presenter(s):Keith D. Calligaro, MD  
4:42 PM - 4:47 PM What Is ERAS (Early Recovery After [Open Aortic] Surgery): How To Do It With AAAs And What Are Its Advantages And Limitations
  Presenter(s):W. Anthony Lee, MD  
4:48 PM - 4:53 PM Strategies And Technical Challenges In The Open Treatment Of Large TAAAs In Patients With Connective Tissue Disorders
  Presenter(s):James H. Black, III, MD  
4:54 PM - 4:59 PM How To Perform All Vascular Operations Through Small Incisions: Technical Tips, Why Is It Advantageous And Results: When Is It Contraindicated
  Presenter(s):Robert M. Proczka, MD, PhD  
5:00 PM - 5:05 PM The Role Of Open AAA Repair In The Era Of F/EVAR And EVAR: Technical Tips
  Presenter(s):Francis Caputo, MD  
5:06 PM - 5:11 PM The Right Retroperitoneal Approach For Open AAA Repair: When To Do It, Advantages And Technical Tips
  Presenter(s):Ashraf Mansour, MD  
5:12 PM - 5:17 PM Update On Renal Consequences Of Left Renal Vein Division During Open AAA Repair: It Is Not Always Benign
  Presenter(s):Kimihiro Komori, MD  
5:18 PM - 5:24 PM Panel Discussion
UPDATE ON COARCTATION TREATMENT
5:24 PM - 5:29 PM Endovascular Repair Of Aortic Coarctation: Balloon Angioplasty Versus Bare Stents Versus Covered Stents And When Is Open Repair Necessary
  Presenter(s):Tilo Koelbel, MD, PhD  
5:30 PM - 5:35 PM Open And Endovascular Treatment Of Aortic Arch Aneurysms Following Aortic Coarctation Repairs - (First Author Germano C.G. Melissano, MD)
  Presenter(s):Andrea Kahlberg, MD / Germano C.G. Melissano, MD / Roberto L.V. Chiesa, MD  
5:36 PM - 5:41 PM Axillo-Unifemoral And Axillo-Bifemoral Bypasses Have Equal Patency For More Than A Year: Why The Bilateral Procedure Should Only Be Used When Bilateral Ischemia Exists
  Presenter(s):Jeffrey J. Siracuse, MD, MBA, FACS  
5:42 PM - 5:47 PM Technical Tips And Lessons Learned To Make In Situ Vein Bypasses More Effective And Better
  Presenter(s):R. Clement Darling III, MD  
5:48 PM - 5:53 PM Anterior Lumbar Spine Exposure: Technical Tips And How To Avoid Pitfalls
  Presenter(s):Timothy K. Liem, MD, MBA  
5:54 PM - 5:59 PM Panel Discussion
End of Program B

END OF SESSION 16
 
SESSION 17 SCHEDULE
Tuesday
SESSION 17: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 1
Moderators:Michael R. Jaff, DO  
x
7:00 AM - 7:05 AM Introduction To The Symposium
  Presenter(s):Frank J. Veith, MD  
7:05 AM - 7:15 AM Welcome And Introduction
  Presenter(s):Michael R. Jaff, DO  
7:15 AM - 7:25 AM The Basics Of Pulmonary Embolism Diagnosis: What Is The Role Of The History, Exam, Biomarkers
  Presenter(s):Raghu Kolluri, MD  
7:25 AM - 7:35 AM Echocardiography Is All You Need To Manage Acute Submassive PE
  Presenter(s):David M. Dudzinski, MD  
7:35 AM - 7:45 AM CTA Is All You Need To Manage Acute Submassive PE
  Presenter(s):Brian B. Ghoshhajra, MD, MBA  
7:45 AM - 7:55 AM Testing For Cancer And Other Hypercoagulable States In PE: Why, When, And What Tests
  Presenter(s):Aditya Sharma, MD  
7:55 AM - 8:10 AM Medical Treatment Of PE: When, Why, For How Long, And How Can I Remember
  Presenter(s):Geno J. Merli, MD, MACP, FHM, FSVM  
8:10 AM - 8:25 AM An Overview Of Clinical Trials For PE: Will Any Of Them Move The Needle?
  Presenter(s):Rachel Rosovsky, MD, MPH  
8:25 AM - 8:35 AM Intravenous Thrombolytic Therapy For PE: Why, When, And At What Dose?
  Presenter(s):Jay Giri, MD, MPH  
8:35 AM - 8:45 AM Ultrasound-Assisted Pharmacomechanical Thrombolysis: Emerging Data To Define Use In PE
  Presenter(s):Assaf Graif, MD  
8:45 AM - 8:55 AM Pharmacomechanical Thrombolysis With The Bashear Catheter: Unique And Differentiated Approach
  Presenter(s):Eric A. Secemsky, MD, MSc  
8:55 AM - 9:05 AM Percutaneous Mechanical Thrombectomy Without Lytics: The FlowTriever System
  Presenter(s):Mitchell D. Weinberg, MD  
9:05 AM - 9:15 AM Percutaneous Mechanical Thrombectomy Without Lytics: The Indigo System
  Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA  
9:15 AM - 9:25 AM Large Bore Aspiration Thrombectomy—Tips, Tricks And Pearls
  Presenter(s):Gary M. Ansel, MD  
Moderator(s): Michael R. Jaff, DO  
9:25 AM - 9:40 AM Panel Discussion
  Panelist(s): Gary M. Ansel, MD / Brian B. Ghoshhajra, MD, MBA / Jay Giri, MD, MPH / Assaf Graif, MD / Raghu Kolluri, MD / Robert A. Lookstein, MD, MHCDL, FSIR, FAHA / Geno J. Merli, MD, MACP, FHM, FSVM / Rachel Rosovsky, MD, MPH / Eric A. Secemsky, MD, MSc / Aditya Sharma, MD / Mitchell D. Weinberg, MD  
9:40 AM - 10:10 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 17
 
SESSION 18 SCHEDULE
Tuesday
SESSION 18: MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
Moderators:Michael R. Jaff, DO  
x
10:10 AM - 10:20 AM The AngioVac Strategy For The Treatment Of PE
  Presenter(s):Christopher J. Kwolek, MD, MBA  
10:20 AM - 10:30 AM ECMO-Assisted Pulmonary Embolectomy In Massive PE: Can It Replace Open Surgical Thrombo-Embolectomy
  Presenter(s):Animesh Rathore, MD  
10:30 AM - 10:40 AM Do Statins Matter In The Treatment Of Patients With PE
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
10:40 AM - 10:55 AM Your Referring Docs Think Heparin Is All They Need To Offer For PE – How To Tell The Intervention Story
  Presenter(s):Patrick Troy, MD  
10:55 AM - 11:10 AM Pulmonary Denervation: A New Frontier In The Treatment Of Pulmonary Hypertension
  Presenter(s):Mark G. Davies, MD  
11:10 AM - 11:25 AM Balloon Pulmonary Angioplasty For Chronic Thromboembolic Pulmonary Hypertension: Has This Become Mainstream
  Presenter(s):Kenneth Rosenfield, MD  
11:25 AM - 11:35 AM The Team Approach To PE Management: The National PERT Consortium
  Presenter(s):Rachel Rosovsky, MD, MPH  
Moderator(s): Michael R. Jaff, DO  
11:35 AM - 12:00 PM Challenging The Experts: Interactive Q&A
  Panelist(s): Anthony J. Comerota, MD, FACS, FACC / Mark G. Davies, MD / Christopher J. Kwolek, MD, MBA / Robert A. Lookstein, MD, MHCDL, FSIR, FAHA / Animesh Rathore, MD / Kenneth Rosenfield, MD / Rachel Rosovsky, MD, MPH / Eric A. Secemsky, MD, MSc / Patrick Troy, MD  
12:00 PM - 1:00 PM Lunch Break – Rhinelander Gallery, 2nd Floor
Visit Exhibits And Pavilions (2nd and 3rd Floors)
End of Program C-1
END OF SESSION 18
 
SESSION 19 SCHEDULE
Tuesday
SESSION 19: HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTS - MEDICAL AND NATURAL HISTORY ISSUES
x
1:00 PM - 1:05 PM Personalized Anticoagulation For Lower Extremity Revascularization Using The Distinctive Utilization Of Antiplatelets Protocol To Decrease Thrombosis (Failure) Rates: How To Do It
  Presenter(s):Anahita Dua, MD, MS, MBA  
1:06 PM - 1:11 PM Why Are Patients Who Undergo Lower Extremity Revascularization At Risk For Major Bleeding: How To Estimate That Risk And What Should Be Done To Decrease It
  Presenter(s):Christian A. Behrendt, MD  
1:12 PM - 1:17 PM Frailty With CLTI: How Best To Measure It And Can It Improve With Revascularization
  Presenter(s):Mark G. Davies, MD  
1:18 PM - 1:23 PM How Atherosclerosis In Peripheral Arteries Differs From That In The Coronary Arteries: What Are The Therapeutic Implications
  Presenter(s):Janet T. Powell, MD, PhD  
1:24 PM - 1:29 PM Premature Peripheral Artery Disease: What Factors Predispose To It: How Should Its Treatment Differ: How Does It Influence Treatment Outcomes
  Presenter(s):Olamide Alabi, MD  
1:30 PM - 1:35 PM Open And Endo Revascularization In Young Patients With PAD: What Works, What Doesn’t, And How Should Treatment Be Modified
  Presenter(s):William P. Robinson, MD  
1:36 PM - 1:41 PM 'Low-Flow State' Induced Limb Ischemia: What’s The Etiology: Is The Incidence Increasing In The Era Of ECMO, IMPELLA, LVADs And Heart Transplantation: How Should It Be Treated
  Presenter(s):Sateesh C. Babu, MD  
1:42 PM - 1:47 PM Renal Failure In CLTI Patients Should Not Be A Contraindication To Limb Salvage Attempts
  Presenter(s):Vincent L. Rowe, MD  
1:48 PM - 2:04 PM Panel Discussion
END OF SESSION 19
 
SESSION 20 SCHEDULE
Tuesday
SESSION 20: MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT – EVALUATING ARTERIAL ANATOMY AND TREATMENT OUTCOMES WITH CLTI
x
2:04 PM - 2:09 PM How To Accurately Evaluate Availability And Nonavailability Of Ipsilateral Or Contralateral Great Saphenous Vein For Use For Potential Bypasses In Patients Being Treated For Severe CLTI: How Can One Determine Optimal Treatment
  Presenter(s):Caron B. Rockman, MD  
2:10 PM - 2:15 PM Value Of Optical Coherence Tomography (OCT) In Treating BTK Arterial Lesions: How Does It Work And Indications
  Presenter(s):Lee Bouwman, MD, PhD  
2:16 PM - 2:21 PM The Value Of Distal Angiography, Selective And Subselective, In The Treatment Of Lesions Causing CLTI
  Presenter(s):Jos C. van den Berg, MD, PhD  
2:22 PM - 2:27 PM

Power Point Presentation with Synched Audio
The Japanese SPINACH Registry Confirms That Open Bypasses Are Superior To Endovascular Treatments In CLTI Patients When Ischemia And Infection Are Advanced
  Presenter(s):Nobuyoshi Azuma, MD  
2:28 PM - 2:33 PM What Is The Role Of IVUS In Peripheral Arterial Endovascular Procedures: When Is It Better Than Contrast Arteriography And When Can It Replace It
  Presenter(s):Hany M. Zayed, MD  
2:34 PM - 2:39 PM What Are The Best Ways To Evaluate CLTI Treatment Outcomes: Physiology (ABIs And PVRs), Wound Healing, Anatomy (Angiography Or Ultrasound), MACE Or MALE: Why It Matters
  Presenter(s):Mitchell D. Weinberg, MD / Ido Weinberg, MD, MSc  
2:40 PM - 2:45 PM How Should We Define Success For CLTI Treatment: What Criteria Are Best: The UK Perspective: Why Is It Different
  Presenter(s):Jonathan R. Boyle, MD, MA (Cantab) FRCS  
2:46 PM - 2:52 PM Panel Discussion
2:52 PM - 3:00 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 20
 
SESSION 21 SCHEDULE
Tuesday
SESSION 21: HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTS
x
3:00 PM - 3:05 PM Technical Tips For Vessel Prep For DCBs Or DESs: It Is Different And Not Simple: How To Do It And How Important Is It
  Presenter(s):Erwin Blessing, MD  
3:06 PM - 3:11 PM Current Comparative Value Of Paclitaxel Coated DCBs Versus Uncoated Balloons In Below The Knee (BTK) Arteries: The SAMBA Trial Shows That DESs Can Work In This Location
  Presenter(s):Gunnar Tepe, MD  
3:12 PM - 3:17 PM When Are Polymer Based Paclitaxel Eluting Stents (Eluvia, Boston Scientific) Superior To Other Endo Treatments For Lower Extremity Lesions
  Presenter(s):Yann Gouëffic, MD, PhD  
3:18 PM - 3:23 PM Update On The Advantages Of The Chocolate Wire Constrained Uncoated Balloon (From Medtronic) For Treating Popliteal And BTK Lesions
  Presenter(s):Gunnar Tepe, MD  
3:24 PM - 3:29 PM Tips For Treating Difficult BTK/BTA Lesions: How To Get A Guidewire Across A Long Calcified Occlusion, Getting A Resistant Balloon To Go Over The Wire And Tips For Retrograde Access
  Presenter(s):Marco G. Manzi, MD  
3:30 PM - 3:35 PM Propensity Matched Comparison Of Uncoated And Paclitaxel-Coated Balloon Angioplasty For Isolated Popliteal Lesions Excluding Bail-Out Stenting: The DCBs Are Better
  Presenter(s):Fabrizio Fanelli, MD, EBIR / Thomas Zeller, MD  
3:36 PM - 3:42 PM Panel Discussion
3:42 PM - 3:47 PM Outcomes Following Profunda Revascularization Using Atherectomy And DCB Angioplasty: Technical Tips And Comparison With Open Surgery
  Presenter(s):Giovanni B. Torsello, MD  
3:48 PM - 3:53 PM First-In-Human Experience With The Efemoral Bioresorbable Scaffold And New Sirolimus DCB (Provision DCB From BD) In FemPop Disease
  Presenter(s):Andrew Holden, MBChB  
3:54 PM - 3:59 PM Why The Zilver PTX DES (Cook) Is A Durable Effective Treatment For Long FemPop Lesions: Based On Worldwide Trials And Experience
  Presenter(s):Charles J. Bailey, MD  
4:00 PM - 4:05 PM Non-Aspiration Based Mechanical Thrombo-Embolectomy With The Pounce (From Surmodics) Or Rotarex (From BD) Devices: How Do They Work And How They May Lead To More Concrete Procedural End Points And Improved Value Analysis
  Presenter(s):Gary M. Ansel, MD  
4:06 PM - 4:11 PM Local Anesthetic Injection Into A Lesion Site Facilitates Angioplasty (PTA) And Stent Placement: How To Do It
  Presenter(s):Andrej Schmidt, MD  
4:12 PM - 4:17 PM Technical Tips For A Successful BTK Intervention In Patients With CLTI Including How To Perform An Antegrade Femoral Artery Puncture And Pass The Guidewire Easily Into The SFA And Not The Profunda
  Presenter(s):Ali Amin, MD, RVT, FACS, FACC  
4:18 PM - 4:23 PM Panel Discussion
END OF SESSION 21
 
SESSION 22 SCHEDULE
Tuesday
SESSION 22: MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE, CLTI AND ITS TREATMENTS
x
4:24 PM - 4:29 PM

Power Point Presentation with Synched Audio
How To Evaluate The Need For Below The Ankle (BTA) Recanalization In CLTI Patients: When Is It Important To Achieve Foot Healing: Technical Tips To Do It And How Durable Is Its Patency
  Presenter(s):Lorenzo Patrone, MD  
4:30 PM - 4:35 PM Lymphatic Embolization For Postoperative Groin Wound Leaks: How To Do It And How Effective Is It
  Presenter(s):Lindsay Machan, MD  
4:36 PM - 4:41 PM When Is Endovascular Treatment For CLTI Justified And Better For Patients Classified As “Bypass Preferred” In The Global Vascular Guidelines: What Are The Guidelines Missing
  Presenter(s):Kimihiro Komori, MD  
4:42 PM - 4:47 PM A Radiologist's View Of Open Bypass vs Endovascular As First Treatment For CLTI: Bypasses Still Have An Important Role
  Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR  
4:48 PM - 4:53 PM How To Size Lower Extremity Target Arteries For Endo Treatments Accurately Using Intravascular Ultrasound (IVUS): How Does It Help
  Presenter(s):Jos C. van den Berg, MD, PhD  
4:54 PM - 4:59 PM Do Diabetic Patients With CLTI And Extensive Foot Necrosis Have Time For An Endovascular First Strategy: Primary Open Bypass Is Better Treatment In This Setting
  Presenter(s):Katariina M. Noronen, MD  
5:00 PM - 5:05 PM Does Intravascular Lithotripsy (IVL) (Shockwave) Eliminate The Need For Other Vessel Prep
  Presenter(s):Lawrence A. Garcia, MD  
5:06 PM - 5:11 PM Panel Discussion
5:12 PM - 5:17 PM Experience With >1500 Retrograde Recanalization For Chronic Total Occlusions (CTOs); What Predicts Technical Success And What Predicts Periprocedural Complications: Are Re-Entry Devices Ever Helpful
  Presenter(s):Erwin Blessing, MD  
5:18 PM - 5:23 PM

Power Point Presentation with Synched Audio
Guillotine TMA After Arterial Revascularization: When And Why Is It Helpful With CLTI And How Should It Be Done
  Presenter(s):Miguel F. Montero-Baker, MD  
5:24 PM - 5:29 PM Value Of Redo Tibial Bypasses: Technical Tips For Facilitating - Some Old And Some New Tricks
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
5:30 PM - 5:35 PM A New Technology (From AOTI) Combining Local Oxygen Therapy With Cycled Compression And Humidification Enhances Healing Of Diabetic Wounds And Ischemic Ulcers After Revascularization
  Presenter(s):Anil P. Hingorani, MD / Enrico Ascher, MD  
5:36 PM - 5:41 PM When Lower Extremity Interventions Are Required In Patients With Prior EVAR Or Kissing Iliac Stents, How Can Contralateral Femoral Access Be Used: Technical Tips
  Presenter(s):Dipankar Mukherjee, MD  
5:42 PM - 5:47 PM Alternate Anatomic Approaches To Lower Extremity Arteries When Standard Approaches Are Prevented By Scarring Or Infection
  Presenter(s):Neal S. Cayne, MD / Enrico Ascher, MD / Frank J. Veith, MD  
5:48 PM - 5:53 PM Effects Of Atherectomy On Immediate Luminal Gain In Patients With In-Stent Restenosis/Thrombosis: Which Atherectomy Device Is Best
  Presenter(s):Joseph J. Ricotta II, MD, MS, DFSVS, FACS  
5:54 PM - 5:59 PM How To Do Bypass Surgery To Heavily Non-Compressible Calcified Target Arteries
  Presenter(s):Enrico Ascher, MD / Frank J. Veith, MD  
5:59 PM - 6:00 PM End of Program C-2

(No formal Panel Discussion will be held. Comments and Questions should be addressed to the Speakers on an individual basis later in the meeting.)

END OF SESSION 22
 
SESSION 23 SCHEDULE
Wednesday
SESSION 23: GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI
x
6:40 AM - 6:45 AM How Do Prior Endovascular Interventions Affect Future Lower Extremity Bypass Outcomes For CLTI: Why Do The Results Of The BEST-CLI Trial Make This More Important
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
6:46 AM - 6:51 AM The Effect Of Optimal Medical Therapy On Outcomes In Patients With CLTI In The BEST-CLI Trial: What Should This Therapy Be And How Should It Be Monitored
  Presenter(s):Vik S. Kashyap, MD  
6:52 AM - 6:57 AM Five-Year Mortality In Medicare Patients Undergoing Interventions For CLTI And IC Is Worse Than We Thought: 67% For CLTI And 33% For IC
  Presenter(s):Jeffrey J. Siracuse, MD, MBA, FACS  
6:58 AM - 7:03 AM DEBATE: An Endo First Approach Is Best For Treating CLTI In Almost All Patients: The Role For Open Bypasses Is Very Limited (What Percent): Why BEST-CLI And BASIL 2 Have Not Changed My Practice
  Presenter(s):Christopher J. Abularrage, MD  
7:04 AM - 7:09 AM DEBATE: Open Bypass Should Be The First Treatment For Many CLTI Patients: When Is This So And In What Percent Of CLTI Patients
  Presenter(s):Michael S. Conte, MD  
7:10 AM - 7:15 AM Is The Open Surgery First Or Endovascular First Approach Controversy Still Alive For CLTI: What Percentage Of An Interventionalist's Patients Should Be Treated First By Open Surgery
  Presenter(s):Marianne Brodmann, MD  
7:16 AM - 7:21 AM What Causes Small Foot Arteries To Have Decreased Blood Flow Resulting In CLTI: Medial Arterial Calcification (MAC) Causes Increased Vascular Stiffness And Decreased Blood Flow; Atheromatous And Non Atheromatous Lesions Further Obstruct Blood As Shown Pathologically: Can Any Of These Be Treated
  Presenter(s):Roberto Ferraresi, MD  
7:22 AM - 7:27 AM What Are The Best Current Techniques For Revascularizing BTK And Below-The-Ankle (BTA) Lesions Causing CLTI: Is Open Bypass Ever The Best
  Presenter(s):Stefan Mueller-Huelsbeck, MD  
7:28 AM - 7:33 AM Microembolization During Complex Endovascular Procedures Is Causing More Damage Than We Think To The Already Compromised Pedal Runoff: Is Paclitaxel A Causal Agent
  Presenter(s):Peter A. Schneider, MD  
7:34 AM - 7:39 AM Is Preop CT Fractional Flow Reserve (FFRCT) Guided Coronary Revascularization Beneficial In Patients Requiring Invasive Treatment For Lower Extremity (LE) Lesions: An RCT Comparing Standard Care Versus Such Revascularization Is Showing The Benefit Of The Latter: What Is The Best Time For The Coronary Procedure—Before Or After The LE Treatment
  Presenter(s):Christopher K. Zarins, MD / Dainis K. Krievins, MD  
7:40 AM - 7:45 AM Radial-to-Peripheral Interventions For Lower Extremity Arterial Lesions (PAD): An Update On Available Tools And Techniques And Precautions: What's Possible And What's Not
  Presenter(s):Craig M. Walker, MD  
7:46 AM - 7:53 AM Panel Discussion
END OF SESSION 23
 
SESSION 24 SCHEDULE
Wednesday
SESSION 24: NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE)
x
PROGRESS IN ATHERECTOMY
7:53 AM - 7:58 AM Which Vascular Specialists Are Performing Tibial Atherectomies And Angioplasties For Intermittent Claudication And Are There Suboptimal Outcomes: Is Atherectomy Usage Overall Being Abused
  Presenter(s):Caitlin W. Hicks, MD, MS  
7:59 AM - 8:04 AM Update On Atherectomy Devices: Do They Still Have A Role In 2024: Which One Or Ones Are Best: Has Their Benefit Been Proven
  Presenter(s):Todd R. Vogel, MD, MPH  
8:05 AM - 8:10 AM Atherectomy In Patients With CLTI, In Stent Restenosis (ISR) And Diabetes: When Is It Helpful; How Durable Is It: Which Devices Are The Best
  Presenter(s):Ignacio Escotto, MD  
8:11 AM - 8:16 AM The Objective Benefits Of Directional Atherectomy In Treating Lower Extremity Occlusive Lesions Are Real: When And How Should It Be Used And When Should It Not
  Presenter(s):Dierk Scheinert, MD / Thomas Zeller, MD  
8:17 AM - 8:22 AM What Is The Evidence That Atherectomy Is Effective In Femoropopliteal Interventions
  Presenter(s):Eric A. Secemsky, MD, MSc  
8:23 AM - 8:28 AM 3-Year Experience With The Rotarex Atherectomy And Thrombectomy System (From BD) For Arterial Occlusive Disease And ISR: How Does It Work And Advantages
  Presenter(s):Michael K.W. Lichtenberg, MD  
DRUG ELUTING STENTS (DESs) FOR BTK LESIONS
8:29 AM - 8:34 AM Update And 2-Year Results Of The LIFE-BTK Randomized Controlled Comparison Of Abbott’s Esprit Drug-Eluting Resorbable Stent (DERS) With Plain Old Balloon Angioplasty (POBA): When Will DERSs Make A Difference
  Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) / Sahil A. Parikh, MD / Brian G. DeRubertis, MD  
8:35 AM - 8:40 AM Update On Bioresorbable Everolimus DESs To Treat BTK Lesions Causing CLTI: Promising Results Up To 5 Years: From The DISAPEAR Registry And A Meta-Analysis Of Other Bioresorbable BTK Stent Results
  Presenter(s):Steven Kum, MD  
8:41 AM - 8:46 AM Updated Experience With Everolimus And Other Nonabsorbable DESs To Treat Infrapopliteal BTK Lesions – Long And Short – Causing CLTI: What Are The Stents And When Do They Help: Why Will The DERSs Be Better
  Presenter(s):Robert A. Lookstein, MD, MHCDL, FSIR, FAHA  
8:47 AM - 8:52 AM Late-Breaking Final Patency And Wound Healing Results With A 3-French Compatible Microstent (From Micro Medical) Versus POBA For Antegrade Or Retrograde Insertion To Treat Tibial Artery Lesions: From The STAND RCT
  Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI / Marco G. Manzi, MD  
8:53 AM - 9:00 AM Panel Discussion
END OF SESSION 24
 
SESSION 25 SCHEDULE
Wednesday
SESSION 25: LOWER EXTREMITY TOPICS RELATED TO DRUG COATED BALLOONS (DCBs), AND DRUG ELUTING STENTS (DESs) AND OTHER INTERWOVEN (SUPERA) STENTS
x
9:00 AM - 9:05 AM One View On The Final Result Of The Scare And Concern That Paclitaxel Coated Devices For Lower Extremity Treatments Increased Mortality And Amputation Rates: The Case Is Closed: What Were Its Costs
  Presenter(s):Peter A. Schneider, MD  
9:06 AM - 9:11 AM Another View On The Final Word: Is There Still Any Validity To The Increased Amputation And Mortality Rate Signals After Use Of Paclitaxel Coated Devices In The Lower Extremity: How Can We Explain These Signals In Older Studies And Their Disappearance In More Recent Data: The Case Is Not Yet Fully Closed
  Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR  
9:12 AM - 9:17 AM Update On DCBs For BTK Angioplasty: RCT Comparing A Paclitaxel DCB (Litos From Acotec) Versus A Sirolimus DCB (Magic Touch From Concept Medical): Update On Enrollment And Data In The DEBATE BTK DUELL RCT And The XTOSI Study
  Presenter(s):Francesco Liistro, MD / Edward T. Choke, MBBS, PhD  
9:18 AM - 9:23 AM Progress With A Sustained Release Sirolimus DCB For FemPop Lesions: 1-Year Results With The Magic Touch DCB Compared To A Paclitaxel DCB: From The SIRONA Study
  Presenter(s):Andrej Schmidt, MD / Thomas Zeller, MD / Dierk Scheinert, MD / Marianne Brodmann, MD  
9:24 AM - 9:29 AM Adventitial Drug Delivery With The BullFrog Device (From Mercator Medical) And The Spur Device (From ReFlow): How Do They Work And How Will We Know They Improve Results
  Presenter(s):William A. Gray, MD  
9:30 AM - 9:35 AM To Reduce Injury In Post Balloon PTA Dissections: The Value Of Stents, Tacks, Etc.
  Presenter(s):Michael K.W. Lichtenberg, MD  
9:36 AM - 9:41 AM Late Breaking Information Shows That Higher Dose Of Statins Greatly Lessens The Risk Of SFA Stent Restenosis: Is It True With DESs
  Presenter(s):Timothy W.I. Clark, MD  
9:42 AM - 9:47 AM

Power Point Presentation with Synched Audio
The Light And Darkness Of Fluoropolymer-Based Limus DESs In The Treatment Of Femoropopliteal Lesions
  Presenter(s):Osamu Iida, MD, PhD  
9:48 AM - 9:53 AM Updated And Long-Term Follow-Up Results With The Vasculomimetic Interwoven Supera Stent In Angulated And Tortuous Lower Extremity Anatomies
  Presenter(s):Rajiv Parakh, MBBS, MS, FRCS  
9:54 AM - 9:59 AM

Power Point Presentation with Synched Audio
Are DESs Ever Associated With Aneurysmal Degeneration: Is It Related To The Drug (Paclitaxel Or Limus) Or To The Fluoropolymer Excipient To Which The Drug Is Attached
  Presenter(s):Osamu Iida, MD, PhD  
10:00 AM - 10:08 AM Panel Discussion
10:08 AM - 10:18 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 25
 
SESSION 26 SCHEDULE
Wednesday
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs
x
NEW INFORMATION ON DCBs AND DESs FOR FEMPOP LESIONS: UPDATES ON RCTs
10:18 AM - 10:23 AM How Should We Move Forward With Limus Coated Devices After FDA Has Cleared Paclitaxel Coated Devices: Are There Promising Results Currently With Limus Coated DCBs
  Presenter(s):Marianne Brodmann, MD  
10:24 AM - 10:29 AM 4-Year Results Of An RCT Comparing Surveil DCBs (Surmodics) With In.Pact DCBs (Medtronic) For Treating FemPop Lesions: From The TRANSCEND Trial
  Presenter(s):Peter A. Schneider, MD  
10:30 AM - 10:35 AM 2-3-Year Results Of The EMINENT RCT Show The Superiority Of DESs (Eluvia-Boston Scientific) Over Bare Metal Stents For Long Complex FemPop Lesions
  Presenter(s):Yann Gouëffic, MD, PhD  
10:36 AM - 10:41 AM Update On The Randomized Head-To-Head Comparison Of In.Pact (Medtronic) And Ranger (Boston Scientific) DCBs For Complex SFA Lesions: 5-Year Results Of The COMPARE RCT: Similar Results With Different Paclitaxel Dosages
  Presenter(s):Dierk Scheinert, MD / Sabine Steiner, MD  
10:42 AM - 10:47 AM Update On The BioMimics 3D Spiral Flow Prosthetic Graft From Veryan Medical: Does It Prevent Neointimal Hyperplasia And Improve Patency: 3-Year Results With FemPop Lesions
  Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI  
10:48 AM - 10:53 AM One Year Results Of The SPORTS RCT – Comparing DESs (Eluvia – Boston Scientific) Versus Bare Metal Stents (BMSs) Versus DCBs: Which Device Is Best And In What Circumstances
  Presenter(s):Gunnar Tepe, MD  
10:54 AM - 10:59 AM Updated 5-Year Results Of The IMPERIAL RCT Head-To-Head Comparison Of The Eluvia DES (Boston Scientific) With The Zilver PTX DES (Cook): Both Are Safe And Effective: What Are The Differences
  Presenter(s):Stefan Mueller-Huelsbeck, MD / William A. Gray, MD / Thomas Zeller, MD  
11:00 AM - 11:05 AM 1-Year Results Of The DEBATE-BTK SHOCK RCT Evaluating The Impact Of Lithotripsy Prior To DCB Treatment In Diabetic Patients Undergoing BTK Revascularization
  Presenter(s):Francesco Liistro, MD  
11:06 AM - 11:11 AM Stellarex (Philips) DCBs With Low Dose Paclitaxel Is Safe And Has Higher Patency Rates Than POBA With De Novo Or Recurrent FemPop Lesions At 5 Years In The ILLUMENATE US And European RCTs
  Presenter(s):Sean P. Lyden, MD / Marianne Brodmann, MD / Sahil A. Parikh, MD / William A. Gray, MD  
11:12 AM - 11:18 AM Panel Discussion
NEW INFORMATION ON BTK DCBs AND DESs
11:18 AM - 11:23 AM Why Some BTK DCB Trials Have Not Shown Uniformly Better Results: Technical And Balloon Factors Matter
  Presenter(s):Francesco Liistro, MD  
11:24 AM - 11:29 AM When, How And With What Devices Are Endovascular Treatments The Best Way To Treat BTK Disease Causing CLTI
  Presenter(s):Brian G. DeRubertis, MD  
11:30 AM - 11:35 AM 5-Year Results From The AcoArt II BTK DCB RCT Show Safety With No Increased Mortality And Improved Patency Versus POBA To Treat BTK Lesions
  Presenter(s):Wei Guo, MD / Francesco Liistro, MD  
11:36 AM - 11:41 AM Sirolimus DCBs For Infrapopliteal Interventions: The Cordis/MedAlliance Selution 4BTK IDE Trial Update: Overseas Results Have Been Promising
  Presenter(s):Patrick J. Geraghty, MD / George L. Adams, MD / Michael K.W. Lichtenberg, MD  
11:42 AM - 11:47 AM How Does The LIFE BTK Study With Esprit Bioresorbable DES (From Abbott) Change The BEST- CLI Conclusions For BTK Lesions
  Presenter(s):Lawrence A. Garcia, MD  
11:48 AM - 11:53 AM Below-The-Ankle Endo Interventions In 2024: Techniques, Devices And Should Balloons Be Drug Coated Or Not
  Presenter(s):Marianne Brodmann, MD  
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – Rhinelander Gallery, 2nd Floor
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 26
 
SESSION 27 SCHEDULE
Wednesday
SESSION 27: PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: OPTIONS TO SAVE THE “NO OPTION FOR TREATMENT” LIMB AND THE “DESERT FOOT”
x
1:00 PM - 1:05 PM Successful Bypasses To Foot Arteries And Their Branches Allowed Limb Salvage In What Were Thought To Be 'No Option For Treatment' CLTI Patients
  Presenter(s):Enrico Ascher, MD / Frank J. Veith, MD  
1:06 PM - 1:11 PM What Presently Defines A No Option Or Desert Foot Before Or After Failed Endo Or Open Treatments: Under What Conditions Are Further Extreme Limb Salvage Procedures Possible
  Presenter(s):Peter A. Schneider, MD  
1:12 PM - 1:17 PM No Option CLTI Is Often A Misnomer: What Diagnostic And Therapeutic Procedures Can Result In Successful Limb Salvage In Many Of These Patients
  Presenter(s):Hisham Rashid, FRCS, FRCS(Gen)  
VALUE OF PROSTHETIC (PTFE) TIBIAL BYPASSES
1:18 PM - 1:23 PM Why PTFE Bypasses To Infrapopliteal Arteries Have Been A Controversial Procedure For More Than 40 Years – And Why They Continue To Be
  Presenter(s):Matthew T. Menard, MD  
1:24 PM - 1:29 PM Long-Term Multicenter Outcomes Show That Prosthetic (PTFE) Bypasses To Tibial And Peroneal Arteries Are Worthwhile
  Presenter(s):Hasan H. Dosluoglu, MD / Richard F. Neville, MD / Enrico Ascher, MD / Frank J. Veith, MD  
UPDATE ON FOOT VEIN ARTERIALIZATION FOR CLTI
1:30 PM - 1:35 PM Value Of Open Surgical Vein Arterialization: When And How It Can Be Useful: Technical Tips From The First One To Make It Work
  Presenter(s):Pramook Mutirangura, FRCS (Edinburgh)  
1:36 PM - 1:41 PM Why Foot Vein Arterialization Can Save Limbs With Truly No Other Option: What Is The Physiology That Allows Successful Arterialization Into Small Veins And The Capillary Bed: What Is Necessary For This To Occur
  Presenter(s):Roberto Ferraresi, MD  
1:42 PM - 1:47 PM Update On The PROMISE Trials And Registry Results In No Option CLTI Patients With Foot Gangrene Shows That Deep Vein Arterialization (DVA) Using The LimFlow Device Can Produce Wound Healing And Limb Salvage: When Does It Work And When Doesn’t It: Are There Drawbacks
  Presenter(s):Daniel G. Clair, MD / Hany M. Zayed, MD / Andrej Schmidt, MD / Daniela Branzan, MD  
1:48 PM - 1:53 PM Technical Advances In (DVA) With The LimFlow Device: Improved Access, Better Post Procedural Care And Wound Management Are Essential
  Presenter(s):Anahita Dua, MD, MS, MBA  
1:54 PM - 1:59 PM Technical Tips For DVA: The Most Important Part Starts After The Procedure
  Presenter(s):Erwin Blessing, MD  
2:00 PM - 2:05 PM Deep Venous Arterialization (DVA): Advantages Of Open Surgical Versus Endovascular Procedures Based On A Single Center Experience
  Presenter(s):Richard F. Neville, MD  
2:06 PM - 2:11 PM Novel Uses Of Selective Superficial Venous Arterialization To Achieve Lower Limb Salvage: Techniques, Indications, Precautions And Results
  Presenter(s):Patrick J. Geraghty, MD  
2:12 PM - 2:17 PM Hybrid Superficial Venous Arterialization For No Option CLTI: Technical Tips: Causes And Patterns Of Failure - Which Is Common
  Presenter(s):Miguel F. Montero-Baker, MD  
2:18 PM - 2:24 PM Panel Discussion
END OF SESSION 27
 
SESSION 28 SCHEDULE
Wednesday
SESSION 28: NEW DEVELOPMENTS IN PROSTHETIC GRAFTS; STENT GRAFTS; PERCUTANEOUS ENDOVASCULAR BYPASSES; STENT OCCLUSIONS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
x
NEW CONCEPTS RE PTFE GRAFTS AND STENT-GRAFTS
2:25 PM - 2:30 PM Heparin-Bonded Expanded PTFE Grafts For BTK Bypasses: What Is The Evidence That They Are Better And Are Propaten (Gore) Grafts The Best For Extensive FemPop Disease: Based On An RCT And A Systemic Review And Meta-Analysis
  Presenter(s):Yann Gouëffic, MD, PhD  
2:31 PM - 2:36 PM Less Invasive And More Effective Hybrid Method For Restoring Patency To Occluded PTFE Bypasses Using A Fluoroscopically Guided Adherent Clot Remover (From Edwards)
  Presenter(s):Neal S. Cayne, MD / Frank J. Veith, MD  
2:37 PM - 2:42 PM

Power Point Presentation with Synched Audio
5-Year Results Of Viabahn Stent-Graft For Complex FemPop Lesions: Technical Tips, Advantages And Limitations
  Presenter(s):Osamu Iida, MD, PhD  
PERCUTANEOUS FEMPOP BYPASSES
2:43 PM - 2:48 PM 3-Year Results With Percutaneous (PQ) Transvenous FemPop PTFE Bypasses Using The Torus 2 Endograft (From Endologix): How Is It Done And Updated Results From The US DETOUR Trial: Does It Have Limitations
  Presenter(s):Sean P. Lyden, MD / Daniel G. Clair, MD / Peter A. Schneider, MD  
2:49 PM - 2:54 PM 5-Year Results With Percutaneous Transvenous PTFE FemPop Bypass (PQ From Endologix) The DETOUR 1 TRIAL: Will Open Bypasses Become Obsolete
  Presenter(s):Dainis K. Krievins, MD  
2:55 PM - 3:00 PM Percutaneous Extravascular FemPop PTFE Bypasses Without Traversing The Vein: Technique And 6-Year Experience In Patients: Is It More Cost Effective: What Are The Limitations
  Presenter(s):Pierre G. Sarradon, Docteur / Jean Pierre Becquemin, MD, FRCS  
STENT OCCLUSIONS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
3:01 PM - 3:06 PM Treatment Of SFA In Stent Occlusions: Technique Of Direct Stent Puncture: And Value Of The Excimer Laser To Cross And Treat The Occlusions: How Is It Done And Advantages
  Presenter(s):Craig M. Walker, MD  
3:07 PM - 3:12 PM What Are The Best Current Treatment Options For ISR: What Are The Results Including Recurrence Rates
  Presenter(s):Stefan Mueller-Huelsbeck, MD  
ROLE OF OPEN PTFE BYPASSES IN CLTI
3:13 PM - 3:18 PM In The Endovascular Era, What Is The Current Role Of Open Bypasses In A Limb Salvage Program: What Percentage Of CLTI Patients Will Need One At Some Time In Their Course And What Percentage Of Those Will Require A PTFE Graft
  Presenter(s):Niten Singh, MD  
3:19 PM - 3:39 PM Panel Discussion And Break
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 28
 
SESSION 29 SCHEDULE
Wednesday
SESSION 29: LOWER EXTREMITY TRIALS; GUIDELINES; FOOT PERFUSION EVALUATION METHODS AND VALUE OF ANGIOSOMES
x
3:40 PM - 3:45 PM An Important Multicenter Propensity Matched Comparison Of Endo Versus Open Infrainguinal Treatment For CLTI Shows That Open Treatment Is Superior And Supports The Main Finding Of BEST-CLI
  Presenter(s):Jean-Baptiste Ricco, MD, PhD  
3:46 PM - 3:51 PM How To Reconcile The Different Primary Outcomes And Main Conclusion Of The BEST-CLI And BASIL-2 RCTs
  Presenter(s):Michael S. Conte, MD  
3:52 PM - 3:57 PM How The Data From BEST-CLI And BASIL-2 Can Be Combined To Produce Conclusions Superior To Those Of Either Trial Alone
  Presenter(s):Alik Farber, MD, MBA / Andrew W. Bradbury, MD, FRCSEd / Matthew T. Menard, MD / Kenneth Rosenfield, MD  
3:58 PM - 4:03 PM New Subanalysis Findings From The BEST-CLI RCT Are Critically Important To The Treatment Of CLTI Patients: Open Surgical Bypass Operations Still Have A Critical Role: Open Versus Endo Treatment Of Infrapopliteal Disease: Does Endo Treatment Burn Bridges
  Presenter(s):Matthew T. Menard, MD / Alik Farber, MD, MBA / Kenneth Rosenfield, MD  
4:04 PM - 4:09 PM Findings From BASIL-3, An RCT Comparing Clinical And Cost Effectiveness Of 3 Treatment Modalities For CLTI From FemPop Disease: POBA Versus DCBs Versus DESs
  Presenter(s):Andrew W. Bradbury, MD, FRCSEd  
METHODS FOR EVALUATING FOOT PERFUSION
4:10 PM - 4:15 PM Foot Perfusion Measurements Are The Best Method To Evaluate Treatment Effectiveness For CLTI: What Methods Are Available And Best
  Presenter(s):Werner Lang, MD  
4:16 PM - 4:21 PM How And Why To Measure Foot Perfusion During And After Endo Treatments: Hyperspectral Imaging, O2 Sensors, Etc.: When Is The Angiosome Concept Helpful; When Not
  Presenter(s):Marianne Brodmann, MD  
4:22 PM - 4:27 PM New Methods For Evaluating The Significance Of Lower Extremity Arterial Lesions And Foot Perfusion Using Fractional Flow Reserve (FFR) And MRI; How They Work And Their Value In Assessing Therapeutic Success
  Presenter(s):Bijan Modarai, PhD, FRCS  
4:28 PM - 4:35 PM Panel Discussion
END OF SESSION 29
 
SESSION 30 SCHEDULE
Wednesday
SESSION 30: NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
x
INTERMITTENT CLAUDICATION (IC)
4:36 PM - 4:41 PM At 2 Years After Endovascular Interventions For IC, Only 32% Of Patients Were Free From Recurrent IC: From A VQI Multicenter Study: What Are The Implications
  Presenter(s):Peter F. Lawrence, MD  
4:42 PM - 4:47 PM Decreasing Unnecessary And Potentially Harmful Endovascular Procedures In Patients With IC Which Are Almost Never Justified And Should Not Be Reimbursed
  Presenter(s):Caitlin W. Hicks, MD, MS  
4:48 PM - 4:53 PM Under What Circumstances Could Tibial Endo Interventions Possibly Be Justified For IC
  Presenter(s):Sahil A. Parikh, MD  
4:54 PM - 4:59 PM When Do Outcomes For Lower Extremity Revascularization Justify Their Use For IC In Patients >80 And >90
  Presenter(s):Jeffrey J. Siracuse, MD, MBA, FACS  
5:00 PM - 5:04 PM Panel Discussion
ACUTE LIMB ISCHEMIA (ALI) (SEE ALSO SESSION 63)
5:04 PM - 5:09 PM When And Why Is ALI Best Treated By Open Surgery: When Are Endovascular Treatments Best
  Presenter(s):Peter Henke, MD  
5:10 PM - 5:15 PM The PROMOTE-ALI Study Shows That Open Surgery Is Still Number One In The Treatment Of ALI
  Presenter(s):Katariina M. Noronen, MD  
5:16 PM - 5:21 PM DEBATE: ALI Is Always Best Treated Endovascularly: Why And What Techniques May Be Required
  Presenter(s):Ali Amin, MD, RVT, FACS, FACC  
5:22 PM - 5:27 PM DEBATE: When Is Open Surgery Required To Treat ALI: When Is Mechanical Thrombectomy And Thrombo-Aspiration The Best Treatment: When Should Lytics Be Used: Based On A Systematic Review And Meta-Analysis
  Presenter(s):Yann Gouëffic, MD, PhD  
5:28 PM - 5:33 PM Characteristics Of All The Commercial Systems For Mechanically Removing Clot To Treat ALI: What Are The Advantages And Disadvantages Of Each
  Presenter(s):Jos C. van den Berg, MD, PhD  
5:34 PM - 5:39 PM What Is New With Penumbra Indigo Clot Aspiration Systems: Improved Mechanical Catheter And Computer Based Clot Removal Indigo Systems: Modulated Pulsed Aspiration Technology (Lightning Bolt And Thunder Bolt) For The Treatment Of Acute Arterial Clot: How It Works And Why It Improves Clot Removal In Various Vascular Beds: Is Open Surgery Ever Needed
  Presenter(s):James F. Benenati, MD  
5:40 PM - 5:45 PM New Findings From The STRIDE Multicenter Trial: Mechanical Suction Thrombectomy With The Indigo Aspiration System (Penumbra) Had Few Complications And Excellent Limb Salvage: When Was It Contraindicated And When Was Angioplasty, Stenting Or Bypass Necessary
  Presenter(s):Thomas S. Maldonado, MD  
5:46 PM - 5:51 PM Endovascular Mechanical Thrombectomy Is Obviating The Need For Thrombolytics In ALI: What Devices Are Available And What Are Their Advantages And Limitations
  Presenter(s):Patrick E. Muck, MD, FACS  
5:52 PM - 5:57 PM Time To Perfusion In ALI: Which Is Faster, Lightning Bolt 7 (Penumbra) Or Open Surgical Embolectomy: When Is Open Surgery Necessary In 2024
  Presenter(s):Sean P. Lyden, MD  
5:58 PM - 6:05 PM Panel Discussion
End of Program D

END OF SESSION 30
 
SESSION 31 SCHEDULE
Wednesday
SESSION 31: ADVANCES IN MEDICAL DIAGNOSIS AND TREATMENTS IN VASCULAR PATIENTS; NEW ANTI-ATHEROGENIC DRUGS AND RIVAROXABAN
x
6:40 AM - 6:45 AM Postop Myocardial Infarctions (MIs) In Vascular Patients: What Are The New Options For Diagnosis, Prevention And Treatment
  Presenter(s):Peter Henke, MD  
6:46 AM - 6:51 AM What Is The Best Current Method For Evaluating The Heart In Patients Undergoing Open And Endo Vascular Surgery: When Is A Stress Test An Important Tool
  Presenter(s):David H. Stone, MD  
6:52 AM - 6:57 AM New Findings From The VOYAGER PAD And COMPASS RCTs With Low Dose Rivaroxaban (Xarelto [Janssen/J&J]) And Aspirin: How Do These Drugs Lower Major Adverse Limb And Cardiac Event Rates After Lower Extremity Revascularization (Endo And Open)
  Presenter(s):Marianne Brodmann, MD / Sebastian E. Debus, MD, PhD  
6:58 AM - 7:03 AM How Does The Morbidity And Pathology Of Adverse Events With Arteriosclerosis Depend On Thrombosis: This Explains The Benefits Of Rivaroxaban And Aspirin Seen In The VOYAGER And COMPASS Trials
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
7:04 AM - 7:09 AM DEBATE: LDL Cholesterol (LDL-C) Lowering And Statins For Prophylaxis Of Vascular Events Are Dangerous And Not Helpful: What Does The Latest Evidence Show
  Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS  
7:10 AM - 7:15 AM DEBATE: Not So: Update On LDL-C Lowering With Statins And Other Drugs: They Are Proven To Stabilize And Shrink Plaques And Decrease Morbid Vascular Events: Stopping Statins Increases Patients’ Risk Of MI And Death
  Presenter(s):Ron Waksman, MD  
7:16 AM - 7:21 AM The Risk Of Arteriosclerosis And Its Complications Are Increased By LDL Cholesterol (LDL-C) Levels, Elevated Lp(a) And Inflammation: What Are The Best Medical Strategies To Decrease These Parameters: Statins, Adjunctive LDL-C Lowering Drugs Inclisiran, Bempedoic Acid, Ezetimibe, PCSK-9 Inhibitors, Lepodisiran, Colchicine, Olezarsen, Etc.) And Anti-Inflammatories: How They Should Be Administered
  Presenter(s):Richard Bulbulia, MA, MD, FRCS  
7:22 AM - 7:27 AM Update On LDL-C Lowering During A Lifetime: How Low To Strive For With Intensive Drug Therapy: How Young To Start If High; How Old To Continue Statins: Why And How Often Should LDL-C Levels Be Measured
  Presenter(s):J. David Spence, MD  
7:28 AM - 7:33 AM An Interesting New Anti-Atherosclerosis Vaccine (AtheroVax): A Drug To Produce Lifelong LDL-C Lowering With A Single Gene Modifying Treatment: The Heart-1 Gene-Editing Trial: How Does AtheroVax Work
  Presenter(s):Nicholas Kipshidze, MD, PhD, DSc  
7:34 AM - 7:42 AM Panel Discussion
END OF SESSION 31
 
SESSION 32 SCHEDULE
Wednesday
SESSION 32: CATHETER BASED TREATMENTS FOR RESISTANT HYPERTENSION; MANAGEMENT OF CARDIAC PROBLEMS, CORONARY DESs, SMOKING AND TRANSFUSION IN VASCULAR SURGERY PATIENTS; PREVENTING VASCULAR AND CARDIAC COMPLICATIONS
Moderators:Ron Waksman, MD / Lindsay Machan, MD  
x
UPDATE ON RENAL DENERVATION FOR HYPERTENSION
7:42 AM - 7:47 AM Renal Denervation For Resistant Hypertension Really Works As Shown By RCTs: What Are The Techniques And Devices: When Should They Be Used
  Presenter(s):Eric A. Secemsky, MD, MSc  
7:48 AM - 7:53 AM The Role Of Pressure Wires And IVUS In The Assessment Of Renal Artery Stenosis In The Treatment Of Hypertension And Other Conditions
  Presenter(s):Lindsay Machan, MD  
7:54 AM - 7:59 AM How And Why Do Thoracic Endografts For TEVAR Negatively Affect The Blood Pressure And The Heart: Can A Compliant Endograft Prevent The Problem: Does This Problem Arise With EVARs
  Presenter(s):Juan C. Parodi, MD  
OTHER TOPICS RELATED TO VASCULAR DISEASE AND ITS TREATMENT
8:00 AM - 8:05 AM When And To What Level Can Postoperative Anemia Be Tolerated After Major Vascular Surgery: When Should It Be Corrected By Transfusion And Do Cardiac Comorbidities Make A Difference
  Presenter(s):Panos Kougias, MD, MSc  
8:06 AM - 8:11 AM New Developments In Methods To Prevent Kidney Damage From Iodinated Contrast Agents
  Presenter(s):Roxana Mehran, MD  
8:12 AM - 8:17 AM How Important Is Inflammation As Determined By C-Reactive Protein (CRP) Levels In Predicting Adverse Cardiac Events: What Drugs Can Lower This Risk
  Presenter(s):Ron Waksman, MD  
8:18 AM - 8:23 AM When Should Smoking Be Stopped Before AAA Repair; Before Lower Extremity Bypass: At Least 4 Weeks: Why Does The Duration Of Cessation Matter
  Presenter(s):Jeffrey J. Siracuse, MD, MBA, FACS  
8:24 AM - 8:29 AM In Patients Undergoing Carotid Endarterectomy (CEA), What Should Best Medical Therapy (BMT) Be: Should Clopidogrel Be Part Of This BMT And Should It Be Continued During The Perioperative Period
  Presenter(s):Timothy M. Sullivan, MD  
8:30 AM - 8:35 AM How To Manage Patients With Recent Coronary DESs Who Require Vascular Operations Or Interventions: What To Do About Antiplatelet Medications: How Long To Wait Before Stopping Safely: What To Do With Urgent Or Emergent Cases To Avoid DES Thrombosis
  Presenter(s):Caron B. Rockman, MD  
8:36 AM - 8:42 AM Panel Discussion
8:42 AM - 8:54 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 32
 
SESSION 33 SCHEDULE
Wednesday
SESSION 33: PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM (FOR IMPORTANT RELATED TALKS SEE SESSION 33 IN OUR 2023 PROGRAM ON OUR WEBSITE VEITHsymposium.org)
x
ALL ENDOLEAKS AFTER EVAR
8:54 AM - 8:59 AM Update On The Optimal Management Of Endoleaks: Key Points From A Systematic Review
  Presenter(s):Bernardo C. Mendes, MD  
9:00 AM - 9:05 AM Dynamic CT Scanning – The Gold Standard For Evaluating Endoleaks: Technical Requirements And How To Make It Help In Diagnosis And Treatment
  Presenter(s):Alan B. Lumsden, MD, FACS  
9:06 AM - 9:11 AM How To Improve Endoleak Detection And Finding Its Source With Contrast Enhanced Sonography
  Presenter(s):Thanila A. Macedo, MD  
TYPE 1 ENDOLEAKS
9:12 AM - 9:17 AM Major Systemic Trauma Can Lead To High-Flow (Type 1) Endoleaks In EVAR Patients: Can They Occur With Endografts Fixed By Hooks Or Barbs And What Is The Best Treatment
  Presenter(s):Carlo Setacci, MD  
9:18 AM - 9:23 AM Update On Embolization Treatment For Type 1 Endoleaks After EVAR: Indications And Technical Tips To Make It Work Successfully: Contraindications
  Presenter(s):Robert A. Morgan, MD  
9:24 AM - 9:29 AM How Can Type I Endoleaks Cause Sac Pressurization (Endotension) Without Contrast Visualization: How To Detect And Treat It: What Else Can Cause Endotension
  Presenter(s):Kenneth Ouriel, MD, MBA  
9:30 AM - 9:35 AM How To Treat Type 1 Endoleaks After EVAR: When Cuff, When F/EVAR, When Chimney, When Open Conversion: What About Embolization
  Presenter(s):Matteo Orrico, MD / Nicola Mangialardi, MD  
9:36 AM - 9:41 AM Panel Discussion
TYPE 2 ENDOLEAKS AFTER EVAR
9:41 AM - 9:46 AM Most Type 2 Endoleaks After EVAR Should Be Left Alone Because Treatments Have Poor Results, Have Complications And Do Not Improve Outcomes: What Are The Exceptions
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
9:47 AM - 9:52 AM When Should We Reintervene And Keep Reintervening For Persistent Type 2 Endoleaks: What Factors With Persistent Type 2 Endoleaks Are Predictors Of AAA Rupture
  Presenter(s):Naoki Fujimura, MD, PhD  
9:53 AM - 9:58 AM When Do Type II Endoleaks Cause Type I Endoleaks After Standard EVAR: How To Best Diagnose And Treat Them: Does One Need Proximal Aortic Control If Treatment Is Open Conversion
  Presenter(s):Randall R. De Martino, MD  
9:59 AM - 10:04 AM The Role Of Mural Thrombus In The Development Of Late Type II Endoleaks: How Best To Prevent Them And Treat Them
  Presenter(s):Natzi Sakalihasan, MD, PhD  
10:05 AM - 10:10 AM Patients On Anticoagulation Are More Likely To Develop Endoleaks After EVAR: How Does It Influence The Outcome Of Endoleak Treatment And Should It Be Stopped If Possible
  Presenter(s):Faisal Aziz, MD  
10:11 AM - 10:16 AM How Can 3D Fusion And ASSIST Guidance (GE) Help In Type 2 Endoleak Treatment By Any Approach: How To Do It
  Presenter(s):Mark W. Mewissen, MD, FSIR, RVT  
10:17 AM - 10:22 AM Panel Discussion
10:23 AM - 10:28 AM Transcaval Approach For Endoleak Embolization: A Minimally Invasive Hot Needle Approach And Other Technical Tips Including How To Close The Aortic Access Site
  Presenter(s):Sean P. Lyden, MD  
10:29 AM - 10:34 AM Transgraft Treatment Of Type 2 Endoleaks After EVAR: When And How To Do It
  Presenter(s):James F. McKinsey, MD  
10:35 AM - 10:40 AM The Latest Advances In The Treatment Of Type 2 Endoleaks: A New Technique With The Taurus Device Will Be Better: What Is It And Results
  Presenter(s):Zvonimir Krajcer, MD, FACC  
10:41 AM - 10:46 AM Innovative Type 2 Endoleak Obliteration Via Collateral Networks: Technical Tips
  Presenter(s):Palma M. Shaw, MD, MBA, FACS, RPVI, DFSVS  
10:47 AM - 10:55 AM An Algorithm For Diagnosing And Treating Challenging Endoleaks After F/B/EVAR For TAAAs
  Presenter(s):Thomas F. Lindsay, MDCM, FRCS  
10:56 AM - 11:00 AM Panel Discussion
END OF SESSION 33
 
SESSION 34 SCHEDULE
Wednesday
SESSION 34: ISSUES IMPORTANT TO VASCULAR SURGEONS/SPECIALISTS
x
11:00 AM - 11:05 AM A Tribute To James S. T. Yao, MD, PhD (1932-2023)
  Presenter(s):Jon S. Matsumura, MD  
11:06 AM - 11:11 AM How Human Behavior – Even With Vascular Surgeons/Specialists – Is Controlled By Biases And Rationalizations: How To Overcome These And Perform Better
  Presenter(s):Scott L. Stevens, MD  
ISSUES RE EVIDENCE BASED PRACTICE
11:12 AM - 11:17 AM RCTs Are Too Often Underpowered With Other Serious Flaws: So They Are Misused As Evidence, Negatively Influencing Practice And Innovation In Health Care
  Presenter(s):Frans L. Moll, MD, PhD  
11:18 AM - 11:23 AM Why Systematic Reviews, Meta-Analyses And RCTs Can Be Misleading: What To Do About It: Does Current Wisdom Help
  Presenter(s):Janet T. Powell, MD, PhD  
11:24 AM - 11:29 AM Answering The Current Big Questions: Vascular Surgeons/Specialists Need To Develop High Quality Evidence To Improve Care: How And Why To Do It
  Presenter(s):Jens Eldrup-Jorgensen, MD  
ISSUES IMPORTANT TO VASCULAR SURGEONS/SPECIALISTS
11:30 AM - 11:35 AM How Can Vascular Surgeons/Specialists Become Successful Entrepreneurs: What To Do And What Not To Do
  Presenter(s):Jeffrey H. Lawson, MD, PhD  
11:36 AM - 11:41 AM The Distracted Surgeon: Lessons Learned From Running Multiple Rooms: Is It Really More Efficient Or A Bad Practice Resulting In Poor Patient Care
  Presenter(s):Patrick A. Stone, MD  
ISSUES IN VASCULAR TRAINING
11:42 AM - 11:47 AM Optimal New Training Paradigm For Vascular Surgeons: 0+5 Vascular Surgery Residency Followed By 2 Years Of Cardiac Surgery Residency Training: Why Is It Better Than 2 Extra Years Of Laboratory Research
  Presenter(s):Alan B. Lumsden, MD, FACS  
11:48 AM - 11:53 AM Obtaining Cardiac Surgery Training After Vascular Surgery Training: I Did It, So It’s Possible: Is It Worthwhile: Advantages And Disadvantages
  Presenter(s):Jennifer L. Perri, MD, MBA  
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – Rhinelander Gallery, 2nd Floor
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 34
 
SESSION 35 SCHEDULE
Wednesday
SESSION 35: RECORDED LIVE CHALLENGING CASES AND INNOVATIVE TECHNIQUES FROM THE PLINIO ROSSI AND LINC COMPONENTS
x
THE PLINIO ROSSI COMPONENT
1:00 PM - 1:08 PM DES Versus DCB+BMS Versus BMS+DCB Versus DCB+DES: The Winner Is: Evaluation Of The Different Treatment Strategies With A Focus On The Now Increasingly Common Combination Of DCB Plus BMS
  Presenter(s):Fabrizio Fanelli, MD, EBIR  
1:08 PM - 1:16 PM Uterine Transplantation and Pregnancy: A Star in the Sky
  Presenter(s):Pierfrancesco Veroux, MD  
1:16 PM - 1:24 PM The Knickerbocker Technique – an Underutilized and Highly Effective Strategy for False Lumen Management in Chronic Aortic Dissection
  Presenter(s):Andrew Holden, MBChB  
1:25 PM - 1:30 PM Panel Discussion
THE LINC COMPONENT
Moderator(s): Dierk Scheinert, MD / Andrej Schmidt, MD / Daniela Branzan, MD  
1:30 PM - 1:59 PM PROGRAM TO BE DETERMINED
END OF SESSION 35
 
SESSION 36 SCHEDULE
Wednesday
SESSION 36: MORE ISSUES IMPORTANT IN VASCULAR SURGERY: HISTORY, PRACTICE PATTERNS, VALUE OF GUIDELINES AND RCTs, MALPRACTICE, SCIENCE, TRAINING AND HUMAN BEHAVIOR
x
2:00 PM - 2:05 PM

Power Point Presentation with Synched Audio
A Tribute To Hans-Henning Eckstein, MD, PhD (1955-2024)
  Presenter(s):Sebastian E. Debus, MD, PhD  
VASCULAR HISTORY
2:06 PM - 2:11 PM Einstein And Nissen: A New York Story About An AAA Wrapped In Cellophane
  Presenter(s):Frank J. Criado, MD  
2:12 PM - 2:17 PM The SVS Digital History Archive: What Is It, Why It Is Important And Should Vascular Surgeons Contribute To It And Use It
  Presenter(s):Jerry Goldstone, MD, FACS, FRCSEd  
2:18 PM - 2:23 PM Multispecialty Vascular Care Departments Or Units Within Institutions Are Best For Patients And Physicians: How Should The Dominant Specialty And Leader Be Chosen: How Should Rewards Be Distributed
  Presenter(s):Barry T. Katzen, MD  
VASCULAR SURGERY’S ROLE AND RECOGNITION
2:24 PM - 2:29 PM Vascular Surgery's Identity And Role Is Usually In A Subservient Position Within A Heart And Vascular Unit: What Should Be Done To Correct This Inequity In The Interest Of Better Patient Care
  Presenter(s):Timur P. Sarac, MD  
2:30 PM - 2:35 PM Vascular Surgery Needs An Independent ABMS Approved Board And Associated RRC To Thrive As A Specialty In The Medical Hierarchy And To Have Its Value Appropriately Recognized
  Presenter(s):Sean P. Lyden, MD  
2:36 PM - 2:41 PM The Negative Impact Of Hospital Administrators On Vascular Surgery And Vascular Surgeons' Careers: Why Is It Happening, Why Is It Worse For Vascular Surgeons Than Other Specialists And What Can Be Done To Counteract It
  Presenter(s):Samuel R. Money, MD, MBA  
2:42 PM - 2:47 PM The Role Of Women In Vascular Surgery: What Has It Been And Where Is It Going
  Presenter(s):Cynthia K. Shortell, MD  
2:48 PM - 2:56 PM Panel Discussion
ISSUES RE THE CONFLICT BETWEEN ETHICS AND FINANCES
2:56 PM - 3:01 PM Simultaneous Overuse And Undertreatment Of Patients With PAD And CLTI: Why The Problem Exists And What Should Be Done To Fix It
  Presenter(s):Joseph L. Mills, MD  
3:02 PM - 3:07 PM Physician And Industry Responsibility In Overuse Of Technology (Atherectomy, CAS, EVAR, Etc.): Especially Important In View Of The Recent Media Spotlight On This Issue
  Presenter(s):Murray L. Shames, MD  
UNIONIZATION FOR VASCULAR SURGEONS
3:08 PM - 3:13 PM Why Vascular Surgeons Should Unionize: The Pros And Cons
  Presenter(s):Enrico Ascher, MD  
3:14 PM - 3:19 PM Racial And Ethnic Disparities In Clinical Trials And The Treatment Of CLTI: What Are The Causes And What Can Be Done About Them
  Presenter(s):Vincent L. Rowe, MD  
3:20 PM - 3:32 PM Panel Discussion And Break
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 36
 
SESSION 37 SCHEDULE
Wednesday
SESSION 37: MORE ISSUE-RELATED TOPICS IMPORTANT TO VASCULAR SURGEONS AND VASCULAR SPECIALISTS; ISSUES RELATED TO OUTPATIENT CENTERS OR OFFICE BASED LABS (OBLs)
x
3:32 PM - 3:37 PM Vascular Spinoff Revenue In Tertiary Healthcare Systems: Substantially More Downstream Benefits FROM Vascular Surgeons: How To Make Hospital Administrators Appreciate The Value Of Vascular Surgeons And Reward Them Appropriately
  Presenter(s):Joseph V. Lombardi, MD, MBA  
3:38 PM - 3:43 PM The Significant Burden Of Iatrogenic Vascular Injury On The Vascular Surgery Workforce At A Tertiary Care Center: What Can And Should Be Done To Offset This Problem
  Presenter(s):Caron B. Rockman, MD  
3:44 PM - 3:49 PM Current Medicare Reimbursement For Complex AAAs (F/B/EVAR) Is Inadequate For Physicians And Less Profitable For Hospitals: How Does It Harm Vascular Surgery
  Presenter(s):Samuel R. Money, MD, MBA  
3:50 PM - 3:55 PM How And Why Aortic And Lower Extremity Artery Gender Differences Matter In The Treatment Of Vascular Disease: What Can Be Done To Offset This Problem
  Presenter(s):Linda M. Harris, MD  
3:56 PM - 4:01 PM The Value Of Telehealth In Vascular Surgery: Reimbursement Issues And When Is It Misleading
  Presenter(s):Misty D. Humphries, MD, MAS  
ISSUES RELATED TO OUTPATIENT CENTERS AND OBLs
4:02 PM - 4:07 PM The Ever-Changing Reimbursement For Lower Extremity Endovascular Therapies In Hospitals And OBLs: Why It’s Happening And Where Is It Going
  Presenter(s):Sean P. Roddy, MD / Robert M. Zwolak, MD, PhD  
4:08 PM - 4:13 PM Limb Preservation Centers: Benefit To Patients, Physicians And Health Care Systems: How To Create One
  Presenter(s):Krishna Jain, MD  
4:14 PM - 4:19 PM How Can OBLs Provide Good Vascular Care With Excellent Results, Be Profitable And Still Allow Vascular Surgeons To Only Work From 8 AM To 5 PM
  Presenter(s):Mark A. Mattos, MD  
4:20 PM - 4:25 PM How To Make Outpatient Vascular Treatment Facilities (OBLs, ASCs) Safe, Effective And Profitable Without Doing Unjustified Procedures: How Can They Make Uniquely Important Vascular Research Contributions
  Presenter(s):Christopher J. Kwolek, MD, MBA / Enrico Ascher, MD  
4:26 PM - 4:32 PM Panel Discussion
END OF SESSION 37
 
SESSION 38 SCHEDULE
Wednesday
SESSION 38: UPDATES AND ISSUES IMPORTANT TO ALL VASCULAR SURGEONS AND SPECIALISTS: FUTURE REIMBURSEMENT; IMPROVING VASCULAR CARE QUALITY; FIXING FALSE TESTIMONY; FLAWED PEER REVIEW; FDA IMPROVEMENTS; LEARNING HEALTH SYSTEMS
x
VASCULAR REIMBURSEMENT ISSUES
4:32 PM - 4:37 PM What’s Happening With Vascular Surgeon Reimbursement In 2024 And What Are The Prospects For 2025: For Hospital And OBL Procedures
  Presenter(s):Sean P. Roddy, MD  
4:38 PM - 4:43 PM Current Medicare Reimbursement For Ch/EVAR And F/EVAR Is Inadequate: The Situation Is Untenable: How Did We Get There And Can The Problem Be Fixed
  Presenter(s):Clayton J. Brinster, MD  
4:44 PM - 4:49 PM Reimbursement For Vascular Procedures Under CMS Is Deeply Flawed And Subject To The Bias Of Others: It Results In Unethical Compensatory Behavior: What Can Be Done About It
  Presenter(s):Sean P. Roddy, MD  
ISSUES RE QUALITY OF VASCULAR CARE
4:50 PM - 4:55 PM New Developments In And Benefits From VQI Participation: It Will Make For Better Doctors And Vascular Care And It Will Cut Hospital Costs
  Presenter(s):Jens Eldrup-Jorgensen, MD  
4:56 PM - 5:01 PM The SVS/ACS Vascular Verification Program (VVP) To Assure Quality Vascular Care In Inpatient And Outpatient Programs: What Is It And How Will It Help Vascular Surgery
  Presenter(s):Anton N. Sidawy, MD, MPH  
5:02 PM - 5:07 PM How Can The Insurance Industry Improve The Quality And Appropriateness Of Vascular Care And Help Vascular Surgery Survive In A Competitive World
  Presenter(s):Russell H. Samson, MD, DFSVS, RVT, FACS  
PUNISHING FALSE TESTIMONY
5:08 PM - 5:13 PM How Do We Hold Physicians Who Provide False Or Misleading Testimony Against Vascular Surgeons Accountable: Has The SVS Committee On This Topic Ever Done Anything To Do What Should Be Done
  Presenter(s):O. William Brown, MD, JD  
5:14 PM - 5:20 PM Panel Discussion
PEER REVIEW RELATED ISSUES
5:20 PM - 5:25 PM Our System Of Peer Reviews Is Flawed: Within Hospitals; Within Journal Reviews: How Might Artificial Intelligence (AI) Improve Them
  Presenter(s):Timothy M. Sullivan, MD  
5:26 PM - 5:34 PM What Is An Impact Factor For A Peer Reviewed Journal Or An Article: What Is Plum X And H-Index: How Are They Calculated And Why Are They Important: What Constitutes Plagiarism – It’s Not Simple (8-Minute Presentation)
  Presenter(s):Peter F. Lawrence, MD / Peter Gloviczki, MD  
FDA RELATED ISSUES
5:35 PM - 5:40 PM I Was From The Government And I'm Here To Help: FDA Resources To Assure Safe And Effective Medical Devices In Vascular Disease: What Is The LEAF Initiative To Assure That Trials Are Appropriate For FDA Approval
  Presenter(s):Robert E. Lee, MD / Philip P. Goodney, MD, MS  
5:41 PM - 5:46 PM Why Do IDEs Fail To Get FDA Approval: Updates To The FDA 510 (K) Program And Why They Are Important
  Presenter(s):Valerie M. Merkle, PhD  
5:47 PM - 5:52 PM Different Perspectives From Industry And The FDA Regarding The Importance Of Innovation, Engineering And Financial Rewards That Influence Innovation
  Presenter(s):Dorothy B. Abel, BSBME  
5:53 PM - 5:58 PM What Is A Learning Health System And Why Should It Matter To Vascular Surgery
  Presenter(s):Charles C. Miller, PhD  
5:59 PM - 6:05 PM Panel Discussion
End of Program E

END OF SESSION 38
 
SESSION 39 SCHEDULE
Wednesday
SESSION 39: MORE TOPICS RELATED TO THE THORACIC AORTA, AORTIC DISSECTIONS, INFLAMMATORY ANEURYSMS AND THEIR TREATMENT
x
6:50 AM - 6:55 AM A Novel Low Profile Stent Graft For The Treatment Of All Thoracic Aortic Segments: What Makes It Unique And Clinical Status
  Presenter(s):Francesco Setacci, MD  
6:56 AM - 7:01 AM Options For Left Subclavian Revascularization During TEVAR: Laser Fenestration, Open Bypass, Single Branch Device (Gore), Etc.: Advantages And Limitations Of Each
  Presenter(s):Timothy A. Resch, MD, PhD  
7:02 AM - 7:07 AM Challenges And Successes With Endografts In The Treatment Of Ascending Aortic Dissections (TAADs), Penetrating Ulcers And Pseudoaneurysms
  Presenter(s):Rodney A. White, MD  
7:08 AM - 7:13 AM DEBATE: The STABILISE Technique To Eliminate The False Lumen And Relaminate The Aorta Will Change The Treatment Of Acute And Subacute TBADs And Will Replace Most False Lumen Occlusion Devices And F/B/EVAR Treatments: How To Do It And Precautions
  Presenter(s):Igor A. Laskowski, MD, PhD / Heepeel Chang, MD  
7:14 AM - 7:19 AM DEBATE: Not So Fast! A Multimodular Approach To Treating Acute, Subacute And Chronic TBADs With TAAAs: Who Needs A F/B/EVAR; Who Needs A Candy-Plug Or Other Techniques
  Presenter(s):Tilo Koelbel, MD, PhD / Fiona Rohlffs, MD, PhD  
7:20 AM - 7:25 AM Outer/Inner/Upward Branches Or Fenestrations: Strategies For Complex Aortic Repair For Patients With Chronic TBADs: Advantages And Limitations Of Each
  Presenter(s):Bijan Modarai, PhD, FRCS  
7:26 AM - 7:31 AM Current Advances In The Treatment For Inflammatory Aneurysms: How Effective Are EVAR And TEVAR
  Presenter(s):Furuzan Numan, MD  
7:32 AM - 7:37 AM Update On The Experience With BeGrafts (From Bentley), A Balloon Expandable Covered Stent For Treating Aortic Coarctations, Aneurysms And Midaortic Syndrome: Advantages And Limitations
  Presenter(s):Elchanan Bruckheimer, MBBS  
7:38 AM - 7:43 AM Relay Custom Made Endografts (Terumo) For TEVAR, Scalloped, Etc.: When And Why Are They Advantageous And Do They Still Have A Role In View Of Other New Endografts
  Presenter(s):Michael P. Jenkins, MBBS, BSc, MS, FRCS, FEBVS / Mo S. Hamady, MD, FRCR, EBIR, FSIR  
7:44 AM - 7:51 AM Panel Discussion
END OF SESSION 39
 
SESSION 40 SCHEDULE
Wednesday
SESSION 40: MORE ADVANCES RELATED TO TREATING PATHOLOGY INVOLVING THE ASCENDING AORTA AND THE AORTIC ARCH; AORTIC DISSECTIONS, INTRAMURAL HEMATOMAS (IMHs) AND THEIR TREATMENT
x
7:52 AM - 7:57 AM Debranching Aortic Arch Branches: When And How To Do It; Technical Tips And How To Avoid Pitfalls
  Presenter(s):Bernardo C. Mendes, MD  
7:58 AM - 8:03 AM With TAADs When And How Should The Distal Aorta Be Treated By TEVAR Before Repair Of The Ascending Aorta
  Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD  
8:04 AM - 8:09 AM With TAADs Why And When Should TEVAR Of The Descending Thoracic Aorta Be Performed Prior To Open Type A Repair: Should The Procedures Be Staged
  Presenter(s):Mazin Foteh, MD  
8:10 AM - 8:15 AM Late Results Of Patients With TAADs Treated By Open Repair Of The Ascending Aorta And Arch With A FET And Completed By The STABILISE Technique Distally
  Presenter(s):Jean-Marc Alsac, MD, PhD  
8:16 AM - 8:21 AM With Chronic TBADs Laser Assisted Resection Of The Dissection Septum Or Membrane Creates A Single Lumen TEVAR Landing Zone: How Is This Technique Performed And Updated Results
  Presenter(s):Nuno V. Dias, MD, PhD / Bjõrn Sonesson, MD, PhD  
8:22 AM - 8:27 AM Panel Discussion
8:27 AM - 8:32 AM Multicenter Study Of Physician Modified Endografts (PMEGs) For TAAA And Complex AAA Repairs: What Does It Show About Their Advantages And Limitations
  Presenter(s):Nikolaos Tsilimparis, MD, PhD  
8:33 AM - 8:38 AM Updated 5-Year Results From The European Experience With The Novel Nexus Single And Double (Duo) Branched (OTS) Endovascular Devices (From Endospan) For The Treatment Of Zone 0 And 1 Aortic Arch Aneurysms: What Makes This Device Unique
  Presenter(s):Mario L. Lachat, MD  
8:39 AM - 8:44 AM Status And Results From The US TRIOMPHE Trial Of The Endospan Nexus Endograft (OTS) For Treating Complex Aortic Arch Lesions Including Chronic Dissections
  Presenter(s):Ross Milner, MD  
8:45 AM - 8:50 AM In Situ Fenestration For Endovascular Repair Of Aortic Arch Lesions: Does It Reduce Perioperative Strokes And How To Avoid Cerebral Ischemia During The Procedure
  Presenter(s):Ralf R. Kolvenbach, MD  
8:51 AM - 8:56 AM Origins Of Intramural Hematomas (IMHs): Why So Many Prove Benign And Do Well With Medical Treatment: When And How To Treat Them With TEVAR
  Presenter(s):Frank J. Criado, MD  
8:57 AM - 9:03 AM Panel Discussion
9:03 AM - 9:16 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 40
 
SESSION 41 SCHEDULE
Wednesday
SESSION 41: OPEN AND ENDO TREATMENT OF COMPLEX AAAs (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAs; INTERESTING NEW DEVICES FOR THEIR TREATMENT
x
COMPLEX AAAs AND TAAAs
9:16 AM - 9:21 AM Does Open Repair Still Remain The Gold Standard For Complex AAA Repair: What The Updated And Good Studies That Bear On This Question Show: It’s Not The Old RCTs (EVAR 1, DREAM And OVER)
  Presenter(s):George Geroulakos, MD, PhD  
9:22 AM - 9:27 AM TAAA Repairs For Aneurysms From Dissections And Degenerative Disease Are Best Treated By Combining Open And Endo Techniques: Technical Tips
  Presenter(s):Yamume Tshomba, MD  
9:28 AM - 9:33 AM Hybrid Repair Of A TAAA (Proximal Endograft + Distal Open Repair - The Upchurch Procedure): When Is It Indicated; What Are The Advantages And Updated Results
  Presenter(s):Gilbert R. Upchurch, MD / Sal Scali, MD / Dean Arnaoutakis, MD  
9:34 AM - 9:39 AM Endovascular Solutions To Effectively Deal With Hostile Neck Anatomy Of AAAs Other Than F/B/EVAR: Why They Should Be Favored
  Presenter(s):Stavros K. Kakkos, MD, PhD  
9:40 AM - 9:45 AM French National (Real World) Comparison Of Results Of F/EVAR And Open Repair (ORFEVAR Trial) For The Treatment Of Complex AAA (Juxtarenal, Suprarenal And Type IV TAAAs): Do We Need An RCT
  Presenter(s):Frederic Cochennec, MD, PhD  
9:46 AM - 9:52 AM Panel Discussion
9:52 AM - 9:57 AM Optimal Surveillance Methods And Timing After F/B/EVAR And EVAR
  Presenter(s):Sara L. Zettervall, MD  
9:58 AM - 10:03 AM Secondary Interventions Up To 30 Days Following F/B/EVAR Of Complex AAAs: How Morbid Are They
  Presenter(s):Jonathan R. Boyle, MD, MA (Cantab) FRCS  
TOPICS RELATED TO INTERESTING NEW DEVICES
10:04 AM - 10:09 AM Shape Memory Polymer Embolization Devices To Treat Gutter Endoleaks After Parallel Grafts: Technique And Results
  Presenter(s):James F. McKinsey, MD  
10:10 AM - 10:15 AM Update On The TAMBE Endograft Device (Gore) For Treating Complex AAAs And TAAAs: Current Configuration And Advantages, Technique For Insertion: Now Approved By The FDA
  Presenter(s):Carlos H. Timaran, MD  
10:16 AM - 10:21 AM Update On The WeFlow Device For Juxtarenal AAA, TAAA And Arch Repairs: A New Inner Branch And Outer Branch Approach: How Does It Work And Promising Results
  Presenter(s):Wei Guo, MD  
10:22 AM - 10:27 AM How To Prevent Patch Aneurysms After Open TAAA Repair With Long Antegrade Grafts: How To Treat Them When They Occur – Endo, Open
  Presenter(s):Manju Kalra, MBBS  
10:28 AM - 10:33 AM Use Of FORS Technology (Philips) In The Treatment Of TAAAs: Technical Tips In Its Use: What Are Its Advantages, Limitations And Disadvantages
  Presenter(s):Geert Willem H. Schurink, MD, PhD  
10:34 AM - 10:40 AM Panel Discussion
END OF SESSION 41
 
SESSION 42 SCHEDULE
Wednesday
SESSION 42: PROGRESS IN TREATING ILIAC ANEURYSMS; ILIAC BRANCHED DEVICES (IBDs); UPDATE ON MULTILAYER FLOW MODULATING (MLFM) AND OTHER BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS
x
TREATMENT OF ILIAC ANEURYSMS WITH IBDs OR PARALLEL GRAFTS
10:40 AM - 10:45 AM 15-Year Experience With Iliac Branched Endografts For Aortoiliac Aneurysms: Advantages, Limitations: Long-Term Results Of The Various IBD Devices
  Presenter(s):Giovanni Pratesi, MD  
10:46 AM - 10:51 AM 5-Year Outcomes Of The ICEBERG Study Of The Gore IBD (IBE Device) For Revascularizing The Hypogastric Artery With Aortoiliac Aneurysms: Advantages And Limitations
  Presenter(s):Michel Reijnen, MD, PhD  
10:52 AM - 10:57 AM 5-Year Outcomes Of The Cook PRESERVE II Study Of The Cook IBD (ZBIS): Why Is It Different From Other IBD Devices: When Is It Contraindicated
  Presenter(s):W. Anthony Lee, MD  
10:58 AM - 11:03 AM Advantages And Current Status Of The Artivion IBD Device For Treating Common And Internal Iliac Artery Aneurysms: From The PLIANT II Multicenter Study: When Will This Device Be Available In The US
  Presenter(s):Lee Bouwman, MD, PhD  
11:04 AM - 11:09 AM Parallel Endograft Techniques For Treating Common And Internal Iliac Artery Aneurysms: When And Why They Are Better Than IBDs And How To Make Them Work Effectively
  Presenter(s):Armando C. Lobato, MD, PhD  
11:10 AM - 11:15 AM Panel Discussion
UPDATE ON MULTILAYER FLOW MODULATING (MLFM) AND OTHER BARE STENTS
11:16 AM - 11:21 AM Why MLFM Bare Stents Should Be The Treatment Of Choice For Visceral, Peripheral And Iliac Aneurysms: Advantages And Has Rupture Been Universally Prevented: What About For TAAAs
  Presenter(s):Michel C. Henry, MD  
11:22 AM - 11:27 AM Treatment Of Aortic Dissections With Multilayer Bare Stents (MLFM) And 9 Years Of Follow Up: When Are They Effective And When Aren’t They
  Presenter(s):Victor S. Costache, MD, PhD / Ivo Petrov, MD, PhD  
11:28 AM - 11:33 AM Value Of Multilayer Bare Stents (MLFM – Allay From Intressa) In The Treatment Of TBAD Patients With Or At High Risk Of End Organ Malperfusion: Long-Term Results
  Presenter(s):Claude D. Vaislic, MD  
11:34 AM - 11:39 AM

Power Point Presentation with Synched Audio
Role Of Bare Metal AMDS Stents From Artivion (Formerly Cryolife/Jotec) For Repair Of Acute Type A Dissections: Indications, Results And Limitations
  Presenter(s):Wilson Y. Szeto, MD  
11:40 AM - 11:45 AM Thoraflex Hybrid Graft Rescue When Treatment Of Aortic Dissection In The Arch With Bare Stents (AMDS From Artivion And Allay From Intressa) Fails: What Is The Mechanism Of Failure And What Is The Bailout Procedure
  Presenter(s):Mazin Foteh, MD  
11:46 AM - 11:51 AM Aortic Dissection In Pregnancy: Why Is The Mortality So High: Why Is Its Diagnosis Delayed: How Should Its Treatment Differ From Non-Pregnant Patients
  Presenter(s):Richard G.J. Gibbs, FRCS  
11:52 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – Rhinelander Gallery, 2nd Floor
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 42
 
SESSION 43 SCHEDULE
Wednesday
SESSION 43: MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAs ARE NOT TIME BOMBS WAITING TO EXPLODE
x
1:00 PM - 1:05 PM Endovascular Strategies For Repairing Giant Hypogastric Artery Aneurysms (>6 cm): What Special Techniques Are Needed
  Presenter(s):Jacques Busquet, MD  
1:06 PM - 1:11 PM Debunking The Lingering Myths Of Asymmetrical Saccular Aneurysms: Are They All Ticking Time Bombs, How Should Their Diameter Be Measured – To Include The Normal Aorta Or Not: Do They Rupture At A Smaller Diameter
  Presenter(s):Frank J. Criado, MD  
1:12 PM - 1:17 PM A Direct Comparison Of Major Contemporary EVAR Devices – Looking At Long-Term Efficacy And Patient Survival Using Big Data And Linkage Techniques
  Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi)  
1:18 PM - 1:23 PM EVAR Patients On Anticoagulation Have Increased Mortality, Endoleaks, Sac Expansion And Reinterventions: From A Meta-Analysis Of >35,000 Patients
  Presenter(s):George A. Antoniou, MD, PhD, MSc, FEBVS  
1:24 PM - 1:29 PM Rapid Gate Cannulation During EVAR: A Technical Tip To Make It Quick And Easy
  Presenter(s):Felice Pecoraro, MD  
1:30 PM - 1:35 PM Panel Discussion
1:36 PM - 1:41 PM An RCT Shows The Advantages Of Inferior Mesenteric Artery (IMA) And Lumbar Embolization: The Next Generation Of EVAR Endografts Must Prevent Endoleaks: How Can It Be Done
  Presenter(s):Dominique Fabre, MD, PhD / Stephan Haulon, MD  
1:42 PM - 1:47 PM Value Of Preemptive Embolization Of AAA Side Branches (IMA And Lumbars) Prior To EVAR: Objective Evidence That It Prevents Sac Enlargement
  Presenter(s):Daniela Branzan, MD / Andrej Schmidt, MD  
1:48 PM - 1:53 PM How To Minimize Gutter Type 1A Endoleaks With Chimney EVAR (Ch/EVAR): How Does A Standard Protocol Help; How To Treat Them When They Occur
  Presenter(s):David J. Minion, MD  
1:54 PM - 1:59 PM DEBATE: Repairs Of Small AAAs (<5.5 cm) Are Justified By Many Evidence Based Reasons: What Are These Reasons And What Are The Downsides
  Presenter(s):Jessica P. Simons, MD, MPH  
2:00 PM - 2:05 PM DEBATE: There Is High Level Evidence That Men With AAAs <5.5 cm Should NOT Undergo Elective Repair: AAAs < 6 cm In Men Rarely Rupture: The Thresholds For Repair Of Aortic And Iliac Aneurysms Need To Be Raised
  Presenter(s):Anders Wanhainen, MD, PhD  
2:06 PM - 2:11 PM Panel Disccusion
END OF SESSION 43
 
SESSION 44 SCHEDULE
Wednesday
SESSION 44: MORE NEW DEVELOPMENTS IN AAAs: WITH HERITABLE AORTIC DISEASE (CONNECTIVE TISSUE GENETIC DISORDERS): HOW DOES THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR; OTHER RELATED AAA TOPICS
x
TREATMENT OF AORTIC ANEURYSMS WITH HERITABLE AORTIC DISEASE AND CONNECTIVE TISSUE DISORDERS
2:12 PM - 2:17 PM In Patients With AAAs From Genetic Aortopathy (Heritable Aortic Disease): Is Active Exercise Beneficial Or Harmful
  Presenter(s):James H. Black, III, MD  
2:18 PM - 2:23 PM Results Of Endovascular Graft Aortic Repair In Mixed Connective Tissue Disease (Heritable Aortic Disease) Patients: Is It Time To Change The Guidelines: In What Circumstance Is Endovascular Repair Indicated
  Presenter(s):Sal Scali, MD  
2:24 PM - 2:29 PM Reasons To Change From Open To Endovascular Aortic Aneurysm Repair In Patients With Heritable Aortic Disease (Connective Tissue Disorders): When Is Open Repair Mandatory In This Setting; Technical Tips
  Presenter(s):Michael J. Jacobs, MD  
2:30 PM - 2:35 PM Value Of F/B/EVAR In The Management Of Failed Open Repairs Of Complex AAAs In Patients With Heritable Aortic Disease: Technical Tips
  Presenter(s):Barend M.E. Mees, MD, PhD, FEBVS / Geert Willem H. Schurink, MD, PhD / Michael J. Jacobs, MD  
2:36 PM - 2:41 PM Why Selection Of Bridging Stent-Graft Type Is Vitally Important For F/B/EVAR Treatment Of Complex AAAs In Patients With Heritable Aortic Disease: Which Stent-Graft Is Best
  Presenter(s):Gustavo S. Oderich, MD, FACS / Carlos H. Timaran, MD / Andres Schanzer, MD  
THE EFFECT OF AAA SAC THROMBUS LOAD
2:42 PM - 2:47 PM DEBATE: Large Flow Luminal Space In An AAA Sac With Minimal Mural Thrombus Is Associated With Adverse Events After EVAR: It Is More Important Than AAA Sac Size: Thrombus May Be Protective
  Presenter(s):Hence J.M. Verhagen, MD, PhD  
2:48 PM - 2:53 PM DEBATE: Large Amount Of AAA Sac Thrombus Promotes Morbidity Without Rupture And With Rupture: By What Mechanisms Is Thrombus Harmful And How Can Thrombus Load Be Quantitated
  Presenter(s):David H. Deaton, MD, FACS  
2:54 PM - 2:59 PM Update On Technical Tips To Perform SAFE Large Sheath Percutaneous Femoral Access And Closure For Complex AAA EVAR In Obese Or Scarred Groins – Even With Calcified Arteries: It Is Almost Always Possible
  Presenter(s):Barend M.E. Mees, MD, PhD, FEBVS  
3:00 PM - 3:05 PM Lessons Learned From The Nellix Experience: Why Sac Sealing Should Still Be Pursued For EVAR, But Not From The Nellix Platform: What Changes Would Make Sac Sealing Devices Work
  Presenter(s):Matt M. Thompson, MD  
3:06 PM - 3:12 PM Panel Discussion
3:12 PM - 3:24 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 44
 
SESSION 45 SCHEDULE
Wednesday
SESSION 45: MORE HOT AORTIC TOPICS
x
3:24 PM - 3:29 PM What's New And What's Wrong With The New SVS Guidelines For Aortic Surgery
  Presenter(s):Michael C. Stoner, MD  
3:30 PM - 3:35 PM Aorto-Enteric Fistulas Associated With Infected EVARs Or Open Prosthetic Grafts: What Are The Differences Between Them And What Are The Implications For Treatment
  Presenter(s):Sal Scali, MD  
3:36 PM - 3:41 PM Active AAA Sac Management With Polymer Plugs: How To Use Them To Improve Outcomes By Preventing Endoleaks After EVAR: Results From The SHAPE AAA Trial (From Shape Memory)
  Presenter(s):Andrew Holden, MBChB  
3:42 PM - 3:47 PM Fenestrated And Branched Graft Treatment Of Failed Open TAAA Repairs
  Presenter(s):Mazin Foteh, MD  
3:48 PM - 3:53 PM Aortic Dissection Tear Size And Morphology: Why Is It Important: How Do Bare Stents Prevent Stent-Graft Induced New Entry Tears (SINEs) After Treatment Of Aortic Dissections
  Presenter(s):Shang Loh, MD  
3:54 PM - 3:59 PM Panel Discussion
4:00 PM - 4:05 PM Coil Embolization To Treat Aortic ‘Blebs’, Entry-Tears And Pseudoaneurysms: How Does It Work, When Is It Indicated, And Results
  Presenter(s):Jos C. van den Berg, MD, PhD  
4:06 PM - 4:11 PM Endovascular Treatment In Patients With Connective Tissue Disorders: When Can This Be Considered First Choice Treatment: Technical Tips And Results
  Presenter(s):Piergiorgio Cao, MD, FRCS  
4:12 PM - 4:17 PM Endovascular Management For Isolated Abdominal Aortic Dissection: When To Treat Invasively And When Not; What To Do If It Involves The Juxtarenal Aorta: How Does Treatment Differ From That Of AAAs
  Presenter(s):Chang Shu, MD  
4:18 PM - 4:23 PM What Modifications Of The Distal Components Of F/EVAR Endografts Help To Avoid Branch Vessel Stent-Graft Compression: Indications And Results
  Presenter(s):Nuno V. Dias, MD, PhD  
4:24 PM - 4:29 PM Lipophilic Statins Like Lipitor Increase Risk Of Paraplegia More Than Hydrophilic Statins Like Crestor After B/EVAR For TAAA Repairs: What Is The Mechanism
  Presenter(s):Jade S. Hiramoto, MD  
4:30 PM - 4:35 PM Panel Discussion
END OF SESSION 45
 
SESSION 46 SCHEDULE
Wednesday
SESSION 46: MORE SHORT HOT NEW TOPICS RELATED TO AORTC DISEASE AND ITS TREATMENT
x
4:36 PM - 4:41 PM DEBATE Round 3: The Vast Majority Of Failed EVARs Can Be Treated Endovascularly
  Presenter(s):Ross Milner, MD  
4:42 PM - 4:47 PM DEBATE Round 3: Not So: Many Failed EVARs Are Best Repaired By Open Conversion
  Presenter(s):Michel Makaroun, MD  
4:48 PM - 4:53 PM Are Low Profile Devices For EVAR And TEVAR Improving Or Worsening Their Outcomes
  Presenter(s):Naoki Fujimura, MD, PhD  
4:54 PM - 4:59 PM There Is No Doubt AAA Screening Saves Lives: Do We Need Changes In The Screening Criteria
  Presenter(s):Maarit Venermo, MD, PhD  
5:00 PM - 5:05 PM What Is The AS-Score And How Does It Influence SCI Risk After Endovascular TAAA Repair: What Can Be Done To Offset This
  Presenter(s):Tilo Koelbel, MD, PhD  
5:06 PM - 5:11 PM What Are The Differences Between The ACC/AHA And The European Guidelines On Ascending Aorta And Arch Disease
  Presenter(s):Ourania Preventza, MD  
5:12 PM - 5:17 PM Panel Discussion
5:18 PM - 5:23 PM 10 Years Of PMEGs For Complex AAAs: How Do The Results Vary With And Without An IDE, The Extent Of The AAA And With And Without A Prior EVAR
  Presenter(s):Marc L. Schermerhorn, MD  
5:24 PM - 5:29 PM With Esophageal Cancer, When Is Prophylactic TEVAR Indicated To Prevent An Aorto-Esophageal Fistula: It Improves Palliation But Does It improve Survival
  Presenter(s):I-Hui Wu, MD, PhD  
5:30 PM - 5:35 PM Small Tips And Modifications In Radiation Safety Can Make A Huge Impact On Staff Exposure: What Are They And How Can They Be Enforced
  Presenter(s):Maarit Venermo, MD, PhD  
5:36 PM - 5:41 PM Pediatric Abdominal Aortic Aneurysms: What Is Their Etiology And How Should They Be Managed
  Presenter(s):Sherene Shalhub, MD, MPH  
5:42 PM - 5:47 PM B/EVAR In Patients With A Narrow Paravisceral Aorta (<2.5 cm) Is Best Performed With Inner Branched Endografts: Technical Tips To Achieve Optimal Results
  Presenter(s):Michele Antonello, MD, PhD / Franco Grego, MD  
5:48 PM - 5:53 PM ZFEN Versus Treo Endografts As Platforms For PMEG F/EVARs: Which Is Best And When: Technical Considerations, Advantages And Disadvantages
  Presenter(s):Joshua D. Adams, MD  
5:54 PM - 5:59 PM When Can Duplex Ultrasound Fully Replace CT Surveillance After EVAR: When Is CT Surveillance Necessary
  Presenter(s):Sal Scali, MD  
6:00 PM - 6:10 PM Panel Discussion
End of Program F

END OF SESSION 46
 
SESSION 47 SCHEDULE
Thursday
SESSION 47: EXCITING NEW OR REDISCOVERED TECHNIQUES, DEVICES, CONCEPTS
x
6:50 AM - 6:55 AM A Patient-Centric Smartphone App For Monitoring Vascular And Endovascular Procedures: What Does It Measure And How Is It Helpful
  Presenter(s):Todd R. Vogel, MD, MPH  
6:56 AM - 7:01 AM A New Robotic Device (From Sentante) To Assist With Endovascular Treatments: It Can Accommodate 3 Devices At Once And Be Operated From A Great Distance
  Presenter(s):Gary M. Ansel, MD  
7:02 AM - 7:07 AM Pediatric Vascular And Endovascular Surgery Is A New Subspecialty Within Vascular Surgery: In Pediatric Patients How Important Are Endovascular Techniques, What Modifications Are Needed And Why Most Aortic Lesions Need To Be Treated By Open Surgery
  Presenter(s):Alex Fairman, MD  
7:08 AM - 7:13 AM Management Of Pediatric Arterial And Aortic Aneurysms In 2024: Differing Etiologies Necessitating Different Therapeutic Interventions
  Presenter(s):James C. Stanley, MD  
7:14 AM - 7:19 AM Update On Remote Monitoring Of Vascular Graft Function And Other Parameters Including Blood Pressure: Where Is It At And Where Is It Going
  Presenter(s):Richard F. Neville, MD  
7:20 AM - 7:25 AM Effect Of Increased Hydration And Protein Intake On Lower Extremity Arteriosclerotic Ischemia With Intermittent Claudication And CLTI: What Is The Evidence And The Mechanism: Will It Change The Game And Decrease The Need For Stents And Bypasses
  Presenter(s):Juan C. Parodi, MD / Samuel Fernandez, MD  
7:26 AM - 7:31 AM Panel Discussion
7:32 AM - 7:37 AM Provider Skill Is Not Appropriately Recognized And Rewarded In The Health Care Value Equation Of Value = Outcome/Cost: Even Within A Specialty All Doctors Are Not Equal: There Are Stars, Superstars And Journeymen: What To Do About It
  Presenter(s):Lars B. Lonn, MD, PhD  
7:38 AM - 7:43 AM Can Advances In MRI Eliminate Radiation From AAA Diagnosis, Its Endovascular Treatment And Its Follow Up: The Zero Radiation Project And Where It Stands
  Presenter(s):Kak Khee Yeung, MD, PhD  
7:44 AM - 7:49 AM How And Why Do Thoracic Endografts For TEVAR Negatively Affect The Blood Pressure And The Heart: Can A Compliant Endograft Prevent The Problem; How Should It Be Made
  Presenter(s):Juan C. Parodi, MD  
7:50 AM - 7:55 AM The Negative Impact On Cardiovascular Hemodynamics: Lessons Of TEVAR, F/EVAR, B/EVAR And EVAR: What Causes The Problem And What Can Be Done To Fix It
  Presenter(s):Sherif A.H. Sultan, MD, FRCS, EBQS-VASC, PhD, FACS  
7:56 AM - 8:01 AM Current Status And Future Potential Of Pig To Human Organ Xenografting
  Presenter(s):Robert A. Montgomery, MD, D Phil  
8:02 AM - 8:07 AM Panel Discussion
END OF SESSION 47
 
SESSION 48 SCHEDULE
Thursday
SESSION 48: PROGRESS IN FENESTRATED AND BRANCHED EVAR (F/B/EVAR) AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
x
8:08 AM - 8:13 AM Outcomes Of Leaving The Celiac Trunk Without A Stent Or Stent-Graft During 4 Vessel F/EVAR: Why A Stent Is Unnecessary And Can There Be Problems With Wires Across The Celiac Or SMA Orifices
  Presenter(s):Timothy A. Resch, MD, PhD  
8:14 AM - 8:19 AM Value Of Parallel Endografts In The Management Of TAAAs And Other Aortoiliac Pathology: Why Do They Fail And How To Make Them Work
  Presenter(s):David J. Minion, MD  
8:20 AM - 8:25 AM Complete Aortic Endovascular Repairs For Zones 0-10 Using Parallel Endografts With A Docking Station: How And Why To Make Them Work Effectively Despite Doubts About Parallel Grafts: What Are The Limitations
  Presenter(s):Manish Mehta, MD, MPH  
8:26 AM - 8:31 AM DEBATE: Long-Term Results Of F/EVAR For Juxta- And Pararenal AAAs: Data From ARC Show That It Should Be The Procedure Of Choice
  Presenter(s):Andres Schanzer, MD  
8:32 AM - 8:37 AM DEBATE: Not So: Other Data Including A Meta-Analysis Indicates That We Still Need An RCT Versus Open Repair To Determine The Best Treatment For Juxta- And Pararenal AAAs
  Presenter(s):Ian Loftus, MD  
8:38 AM - 8:44 AM Panel Discussion
8:45 AM - 8:50 AM Why Balloon Expandable Bridging Stent-Grafts Are Best For F/B/EVAR: Which One Is Best And Why: A US Perspective: Advantages Of The Gore VBX Stent-Graft
  Presenter(s):Mark A. Farber, MD  
8:51 AM - 8:56 AM Which Bridging Covered Stents Or Stent-Grafts Work Best For F/B/EVAR: A European Perspective: Why Renal Artery Bridging Stent-Grafts Are The Achilles Heel In B/EVAR And What To Do About It
  Presenter(s):Martin J. Austermann, MD  
8:57 AM - 9:02 AM The Role Of Open Surgery As Both An Adjunct And Bailout For Failed F/B/EVAR Procedures For Complex AAAs: How To Choose Between Endo And Open Repairs As The Primary Procedure
  Presenter(s):Bijan Modarai, PhD, FRCS  
9:03 AM - 9:08 AM Aneurysm Rupture During The Interval Of Staged Endovascular TAAA Repairs: How Frequent Is It And What Can Be Done To Prevent It: Optimal Delay For Stage 2
  Presenter(s):Randall R. De Martino, MD / Bernardo C. Mendes, MD  
9:09 AM - 9:14 AM Evolving Roles Of In Situ Laser F/EVAR For TAAA Repairs: Technical Tips And Results
  Presenter(s):Sukgu Han, MD  
9:15 AM - 9:23 AM Panel Discussion
9:23 AM - 9:38 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 48
 
SESSION 49 SCHEDULE
Thursday
SESSION 49: MORE PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
x
9:38 AM - 9:43 AM The Value Of Intraoperative Cone Beam CT During F/B/EVAR: What Defects Can Be Detected That Would Otherwise Be Missed: What Equipment Is Required
  Presenter(s):Nuno V. Dias, MD, PhD  
9:44 AM - 9:49 AM Causes Leading To Branch Leaks And Occlusions After F/B/EVAR: What Forces Are Important And What Can Be Done To Prevent Them
  Presenter(s):Thomas L. Forbes, MD  
9:50 AM - 9:55 AM Update On Optimal Bridging Stent-Grafts For F/B/EVAR: Advantages And Disadvantages Of The BeGraft, BeGraft Plus (Bentley) And Advanta (iCast – Getinge): Experience With >2,000 Target Vessels
  Presenter(s):Eric L.G. Verhoeven, MD, PhD / Athanasios Katsargyris, MD  
9:56 AM - 10:01 AM Percutaneous Axillary And Femoral Access For Various Parts Of Complex Endovascular AAA Repair: How To Do Them Safely And How To Downsize Femoral Sheaths To More Rapidly Restore Lower Extremity Flow: Why Is It Important
  Presenter(s):Darren B. Schneider, MD  
10:02 AM - 10:07 AM Prediction Of 1-Year Mortality After Endovascular TAAA Repair: When Should We NOT Offer The Procedure
  Presenter(s):Adam Beck, MD  
10:08 AM - 10:13 AM Panel Discussion
10:14 AM - 10:19 AM Reasons For And Outcomes Of Open AAA Repair In A High Volume Endovascular Center
  Presenter(s):Athanasios Katsargyris, MD / Eric L.G. Verhoeven, MD, PhD  
10:20 AM - 10:25 AM F/EVAR Versus Ch/EVAR For Juxtarenal AAAs: How Do The Results Compare After Up To 8 Years Follow-Up In A Real World Experience
  Presenter(s):Ignacio Escotto, MD  
10:26 AM - 10:31 AM Parallel Endografts For Aortoiliac Lesions: The Good, The Bad And The Ugly: A Balanced View
  Presenter(s):Grace J. Wang, MD, MSCE  
10:32 AM - 10:37 AM Why Is A Distal AUI The Preferred Approach For ZFEN F/EVAR Treatment Of Failed EVAR Devices: When And How To Do It And Outcomes
  Presenter(s):Martin R. Back, MD  
10:38 AM - 10:43 AM With Failed EVAR, When Is F/EVAR The Best Treatment: Tips And Tricks For Performing It Successfully
  Presenter(s):Andres Schanzer, MD  
10:44 AM - 10:49 AM Tips For Beginners To Avoid Traps When Starting A F/BEVAR Program: It Is Doable But Not Simple
  Presenter(s):Piotr Myrcha, MD  
10:50 AM - 10:56 AM Panel Discussion
END OF SESSION 49
 
SESSION 50 SCHEDULE
Thursday
SESSION 50: A TRIBUTE TO OUR MILITARY AND MILITARY PHYSICIANS: SOME MILITARY HISTORY; TREATMENT OF MILITARY AND CIVILIAN VASCULAR INJURIES AND CONTROL OF HEMORRHAGE; UPDATE ON REBOA
x
10:56 AM - 11:06 AM The Battle of Midway: How It Saved The United States And The World
  Presenter(s):Wayne F. Yakes, MD  
11:07 AM - 11:12 AM Update On A Vascular Surgeon’s Impressions About The Devastating Ukraine War: What Is Happening With Major Vascular Injuries
  Presenter(s):Andriy O. Nykonenko, MD / Oleksandr Sokolov, MD, PhD  
11:13 AM - 11:18 AM What Is Happening With Major Vascular Injuries To Civilians During The Ukraine War: Are The Resources And Medical Personnel Adequate: Are The US And Western Europe Doing Enough
  Presenter(s):Yuliia Nahaliuk , MD  
11:19 AM - 11:24 AM What Has Been The Impact Of The War In Israel On Health Care And Trauma Management For Its Civilian Population
  Presenter(s):Gabriel Szendro, MD  
11:25 AM - 11:30 AM Lessons Learned On Treating Major Military And Civilian Vascular Trauma From The October 7th Attack On Israel And Its Combat Aftermath
  Presenter(s):Samy S. Nitecki, MD  
11:31 AM - 11:36 AM How The US Military Pursued A Policy Of Zero Preventable Combat Deaths From Wounds In Iraq And Afghanistan: Leave No One Behind: How It Applies To Civilian Casualties
  Presenter(s):Todd E. Rasmussen, MD, FACS  
11:37 AM - 11:42 AM Update On Isolated Limb Perfusion To Enable Traumatically Amputated Limb Reimplantation
  Presenter(s):Zachary M. Arthurs, MD  
11:43 AM - 11:48 AM Progress In Resuscitation And Endovascular Trauma Management With Catheter Based Treatments Including REBOA And Other Devices: What Is Partial And Intermittent REBOA And What Is Their Value
  Presenter(s):Tal M. Hoerer, MD, PhD  
11:49 AM - 11:54 AM When Is REBOA A Valuable Procedure And When Is It Not: Limitations And Precautions: Does It Have Value In Conditions Other Than Trauma
  Presenter(s):Joseph J. DuBose, MD  
11:55 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – Rhinelander Gallery, 2nd Floor
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 50
 
SESSION 51 SCHEDULE
Thursday
SESSION 51: PROGRESS IN THE TREATMENT OF RUPTURED INFRARENAL AAAs, COMPLEX AAAs, TAAAs AND RELATED TOPICS
x
1:00 PM - 1:05 PM How Can The Turndown Rate For Invasive Treatment Of Ruptured AAAs Be Decreased And Is It Worthwhile
  Presenter(s):Matthew W. Mell, MD, MS  
1:06 PM - 1:11 PM

Power Point Presentation with Synched Audio
Selection Of Patients With Ruptured AAAs For Noninvasive (Comfort) Care Based On Scoring System Or Advanced Age Is Inappropriate And Unfair To Some Patients
  Presenter(s):Isabelle Van Herzeele, MD, PhD  
1:12 PM - 1:17 PM Only One-Third Of Ruptured AAA Patients In The 3 RCTs Comparing EVAR With Open Repair Were Randomized: Why Does This And Other Flaws Invalidate The RCT Conclusions: RCTs Can Be Misleading
  Presenter(s):Thomas L. Forbes, MD  
1:18 PM - 1:23 PM Long-Term Results Of The AJAX RCT Comparing EVAR With Open Repair For Ruptured AAAs: Despite Its Flaws, EVAR Wins In The End – Especially In Patients >80
  Presenter(s):Willem Wisselink, MD  
1:24 PM - 1:29 PM Reasons Why The Use Of Open Repair Versus EVAR For Ruptured AAAs Still Varies Greatly Even Though EVAR Has Been Proven Superior: Bias Rules
  Presenter(s):Martin Malina, MD, PhD  
1:30 PM - 1:35 PM Update On Treating All (100%) Ruptured AAAs, Complex AAAs And Thoracic Aneurysms Endovascularly: A 15-Year Experience Shows This Is The Best Treatment And Lowers The Turndown Rate: What Adjuncts May Be Necessary To Achieve This
  Presenter(s):David T. McGreevy, MD, PhD / Tal M. Hoerer, MD, PhD  
1:36 PM - 1:41 PM Aortic Endograft Diameter Sizing With Ruptured Aneurysms: Why Is It Different And How To Do It
  Presenter(s):Zoran Rancic, MD, PhD, EMBA HSG  
1:42 PM - 1:47 PM Update On Advances In Treatment Of Abdominal Compartment Syndrome Associated With Ruptured AAAs: When And How To Treat Medically And When And How To Treat With Opening The Abdomen
  Presenter(s):Martin Björck, MD, PhD  
1:48 PM - 1:53 PM AAA Rupture After EVAR Behaves Differently From De Novo Rupture: How Should Treatment Be Modified In Patients With Post EVAR Ruptures
  Presenter(s):Piotr Szopinski, MD, PhD  
1:54 PM - 1:59 PM Panel Discussion
END OF SESSION 51
 
SESSION 52 SCHEDULE
Thursday
SESSION 52: MORE NEW DEVELOPMENTS IN TECHNIQUES OF ENDO TREATMENT OF RUPTURED AAAs, COMPLEX AAAs AND TAAAs; WHAT IS AND SHOULD BE HAPPENING WITH AAA SCREENING
x
CURRENT TECHNIQUES FOR TREATING RUPTURED ANEURYSMS
2:00 PM - 2:05 PM With Ruptured Complex AAAs And TAAAs Parallel Grafts Are The Best Treatment: They Are Simpler, More Effective And Less Costly Than Other Treatments
  Presenter(s):Manish Mehta, MD, MPH  
2:06 PM - 2:11 PM In Situ Laser Fenestration For Endovascular Treatment Of Complex Ruptured AAAs: What Equipment Is Needed: When Is It Feasible And Why Is It Better Than Other Treatments: Technical Tips
  Presenter(s):Anders Wanhainen, MD, PhD  
2:12 PM - 2:17 PM Physician Modified Endografts (PMEGs) And Off-The-Shelf (OTS) Devices Are Both Options For Urgent/Emergent Treatment Of Ruptured Complex AAAs: Technical Tips
  Presenter(s):Bernardo C. Mendes, MD / Gustavo S. Oderich, MD, FACS  
2:18 PM - 2:23 PM Modifications Of The TREO-FIT Endograft (Terumo) For EVAR That Make It Suitable For Physician Modification (PMEGs) For Use In Emergent And Ruptured Juxtarenal AAAs
  Presenter(s):Benjamin W. Starnes, MD  
2:24 PM - 2:29 PM Applicability And Results Of Cook t-Branch OTS Endograft In Complex Ruptured AAAs: Advantages And Limitations
  Presenter(s):Ciro Ferrer, MD, PhD / Rocco Giudice, MD  
2:30 PM - 2:35 PM Outcomes Of A Novel Off-The-Shelf Inner Branch Stent-Graft (E-nside From Artivion) For Urgent TAAA Repair: Insights From An Italian Multicenter Registry
  Presenter(s):Rocco Giudice, MD  
2:36 PM - 2:41 PM For Treatment Of Ruptured Complex AAAs A Short Custom Made Single Fenestrated Graft Can Be Used To Revascularize The SMA Followed By A Bifurcated Graft And Laser Fenestration For The Renal Arteries: Technique And Experience
  Presenter(s):Nuno V. Dias, MD, PhD  
2:42 PM - 2:47 PM Panel Discussion
2:48 PM - 2:53 PM A Transvenous (Transcaval) Approach To Endovascular Repair Of Ruptured Thoracic Aneurysms And TAAAs In Patients With Poor Arterial Access: Technical Tips And Can One Deal With Aortic Bifurcation Lesions
  Presenter(s):Tilo Koelbel, MD, PhD  
2:54 PM - 2:59 PM Open Retroperitoneal Aortic Approach For Ruptured AAAs: Technical Tips, Advantages And Limitations: When Is It Better Than EVAR And F/EVAR
  Presenter(s):R. Clement Darling III, MD  
NEW DEVELOPMENTS IN AAA SCREENING
3:00 PM - 3:05 PM Update On Current Screening For AAAs In The US: Most Ruptured AAAs Occur In Patients Not Being Screened: How Should US PSTF Recommendations Be Changed And How Should Screening Groups Be Expanded
  Presenter(s):Marc L. Schermerhorn, MD / Thomas F.X. O'Donnell, MD  
3:06 PM - 3:11 PM New Developments In AAA Screening: Should We Change Who Is Being Screened
  Presenter(s):Jes S. Lindholt, MD  
3:12 PM - 3:17 PM The Future Of AAA Screening: The Changing Epidemiology Especially Persistent Declining Prevalence Mandates Changes In Screening Recommendations
  Presenter(s):Anders Wanhainen, MD, PhD  
3:18 PM - 3:24 PM Technical Tips To Deploy F/EVAR Endografts Precisely With Tortuous Anatomy: How To Compensate For Endograft Rotation And Still Match Fenestrations To Branch Orifices Perfectly
  Presenter(s):Neal S. Cayne, MD / Bjõrn Sonesson, MD, PhD  
3:24 PM - 3:36 PM Panel Discussion And Break
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 52
 
SESSION 53 SCHEDULE
Thursday
SESSION 53: EXCITING NEW OR UPDATED CONCEPTS, TECHNIQUES AND TREATMENTS
x
3:36 PM - 3:41 PM Update On External Sirolimus Patch Wrap-Arounds For PTFE Graft Anastomoses: Do They Decrease Intimal Hyperplasia And Improve Prosthetic Graft Patency
  Presenter(s):Sriram S. Iyer, MD, FACC  
3:42 PM - 3:47 PM Implantable Carotid Stent-Like Device To Stimulate The Carotid Sinus Nerve (Of Hering) And Treat Intractable CHF And Hypertension (The Barostim System): Current Clinical Status
  Presenter(s):Fred A. Weaver, MD, MMM / John F. Eidt, MD / Miguel Manzur, MD  
3:48 PM - 3:53 PM Reducing Fiber And Lint Contamination During Endovascular And Surgical Procedures: Why Is It Important And How To Prevent it
  Presenter(s):John R. Laird, MD  
3:54 PM - 3:59 PM Value Of Prostate Artery Embolization For BPH: Indications, Technique And Results
  Presenter(s):Lars B. Lonn, MD, PhD  
4:00 PM - 4:05 PM Peripheral Embolization With TEVAR And EVAR Procedures: How Widespread And Important Is It And An Update On Devices To Prevent It
  Presenter(s):Ralf R. Kolvenbach, MD  
4:06 PM - 4:11 PM Cancer Incidence After Lower Extremity Bypass Surgery: How Does It Affect Long-Term Outcome In Patients With CLTI: Why The Relationship With Cancer Exists
  Presenter(s):Dittmar Boeckler, MD  
4:12 PM - 4:17 PM Special Technical Tips For The Management Of Pediatric Vascular Trauma And Emergencies: Evolving Endovascular Strategies, Expanded Device Availability, And How To Deal With Spasm
  Presenter(s):Dawn M. Coleman, MD, FACS  
4:18 PM - 4:23 PM Visceral Arterial Compression Syndromes And Their Relationship To Genetic Disorders: Current Optimal Diagnosis And Treatment
  Presenter(s):Prof. Dr. Med Wilhelm Sandmann, MD  
4:24 PM - 4:29 PM High Resolution Infrared Thermography To Detect Vascular Pathology: How Does It Work And How Does It Help
  Presenter(s):Ivo Petrov, MD, PhD  
4:30 PM - 4:37 PM Panel Discussion
END OF SESSION 53
 
SESSION 54 SCHEDULE
Thursday
SESSION 54: PROGRESS IN RADIATION SAFETY AND MORE NEW CONCEPTS, DEVICES AND TECHNIQUES
x
4:38 PM - 4:43 PM Intravascular Lithotripsy (From Shockwave): A New Valuable Tool To Facilitate Access For Large Sheaths In F/BEVAR
  Presenter(s):Eric L.G. Verhoeven, MD, PhD / Athanasios Katsargyris, MD  
WHAT’S NEW IN RADIATION SAFETY
4:44 PM - 4:49 PM The Occupational Hazards Of The Pregnant Surgeon: What Modifications In Practice And Techniques Are Necessary To Avoid Or Minimize Them
  Presenter(s):Venita R. Chandra, MD  
4:50 PM - 4:55 PM Myths And Facts Regarding Radiation Protection And Safety: Imperfections In Protection From Leaded Glasses, Caps, Gloves And Light Weight Leaded Gowns
  Presenter(s):Lindsay Machan, MD  
4:56 PM - 5:01 PM Improved Radiation Protection With The Protego System: What Is It, How Does It Work; Experience And Results With Operators, Staff And Patients
  Presenter(s):Venkatesh G. Ramaiah, MD  
NEW CONCEPTS, ETC.
5:02 PM - 5:07 PM Endovascular Options For The Control Of Submassive And Massive Hemoptysis: It Is Lifesaving: When And How To Do It: Coils Are Required
  Presenter(s):Jacob Cynamon, MD, FACR, FSIR  
5:08 PM - 5:13 PM What’s New In Gene And Stem Cell Therapy For No Option CLTI In 2024: Are There Technologies And Trials That Hold Promise – Like BioGenCell
  Presenter(s):Richard J. Powell, MD / Yael Porat, PhD  
5:14 PM - 5:19 PM Panel Discussion
5:20 PM - 5:25 PM The Aortyx Aortic Patch: A More Compliant Way Than TEVAR To Seal Aortic Defects With TBADs And Other Lesions: A New Endovascular Approach: How Does It Work: Improved Delivery System And Progress To Date
  Presenter(s):Vicente Riambau, MD, PhD  
5:26 PM - 5:31 PM Disseminated Fungal Infections Of The Vascular System: Why Are They Important And How Should They Be Diagnosed And Treated
  Presenter(s):Sateesh C. Babu, MD  
5:32 PM - 5:37 PM Endovascular Emergency Treatment Of Carotid Blowout From Head And Neck Cancer Or Carotid Patch Infections: Planning, Preparation And Technical Tips Are Essential
  Presenter(s):Michael B. Silva, Jr., MD  
5:38 PM - 5:43 PM Gore Excluder Iliac Branch Endoprosthesis (IBE) Extension Into The Gluteal Artery To Treat Hypogastric Aneurysms: Technique And Mid-Term Results
  Presenter(s):Mark W. Mewissen, MD, FSIR, RVT  
5:44 PM - 5:49 PM Best Bridging Stent Selection For The Gore Excluder Iliac Branch Endoprosthesis (IBE): What Works And What Doesn’t
  Presenter(s):Steven Maximus, MD / Gustavo S. Oderich, MD, FACS  
5:50 PM - 6:00 PM Panel Discussion
End of Program G

END OF SESSION 54
 
SESSION 55 SCHEDULE
Thursday
SESSION 55: NEW OR IMPROVED DEVICES FOR INFRARENAL AAA REPAIR WITH STANDARD EVAR
x
7:00 AM - 7:05 AM Updated Results From The AFX 2-LIVE European Registry: An Experience With The Outcomes Of >500 AFX EVAR Cases: Benefits, Complications, Conversions And Technical Considerations
  Presenter(s):Francesco Speziale, MD  
7:06 AM - 7:11 AM Current Status Of The AFX 2 Endograft (From Endologix) For EVAR: Is Increased Surveillance Indicated
  Presenter(s):Robert W. Chang, MD  
7:12 AM - 7:17 AM Are We Overtreating AAAs: The Current Diameter Thresholds For AAA Repair (5.5 cm For Men; 5.0 cm For Women) Are No Longer Relevant: Based On New Scrutiny Of Old Trials And A Meta-Analysis Of AAA Rupture Risk
  Presenter(s):Timothy A. Resch, MD, PhD  
7:18 AM - 7:23 AM Mid-Term Results Of The Alto (Ovation) Low Profile Endograft (From Endologix): Advantages And Current Role In Treating AAAs
  Presenter(s):Gianmarco de Donato, MD  
7:24 AM - 7:29 AM Comparison Of Excluder Versus Endurant Endografts For EVAR: Which Graft Is Best And In What Circumstances: From A Multicenter Propensity Score Matched Study
  Presenter(s):Naoki Fujimura, MD, PhD  
7:30 AM - 7:35 AM Panel Discussion
7:36 AM - 7:41 AM Gore Conformable Excluder For EVAR: Advantages And Indications: From The European EXCeL Registry
  Presenter(s):Marc R.H.M. van Sambeek, MD, PhD  
7:42 AM - 7:47 AM How To Optimize Infrarenal Aortic Neck Sealing With Short Or Angulated Necks (>60-90 Degrees) Without Placing Branches In The Renals: The Unique Features Of The Gore Excluder Conformable AAA Endograft: >1 Year Results
  Presenter(s):Robert Y. Rhee, MD  
7:48 AM - 7:53 AM New Polymer Filled Low Profile Endograft Device With O-Ring Sealing: Advantages, How Does It Work And Why Is It Better In Patients With Complex Proximal Neck Anatomy
  Presenter(s):Piotr Szopinski, MD, PhD  
7:54 AM - 7:59 AM 10-Year Results With The Gore Excluder Endograft For EVAR Show Its Durability: From The GREAT Registry
  Presenter(s):Eric L.G. Verhoeven, MD, PhD / Athanasios Katsargyris, MD  
8:00 AM - 8:05 AM Mid-Term Results Of EVAR With Endoanchors In Patients With Hostile Neck Anatomy: Do They Work Better When Used Prophylactically Or Therapeutically: Do They Work Equally Well With All Endografts
  Presenter(s):Apostolos K. Tassiopoulos, MD  
8:06 AM - 8:11 AM Panel Discussion
END OF SESSION 55
 
SESSION 56 SCHEDULE
Thursday
SESSION 56: NEW OR UPDATED DEVICES FOR STANDARD EVAR OR F/B/EVAR
x
STANDARD EVAR DEVICES
8:12 AM - 8:17 AM Five-Year Results And Advantages Of The TREO (Terumo) Endograft For Standard EVARs: Status In The US
  Presenter(s):Matthew J. Eagleton, MD  
8:18 AM - 8:23 AM Real World Outcomes With The TREO Endograft (Terumo Aortic): Results From The European TIGER Registry
  Presenter(s):Vicente Riambau, MD, PhD  
8:24 AM - 8:29 AM Status Of The Low Profile Alto Endograft (From Endologix) With More Proximal Polymer Sealing Rings For Standard EVAR: Up To 5-Year Results Show Its Advantages: Status Of The JAGUAR RCT Comparing It With Standard EVAR Endografts
  Presenter(s):Sean P. Lyden, MD / Christopher J. Kwolek, MD, MBA / Andrew Holden, MBChB  
8:30 AM - 8:35 AM AFX 2 Anatomically Fixed (On The Aortic Bifurcation) Endografts For AAA Repair: The LEOPARD RCT 5-Year Results Show It Has Similar Outcomes To Other Widely Used Proximally Fixed Endografts
  Presenter(s):Christopher J. Kwolek, MD, MBA  
F/B/EVAR TOPICS FOR COMPLEX AAAs
8:36 AM - 8:41 AM Comparison Of Various Fenestrated Endografts From Cook, Terumo, Etc.: Advantages And Limitations Of Each
  Presenter(s):Sonia Ronchey, MD, PhD  
8:42 AM - 8:47 AM Real World Evaluation Of The OTS Pre-Cannulated Inner Branched Endograft (E-nside From Artivion) For Pararenal Aortic Aneurysms: Advantages And Limitations
  Presenter(s):Lee Bouwman, MD, PhD / Theodosios Bisdas, MD  
8:48 AM - 8:53 AM One-Year Outcomes Of The Fenestrated Anaconda (Terumo Aortic) Endograft For Treating Complex AAAs From The GLOBAL FACT Study: What Makes This Endograft Different: Advantages And Limitations
  Presenter(s):Clark J. Zeebregts, MD, PhD  
8:54 AM - 8:59 AM Retrospective Analysis Of Laser In Situ Fenestration Of All Endografts: What Does The LIFE Registry Show
  Presenter(s):Jonathan Bath, MD  
9:00 AM - 9:06 AM Panel Discussion
9:06 AM - 9:19 AM Break - Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 56
 
SESSION 57 SCHEDULE
Thursday
SESSION 57: NEW OR IMPROVED DEVICES FOR THORACOABDOMINAL ANEURYSM (TAAA) REPAIRS AND THORACIC AORTIC LESION REPAIRS (TEVAR)
x
IMPROVED DEVICES FOR TAAA REPAIRS
9:20 AM - 9:25 AM Progress With A New Hybrid Device (Thoracoflo From Terumo Aortic) For TAAA Repair: How It Works, Clinical Experience And Advantages
  Presenter(s):Sebastian E. Debus, MD, PhD / Sabine H. Wipper, MD, PhD / Randy D. Moore, MD  
9:26 AM - 9:31 AM Value Of Endo TAAA Repair In Patients With Connective Tissue Disorders: Which Device Or Devices Are Best And Why
  Presenter(s):Gustavo S. Oderich, MD, FACS  
9:32 AM - 9:37 AM Comparison Of The Cook t-Branch OTS Endograft Device With The E-nside (Artivion) Multibranched Device For Juxta- And Pararenal AAAs And TAAAs: Advantages And Limitations Of Each
  Presenter(s):Matteo Orrico, MD / Nicola Mangialardi, MD  
9:38 AM - 9:43 AM Optimizing Endovascular Treatment Of TAAAs With The Cook OTS t-Branch Endograft: Technical Tips And Contraindications
  Presenter(s):Marcelo Ferreira, MD  
9:44 AM - 9:49 AM Current Status And Results With Manifold Branched Grafts For TAAA Repairs: What Are They: What Are Their Limitations And Why Haven’t They Been Commercialized
  Presenter(s):Murray L. Shames, MD / Patrick W. Kelly, MD  
9:50 AM - 9:55 AM Treatment Of Narrow True Lumen In Chronic Aortic Dissection Using i-BEVAR E-nside OTS Endograft With Inner Branches (From Artivion): How Does IVUS Help
  Presenter(s):Giovanni Tinelli, MD, PhD / Dittmar Boeckler, MD  
9:56 AM - 10:01 AM Twinbranch – A New Approach: Evolution Of The Colt Manifold Device For TAAA Repairs To An Inner Branched Technology
  Presenter(s):Piotr Szopinski, MD, PhD  
10:02 AM - 10:07 AM Panel Discussion
IMPROVED DEVICES FOR TEVAR
10:08 AM - 10:13 AM Low Profile Devices For TEVAR And B/EVAR: Disadvantages And Advantages Based On A 10-Year Experience With Matched Patients
  Presenter(s):Giovanni B. Torsello, MD  
10:14 AM - 10:19 AM Current US Status And Results With The RelayPro NBS Endograft For TEVAR: Advantages And Limitations
  Presenter(s):Frank R. Arko, MD  
10:20 AM - 10:25 AM Details Of A Novel Low Profile Stent Graft For The TEVAR Treatment Of All Thoracic Aortic Segments: What Makes It Unique And Clinical Status
  Presenter(s):Francesco Setacci, MD  
10:26 AM - 10:31 AM Hybrid Repair Of Arch And Descending Aorta Lesions With The Thoraflex Device And RelayPro TEVAR Device: Technical Tips And Clinical Experience
  Presenter(s):Francis Caputo, MD  
10:32 AM - 10:37 AM Real World, Long-Term Results With Cook Zenith Alpha Thoracic Low-Profile Endograft: What Have We Learned
  Presenter(s):Germano C.G. Melissano, MD / Roberto L.V. Chiesa, MD  
10:38 AM - 10:43 AM The New Cook Custom Single Branch Endograft For TEVAR Of Lesions Close To Or Involving The LSA: Advantages And Results
  Presenter(s):Tilo Koelbel, MD, PhD  
10:44 AM - 10:49 AM Status Of And When And How To Use The Gore Conformable CTAG Endograft With Variable Angulation Control Optimally: Advantages And Limitations
  Presenter(s):Sukgu Han, MD  
10:50 AM - 11:00 AM Panel Discussion
END OF SESSION 57
 
SESSION 58 SCHEDULE
Thursday
SESSION 58: NEW OR IMPROVED DEVICES FOR THE ASCENDING AORTA, THE AORTIC ARCH OR NEAR THE ARCH AND TAAAs (SEE ALSO SESSIONS 1, 2, 3 AND 40 FOR RELATED TOPICS)
Moderators:Rodney A. White, MD / Weiguo Fu, MD  
x
11:00 AM - 11:05 AM Current Status And Results With Terumo Ascending Aorta Endograft: What Makes It Different And What Lesions Can It Treat
  Presenter(s):Vicente Riambau, MD, PhD / Afshin Assadian, MD / Mo S. Hamady, MD, FRCR, EBIR, FSIR  
11:06 AM - 11:11 AM Current Status In The US Of The Relay Branch Investigational Device (Terumo Aortic) For Endo Repair Of Aortic Arch Lesions: How Many Branches Can And Should Be Revascularized: Advantages And Limitations
  Presenter(s):Luis A. Sanchez, MD / Eric E. Roselli, MD  
11:12 AM - 11:17 AM Aortic Arch Endovascular Repairs: Which Device Is Best For Degenerative Aneurysms And For Dissection: Technical Tips
  Presenter(s):Javairiah Fatima, MD  
11:18 AM - 11:23 AM Update On Fenestrated Endovascular Aortic Repair Plus Chimney Graft For TAAA Repairs: The FEVAR/Ch Technique: When And How Is It Beneficial
  Presenter(s):Ross Milner, MD  
11:24 AM - 11:29 AM Changes In The Aortic Valve And Aortic Morphometrics After Ascending Aorta And Arch Endograft Placement: Why Are They Important And How Can They Be Avoided
  Presenter(s):Jean Bismuth, MD / Ross Milner, MD  
11:30 AM - 11:35 AM How To Manage Dissected Supra Aortic Trunks During Arch Branch Endovascular Repair
  Presenter(s):Stephan Haulon, MD  
11:36 AM - 11:41 AM Preloaded Fenestrated Endografts With A Modified Biport Handle (From Cook): A Way To Make F/EVAR Easier: Results From An International Multicenter Study
  Presenter(s):Nikolaos Tsilimparis, MD, PhD  
11:42 AM - 11:47 AM What Devices Are Best For Enabling Laser Fenestration For The Endo Treatment Of Arch Lesions: Is The Laser Hole In The Main Graft Made From Below Or Above: How Is The Brain Perfused After The Aortic Graft Is Deployed And Before The Hole Is Made
  Presenter(s):Jean M. Panneton, MD  
11:48 AM - 11:53 AM How To Accommodate For Main Endograft Length Discrepancy And Avoid Errant Coverage Of The Supra Aortic Trunks During Emergency Repair Of Ascending Aortic Lesions Coverage
  Presenter(s):Gustavo S. Oderich, MD, FACS / Steven Maximus, MD  
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – Rhinelander Gallery, 2nd Floor
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 58
 
SESSION 59 SCHEDULE
Thursday
SESSION 59: NEW OR UPDATED INFORMATION ON RE-ENTRY DEVICES, LOWER EXTREMITY PROSTHETIC GRAFTS (SEE ALSO SESSION 28) AND MANAGEMENT OF PERIGRAFT SEROMAS
x
A NEW LOOK AT RE-ENTRY DEVICES
1:00 PM - 1:05 PM Pros And Cons Of Re-Entry Devices In Treating CTOs: Why, Where And When To Use Them: Are They Worth The Cost And Have Other Techniques Like Retrograde Access Largely Replaced Them
  Presenter(s):Maria A. Ruffino, MD, EBIR, FCIRSE  
1:06 PM - 1:11 PM Re-Entry Devices Are Currently Almost Never Necessary: Techniques To Treat Lower Extremity Lesions Successfully Without Them: When Might They Be Needed
  Presenter(s):Ali Amin, MD, RVT, FACS, FACC  
PROSTHETIC GRAFTS
1:12 PM - 1:17 PM Final 5-Year Results Of The ZILVERPASS RCT Comparing Prosthetic PTFE Bypasses With Zilver PTX (Cook) Stents To Treat Long FemPop Lesions: Clinical And Financial Results And Their Implications
  Presenter(s):Michel J. Bosiers, MD / Marc Bosiers, MD  
1:18 PM - 1:23 PM PTFE Bypasses To Infrapopliteal Targets Can Be Worthwhile For Limb Salvage In Patients With End Stage CLTI: When Is This So And Technical Tips To Make Them Work
  Presenter(s):Matthew T. Menard, MD  
1:24 PM - 1:29 PM Heparin Coated (Propaten) PTFE Grafts (Gore) Versus Autologous Vein Grafts For Bypasses To Targets Above And Below The Knee: The Heparin Coated Grafts Are Better And Worth The Cost: Based On A Propensity Matched Analysis
  Presenter(s):David J. Dexter, MD  
1:30 PM - 1:35 PM Which Patients With CLTI Should Be Treated Primarily With A Heparin Bonded PTFE Graft And Why: How Can An Amputation-Free Survival Score Be Helpful
  Presenter(s):Carlo Pratesi, MD / Giovanni Pratesi, MD  
1:36 PM - 1:41 PM Update On Novel Supramolecular Polymer Technology To Create Endogenous Tissue With Host Collagen And Endothelium Compatible With Flowing Blood: 2-Year Clinical Results Of The aXess Graft (From Xeltis)
  Presenter(s):Frans L. Moll, MD, PhD  
1:42 PM - 1:47 PM Perigraft Seromas After PTFE Lower Extremity And Aortic Arterial Grafts: Frequency, Etiology, When Do They Need To Be Treated And How
  Presenter(s):Jae S. Cho, MD  
1:48 PM - 1:54 PM Panel Discussion
END OF SESSION 59
 
SESSION 60 SCHEDULE
Thursday
SESSION 60: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
x
ATHERECTOMY AND LITHOTRIPSY RELATED TOPICS
1:54 PM - 1:59 PM A Balanced View Of The Value Of Atherectomy For Treatment Of Lower Extremity Lesions: Has It Been Overutilized And Why: When Can It Be Helpful And Which Device Is Best
  Presenter(s):John R. Laird, MD  
2:00 PM - 2:05 PM The Value Of Directional Atherectomy Followed By DCBs For Long Calcified FemPop Lesions As Demonstrated By The Results Of The REALITY Trial
  Presenter(s):Brian G. DeRubertis, MD  
2:06 PM - 2:11 PM Update On Orbital And Laser Atherectomy: Indications, Advantages And Precautions With Above And Below Knee De Novo Lesions And ISR
  Presenter(s):Craig M. Walker, MD  
2:12 PM - 2:17 PM A New More Complex Device For Treating Calcified Arterial Lesions With Lithotripsy (From BOLT Medical): How Does It Work And Advantages
  Presenter(s):Marianne Brodmann, MD  
2:18 PM - 2:23 PM Aortobifemoral Bypass For Aortoiliac Disease Has Gone From A Favored Procedure To A Rarity Because Of Endovascular Techniques Including Intravascular Lithotripsy (Shockwave): Options And Indications
  Presenter(s):Christopher J. Smolock, MD  
2:24 PM - 2:30 PM Panel Discussion
ANCILLARY TECHNIQUES AND RELATED TOPICS
2:30 PM - 2:35 PM An Update On The Soundbite Technology For Traversing And Treating Calcified Arterial Lesions: How Does It Work, Advantages, And Clinical Experience
  Presenter(s):Marianne Brodmann, MD  
2:36 PM - 2:41 PM How Do The Results Of Invasive Treatment Of FemPop Disease Differ In Women And Minorities: The ELEGANCE Global Registry Of Such Treatment With Eluvia DESs And Ranger DCBs Shows How
  Presenter(s):Eric A. Secemsky, MD, MSc / Lee Kirksey, MD  
NEW INFORMATION ON STENTS AND COVERED STENTS
2:42 PM - 2:47 PM

Power Point Presentation with Synched Audio
5-Year Results With The VBX Covered Stent For Aortoiliac Disease: Patency Rates, Advantages And Cost Effectiveness
  Presenter(s):Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi)  
2:48 PM - 2:53 PM The Eiffel Tower Technique For Endovascular Treatment Of Common Femoral Artery Bifurcation Lesions: What Is It And What Are Its Results: Lessons From The TECCO RCT
  Presenter(s):Yann Gouëffic, MD, PhD  
2:54 PM - 2:59 PM Advantages Of Supera VMI Stent For Complex FemPop Occlusive Lesions: Technical Tips: They Work Even In The Subintimal Position
  Presenter(s):Erwin Blessing, MD  
3:00 PM - 3:06 PM Panel Discussion
3:06 PM - 3:18 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 60
 
SESSION 61 SCHEDULE
Thursday
SESSION 61: NEW OR IMPROVED ENDOVASCULAR DEVICE COMBINATIONS FOR LOWER EXTREMITY TREATMENTS: ANGIOPLASTY BALLOON IMPROVEMENTS
x
3:18 PM - 3:23 PM The Value Of High-Pressure PTA Balloons And Long-Term Results Of pDVA (Percutaneous Deep Vein Arterialization): Practice Changing Techniques For CLTI: pDVA Produces Sustained Increased TcPO2
  Presenter(s):Steven Kum, MD  
3:24 PM - 3:29 PM Update On The Temporary Stent Assisted DCB Angioplasty In BTK Lesions With The Spur Spiked Stent System (Reflow Medical): The DEEPER OUS Trial
  Presenter(s):Michael K.W. Lichtenberg, MD / Thomas Zeller, MD  
3:30 PM - 3:35 PM Update On The TOBA Trials Of The Tack Device (From Philips): Indications, Advantages In Improving Outcomes And Limitations
  Presenter(s):Patrick J. Geraghty, MD  
3:36 PM - 3:41 PM The Serranator® Balloon Catheter (From Cagent Vascular) For Vessel Prep In BTK Arteries: It Makes Microserrations, Prevents Dissections, Lessens Elastic Recoil With PTA: Current Status
  Presenter(s):Steven Kum, MD / Andrew Holden, MBChB  
3:42 PM - 3:47 PM Intravascular Lithotripsy (From Shockwave) In BTK Arteries: Updated Data And New Technologies
  Presenter(s):Andrew Holden, MBChB  
3:48 PM - 3:53 PM IVUS Studies Before And After PTAs With The Ultrascore Scoring Balloons (From BD) Show The Benefits Of Such Balloons And How They Work
  Presenter(s):Robert E. Beasley, MD, FSIR, FSCAI  
3:54 PM - 3:59 PM Progress In Developing A Curved Angioplasty Balloon: How It Works And Why It’s Important: When Will It Be Available
  Presenter(s):Timothy A.M. Chuter, MD  
4:00 PM - 4:05 PM Unfavorable Balloon (Candy) Wrap Can Cause Dissections With Angioplasty: What Is The Mechanism: How Can It Be Recognized And Dissection Avoided: When Does Dissection Have To Be Treated And When Not
  Presenter(s):Jos C. van den Berg, MD, PhD  
4:06 PM - 4:12 PM Panel Discussion
END OF SESSION 61
 
SESSION 62 SCHEDULE
Thursday
SESSION 62: NEW OR IMPROVED DEVICES AND TECHNIQUES TO PREVENT OR TREAT ENDOLEAKS OR DEVICE MIGRATION: ENDOANCHORS, ETC.
x
4:12 PM - 4:17 PM New Findings From The ANCHOR Study Support The Prophylactic Use Of Heli-FX Endoanchor (Medtronic) Fixation: Use Of Its Variable Curve Sheath As A Rescue Tool To Fix Poorly Deployed Endografts
  Presenter(s):William D. Jordan Jr., MD  
4:18 PM - 4:23 PM 5-Year Results Of Endoanchors In The Global ANCHOR Registry To Treat Complications With Focus On Preventing And Treating Type IA Endoleaks: Can Virtual Techniques Predict The Need For Endoanchors
  Presenter(s):Jean-Paul de Vries, MD, PhD  
4:24 PM - 4:29 PM Endoanchors Improve Seal Zones And Outcomes With Fenestrated Endografts: When And Where Should They Be Used And Technical Tips
  Presenter(s):Shadi J. Abu-Halimah, MD  
4:30 PM - 4:35 PM Prophylactic Endoanchors In TEVAR For Complex Anatomy Decrease Endoleaks And Reintervention Rates: Indications And Technical Tips For Their Use
  Presenter(s):Jean M. Panneton, MD  
4:36 PM - 4:41 PM Novelrad Percutaneous Endovascular Suturing Device: How Does It Work And Clinical Experience
  Presenter(s):Elchanan Bruckheimer, MBBS  
4:42 PM - 4:47 PM Update On The VESTECK Catheter Based Endosuturing Technology For EVAR And TEVAR Fixation: How Does It Work; How Is It Different From Endoanchors And Successful Clinical Results
  Presenter(s):Dainis K. Krievins, MD / Sean P. Lyden, MD / David H. Deaton, MD, FACS  
4:48 PM - 4:54 PM Panel Discussion
END OF SESSION 62
 
SESSION 63 SCHEDULE
Thursday
SESSION 63: NEW OR IMPROVED ENDOVASCULAR DEVICES FOR CLOT REMOVAL OR EMBOLIZATION (SEE ALSO SESSION 30)
x
CLOT REMOVING DEVICES
4:54 PM - 4:59 PM Endovascular Arterial Thrombo-Embolectomy Devices: What's The Difference Between Them: Jeti, Penumbra, AngioJet, Pounce, Etc.: What's Coming Down The Road
  Presenter(s):Loay S. Kabbani, MD, MHSA  
5:00 PM - 5:05 PM Newer Pharmacomechanical Endovascular Clot Removal Systems: When And Why Is Each Device Best To Use: When Is Open Surgery Needed
  Presenter(s):Guillermo A. Escobar, MD  
5:06 PM - 5:11 PM Different Options For Thrombosuction Treatment In ALI: Which Device For Which Case And When To Go For Open Surgery
  Presenter(s):Athanasios Katsargyris, MD  
5:12 PM - 5:17 PM Endovascular Hydrodynamic Thrombectomy Of Occluded Visceral Vessels/Stents: Device Description And Clinical Experience
  Presenter(s):Marco V. Usai, MD  
5:18 PM - 5:23 PM Rotarex Device Is A Treatment For Subacute Or Chronic Lower Extremity Thrombosed Bypasses Or Stents: How And When Does It Work And When Does It Not
  Presenter(s):Animesh Rathore, MD  
5:24 PM - 5:29 PM Panel Discussion
ENDOVASCULAR OCCLUSIVE DEVICES
5:30 PM - 5:35 PM Embolization Device Selection: The Pros And Cons Of Liquid Agents Versus Coils, Or Plugs
  Presenter(s):Frank R. Arko, MD  
5:36 PM - 5:41 PM How Can Shape Memory Polymer Plug Embolization Devices Be Used To Improve Results After TEVAR For Degenerative Aneurysms And TBADs By False Lumen Obliteration
  Presenter(s):Virendra I. Patel, MD, MPH  
5:42 PM - 5:47 PM Fibered And Non-Fibered Coil Embolism Technology: Which Type Of Coils Are Best For Different Indications
  Presenter(s):James F. Benenati, MD  
5:48 PM - 5:53 PM Indications And Outcomes Of The Impede Embolization Plug (From Shape Memory) For Treatment Of Peripheral And Visceral Artery Lesions: What Makes It Unique
  Presenter(s):Robert A. Morgan, MD  
5:54 PM - 5:59 PM Panel Discussion
End of Program H

END OF SESSION 63
 
SESSION 64 SCHEDULE
Thursday
SESSION 64: VENOUS CLINICAL EXAMINATION AND HEMODYNAMICS
x
7:00 AM - 7:04 AM Introduction To Veins At VEITH
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
7:05 AM - 7:10 AM Overview Of Lymphatic Anatomy, And Physiology
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
7:11 AM - 7:16 AM Inflammatory Pathways In Chronic Venous Disease
  Presenter(s):Joseph D. Raffetto, MD  
7:17 AM - 7:22 AM Genetics And Venous Disease
  Presenter(s):Sarah Onida, MD, PhD  
7:23 AM - 7:28 AM Different Types Of Venous Reflux Identified In 100 Consecutive Patients And Their C Classification And Percentage
  Presenter(s):Ayman Fakhry, MD  
7:29 AM - 7:34 AM We Should Revise The Definition Of Venous Reflux: What Other Modality Should We Consider
  Presenter(s):Fedor Lurie, MD, PhD  
7:35 AM - 7:40 AM Factors Impacting Venous Return
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
7:41 AM - 7:46 AM Venous Thermography And Its Clinical Use
  Presenter(s):Dale Maharaj, FACS  
7:47 AM - 7:52 AM Panel Discussion
END OF SESSION 64
 
SESSION 65 SCHEDULE
Thursday
SESSION 65: VENOUS GUIDELINES, IMPORTANT PAPERS, AND REIMBURSEMENT
x
7:53 AM - 7:58 AM Are Venous Maps Standard Of Care: What Should They Include
  Presenter(s):Jan M. Sloves, RVT  
7:59 AM - 8:04 AM SVS, AVF, AVLS Varicose Vein Guidelines
  Presenter(s):Peter Gloviczki, MD  
8:05 AM - 8:10 AM A Comparison Of The Revised SVS/AVF/ASVL/ESVS Clinical Practice Guidelines In The Management Of Varicose Veins: Contact And Agree II Analysis
  Presenter(s):Thomas F. O'Donnell, Jr., MD  
8:11 AM - 8:16 AM Summary Of Important Venous And Lymphatic Articles – International Angiology
  Presenter(s):Armando Mansilha, MD, PhD, FEBVS  
8:17 AM - 8:22 AM Summary Of Important Venous And Lymphatic Articles – Journal of Phlebology Editor’s Choice
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FLSW, FMedSci, FEBVS  
8:23 AM - 8:28 AM Summary Of Important Venous And Lymphatic Articles – Journal of Vascular Surgery Venous and Lymphatic Disorders – Editor’s Choice
  Presenter(s):Ruth L. Bush, MD, MPH  
8:29 AM - 8:34 AM Primary Venous Insufficiency Increases Risk Of Deep Vein Thrombosis
  Presenter(s):Maxim Shaydakov, MD, PhD  
8:35 AM - 8:40 AM Compression: Does It Work: What Data Do You Have To Support
  Presenter(s):William A. Marston, MD  
8:41 AM - 8:46 AM Sclerotherapy Of Lower Limb – Consensus Document UIP
  Presenter(s):Oscar Bottini, MD  
8:47 AM - 8:52 AM Panel Discussion
END OF SESSION 65
 
SESSION 66 SCHEDULE
Thursday
SESSION 66: SUPERFICIAL VEIN TREATMENT STRATEGIES I
x
8:53 AM - 8:58 AM The Length Of Treated Great Saphenous Vein As A Marker Of Post-Procedural Improvement In Clinical And Patient Reported Outcomes
  Presenter(s):Windsor Ting, MD  
8:59 AM - 9:04 AM Update On Fovelass – Society Of French Phlebology Study: RCT Comparing Foam And EVLA In SSV Incompetence
  Presenter(s):Claudine M. Hamel-Desnos, MD  
9:05 AM - 9:10 AM What Do You Treat First In C2s With Reflux Of The GSV, SSV, And Vein Of Giacomini
  Presenter(s):Jean Luc Gerard, MD  
9:11 AM - 9:16 AM Saphenous Sparing: Why And Instructions For Users
  Presenter(s):Sergio Gianesini, MD, PhD, FACS  
9:17 AM - 9:22 AM Thermal Saphenous Vein Recanalization: Risk Factors
  Presenter(s):Ruth L. Bush, MD, MPH  
9:23 AM - 9:28 AM Ultrasound Aspects Of The Vein Over Time After Foam Sclerotherapy, And Clinical Consequences
  Presenter(s):Claudine M. Hamel-Desnos, MD  
9:29 AM - 9:34 AM Thrombus Extension After Cyanoacrylate Closure Versus Endovenous Glue Induced Thrombosis: What Is The Difference
  Presenter(s):Nuttawut Sermsathanasawadi, MD, PhD  
9:35 AM - 9:40 AM Synchronous Trial 12 Months Follow-Up Data (Simultaneous AASV Treatment For Patients Undergoing GSV Ablation)
  Presenter(s):Tobias Hirsch, MD  
9:41 AM - 9:46 AM Effects Of Truncal Ablation On Pregnancy
  Presenter(s):Kursat A. Bozkurt, MD  
9:47 AM - 9:52 AM Saphenous Ablation On Direct Oral Anticoagulants: Safe, Effective And Durable
  Presenter(s):Glenn Jacobowitz, MD  
9:53 AM - 9:57 AM Panel Discussion
END OF SESSION 66
 
SESSION 67 SCHEDULE
Thursday
SESSION 67: SUPERFICIAL VEIN TREATMENT STRATEGIES II
x
9:58 AM - 10:03 AM Decision Making In Saphenous Ablation: What To Use And When
  Presenter(s):Steve Elias, MD  
10:04 AM - 10:09 AM Diameters Of The Great Saphenous Vein In Phlebological Practice In France: Report Of The DIAGRAVES Study By The French Society of Phlebology
  Presenter(s):Matthieu M.J. Josnin, MD  
10:10 AM - 10:15 AM Non-Compounded Polidocanol 1% Endovenous Microfoam (Varithena) Or Thermal Ablation: A Network Meta-Analysis
  Presenter(s):Lowell S. Kabnick, MD, FACS, FAVLS, DFAVF  
10:16 AM - 10:21 AM The Persistent Sciatic Vein
  Presenter(s):Julianne Stoughton, MD, FACS  
10:22 AM - 10:27 AM SVT Treatment During Pregnancy: Treatment Choices
  Presenter(s):Kathleen J. Ozsvath, MD  
10:28 AM - 10:33 AM Would Treatment Of The Whole Length Of The GSV Reduce Recurrence And Reinterventions
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FLSW, FMedSci, FEBVS  
10:34 AM - 10:39 AM Thermal Versus Nonthermal: Is It Time To Stop The FIRE
  Presenter(s):Sergio Gianesini, MD, PhD, FACS  
10:40 AM - 10:44 AM African American Patient Outcomes After Saphenous Ablation For Advanced Venous Disease
  Presenter(s):Faisal Aziz, MD  
10:45 AM - 10:49 AM The Use Of Simultaneous Foam Sclerotherapy And Thermal Treatment In Varicose Vein Treatment: Why
  Presenter(s):Tobias Hirsch, MD  
10:50 AM - 10:54 AM Complications Of Endovenous Thermal Ablation Of The GSV
  Presenter(s):Dale Maharaj, FACS  
10:55 AM - 11:00 AM Panel Discussion
END OF SESSION 67
 
SESSION 68 SCHEDULE
Thursday
SESSION 68: SUPERFICIAL VEIN TREATMENT STRATEGIES III
x
11:01 AM - 11:05 AM When Is It OK To Ablate The Truncal Leg Veins With Chronic Iliofemoral Outflow Obstruction
  Presenter(s):Houman Jalaie, MD, PhD  
11:06 AM - 11:10 AM SVT Medical Management In 2024: Is There A Role For Surgical Intervention And When
  Presenter(s):Manj S. Gohel, MD, FRCS, FEBVS  
11:11 AM - 11:15 AM Management Of Labial And Vulvar Veins
  Presenter(s):Julianne Stoughton, MD, FACS  
11:16 AM - 11:20 AM VEINS – An International Platform Trial Collaboration
  Presenter(s):Sarah Onida, MD, PhD  
11:21 AM - 11:25 AM What You Should Know About Klippel-Trenaunay Syndrome
  Presenter(s):Byung-Boong Lee, MD  
11:26 AM - 11:30 AM Treatment And Pitfalls: Lateral Marginal Vein
  Presenter(s):Peter Gloviczki, MD  
11:31 AM - 11:35 AM Overview Of Multicenter Venclose Study And Early Results
  Presenter(s):Erin H. Murphy, MD  
11:36 AM - 11:40 AM Great Saphenous Vein Crossectomy: Why
  Presenter(s):Ayman Fakhry, MD  
11:41 AM - 11:45 AM What Is Maven: Is There Any Data
  Presenter(s):Jeffrey G. Carr, MD  
11:46 AM - 11:50 PM Does Vein Stenting Reduce Great And Small Saphenous Venous Reflux
  Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM  
11:51 AM - 11:55 AM Safety And Efficacy Of Endovenous Ablation In Patients With A History Of Deep Venous Thrombosis
  Presenter(s):Mikel Sadek, MD  
11:56 AM - 12:00 PM Value And Limitations Of Postoperative Duplex Scans After Endovenous Thermal Ablation
  Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM  
12:01 PM - 12:05 PM VEINRESET: US Multicenter HIFU Trial: 6-Month Results
  Presenter(s):Steve Elias, MD  
12:06 PM - 12:11 PM Panel Discussion
12:12 PM - 1:12 PM Lunch Break – Rhinelander Gallery, 2nd Floor
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 68
 
SESSION 69 SCHEDULE
Thursday
SESSION 69: SUPERFICIAL VEIN TREATMENT STRATEGIES IV
x
1:13 PM - 1:18 PM Cyanoacrylate And The Small Saphenous Vein: How To Treat The Various Anatomy
  Presenter(s):Janna Bentley, MD  
1:19 PM - 1:24 PM Lack Of Symptom Improvement: Why
  Presenter(s):Jeffrey G. Carr, MD  
1:25 PM - 1:30 PM Is There Any Evidence For Compression
  Presenter(s):William A. Marston, MD  
1:31 PM - 1:36 PM New Superficial Venous Devices: Pre FDA Approval
  Presenter(s):Lowell S. Kabnick, MD, FACS, FAVLS, DFAVF  
1:37 PM - 1:42 PM Forecast For Venous Reimbursement 2025
  Presenter(s):John Blebea, MD, MBA  
1:43 PM - 1:48 PM Factors Associated With Recanalization And Reintervention Following Below Knee Polidocanol Endovenous Microfoam
  Presenter(s):Natalie A. Marks, MD, RPVI, RVT, FSVM  
1:49 PM - 1:54 PM Which Saphenous Vein Recanalization Should Be Treated And By What Method: Evidence Based
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
1:55 PM - 2:00 PM Varithena Meta-Analysis “RELOADED”, The Living Approach
  Presenter(s):Lowell S. Kabnick, MD, FACS, FAVLS, DFAVF  
2:01 PM - 2:06 PM Accessory Veins And Their Impact On Recurrence
  Presenter(s):Kerstin S. Schick, MD  
2:07 PM - 2:12 PM Deviation Operation In Patients With Deep Venous Reflux And CVI: First Clinical Results
  Presenter(s):Sebastian E. Debus, MD, PhD  
2:13 PM - 2:18 PM Do You Need To Treat Venous Tributaries: Pros And Cons
  Presenter(s):Kerstin S. Schick, MD  
2:19 PM - 2:24 PM Venous VQI: Ten Years Of Improving Venous Outcomes And Quality
  Presenter(s):Marc A. Passman, MD  
2:25 PM - 2:30 PM Panel Discussion
END OF SESSION 69
 
SESSION 70 SCHEDULE
Thursday
SESSION 70: SUPERFICIAL VEIN TREATMENT STRATEGIES V
x
2:31 PM - 2:36 PM Venous Lesions Of The Face
  Presenter(s):Kasuo Miyake, MD, PhD  
2:37 PM - 2:42 PM Truncal Vein Treatment For Chronic Venous Disease: Is Varithena Endovenous Ablation Or Physician Compounded Foam The Answer
  Presenter(s):Edward G. Mackay, MD  
2:43 PM - 2:48 PM Physician Compounded Foam For Truncal Vein Disease: When And Where
  Presenter(s):Matthieu M.J. Josnin, MD  
2:49 PM - 2:54 PM Varithena®VLU Registry: Update On The Effects Of Polidocanol Endovenous Microfoam On Wound Healing And Recurrence
  Presenter(s):Raghu Kolluri, MD  
2:55 PM - 3:00 PM Phlebectomy Versus Sclerotherapy: Which Is Superior When Considering Efficacy, Complications, And Aesthetics
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FLSW, FMedSci, FEBVS  
3:01 PM - 3:06 PM Ultrasound Guided Foam Sclerotherapy For Reticular Venous Plexus: Systematization Of The Technique
  Presenter(s):Alvaro Orrego, MD, FACS  
3:07 PM - 3:12 PM Tips And Tricks Of Sclerotherapy: What Makes It Easier And Successful
  Presenter(s):Victor M. Canata, MD, PhD  
3:13 PM - 3:18 PM How To Avoid Complications From Sclerotherapy
  Presenter(s):Jean Luc Gerard, MD  
3:19 PM - 3:24 PM Comparison Of Laser And Chemical Sclerosant Versus Sclerosant
  Presenter(s):Kasuo Miyake, MD, PhD  
3:25 PM - 3:30 PM Quick Case 1: Ask The Panel Or Audience What Would You Do (Cosmetic)
  Presenter(s):Edward G. Mackay, MD  
3:31 PM - 3:36 PM Quick Case 2: Ask The Panel Or Audience What Would You Do (Cosmetic)
  Presenter(s):Janna Bentley, MD  
3:37 PM - 3:42 PM Panel Discussion
END OF SESSION 70
 
SESSION 71 SCHEDULE
Thursday
SESSION 71: SUPERFICIAL VEIN TREATMENT STRATEGIES VI
x
3:43 PM - 3:48 PM Global Epidemiology Of Chronic Venous Disease: A Systematic Review With Pooled Prevalence Analysis
  Presenter(s):Sarah Onida, MD, PhD  
3:49 PM - 3:54 PM When Evaluating Superficial Disease, When Do You Look For Deep Venous Obstruction
  Presenter(s):Gloria Salazar, MD  
3:55 PM - 4:00 PM Not All C2 Disease Should Be Treated: An Algorithm To Predict Severity
  Presenter(s):Mikel Sadek, MD  
4:01 PM - 4:06 PM Ablative Risks Prior And After Flying: What Do You Tell Your Patients
  Presenter(s):Sarah Onida, MD, PhD  
4:07 PM - 4:12 PM Body Mass Index And CEAP Clinical Severity Score
  Presenter(s):Oscar Bottini, MD  
4:13 PM - 4:18 PM How Do We Assess Quality Of Life After Venous Interventions: Patient-Reported Outcomes For Chronic Venous Insufficiency
  Presenter(s):Kathleen D. Gibson, MD  
4:19 PM - 4:24 PM Optimal Thromboprophylaxis And Post-Op Duplex Imaging Following Superficial Venous Procedures: Evidence Based
  Presenter(s):Andrea T. Obi, MD  
4:25 PM - 4:30 PM Mechanical Chemically Assisted Ablation Of Varicose Veins For Venous Insufficiency: American Vein And Lymphatic Society Position Statement
  Presenter(s):John Blebea, MD, MBA  
4:31 PM - 4:36 PM Radiofrequency Ablation Versus Polidocanol Endovenous Microfoam Ablation Of Large Diameter Saphenous And Tributary Veins
  Presenter(s):Juan Carlos Jimenez, MD, MBA  
4:37 PM - 4:42 PM Outcome Of Early CAC And Compression Therapy In Healing Of VLU
  Presenter(s):Nuttawut Sermsathanasawadi, MD, PhD  
4:43 PM - 4:48 PM Randomized Clinical Trial Comparing Cyanoacrylate Glue Closure With Surgical Striping: 30D And 6M Outcomes
  Presenter(s):Manj S. Gohel, MD, FRCS, FEBVS  
4:49 PM - 4:54 PM How To Avoid Complications Of The Small Saphenous Vein
  Presenter(s):Jean Luc Gerard, MD  
4:55 PM - 5:00 PM Mechanical Occlusion Segmental Chemical Ablation (MOSCA): Animal Study With Wavella Device
  Presenter(s):Steve Elias, MD  
5:01 PM - 5:06 PM Panel Discussion
END OF SESSION 71
 
SESSION 72 SCHEDULE
Thursday
SESSION 72: LIPEDEMA, LYMPHEDEMA, PHLEBOLYMPHEDEMA
Moderators:Raghu Kolluri, MD / Ayman Fakhry, MD  
x
5:07 PM - 5:12 PM Lower Extremity Edema Workup
  Presenter(s):Maxim Shaydakov, MD, PhD  
5:13 PM - 5:18 PM What Is Lipedema And The Current Management
  Presenter(s):Steven M. Dean, DO  
5:19 PM - 5:24 PM Risks And Contraindications Of Medical Compression Treatment – A Critical Reappraisal: An International Consensus Statement
  Presenter(s):Tomasz Urbanek, MD  
5:25 PM - 5:30 PM Venolymphatic Edema And Its Treatment Options
  Presenter(s):Raghu Kolluri, MD  
5:31 PM - 5:36 PM Are Lymphedema, Lipedema, And Edema Related
  Presenter(s):Steven M. Dean, DO  
5:37 PM - 5:42 PM Role Of Hydrotherapy In Lymphedema Treatment
  Presenter(s):Ayman Fakhry, MD  
5:43 PM - 5:48 PM Update On Pharmacological Treatment For Lymphedema
  Presenter(s):Monika L. Gloviczki, MD, PhD  
5:49 PM - 5:54 PM Panel Discussion
END OF SESSION 72
 
SESSION 73 SCHEDULE
Thursday
SESSION 73: VENOUS ULCERS
x
5:55 PM - 6:00 PM Turkish Glue And Perforating Veins In VLU Patients
  Presenter(s):Kursat A. Bozkurt, MD  
6:01 PM - 6:06 PM Factors That Influence Venous Leg Ulcer Healing And Recurrence Rate After Endovenous Ablation Of Truncal Veins
  Presenter(s):Nuttawut Sermsathanasawadi, MD, PhD  
6:07 PM - 6:12 PM Review Of Current Evidence For Topical Treatment For Venous Leg Ulcers
  Presenter(s):Yuri Casseres, MD  
6:13 PM - 6:18 PM Why Venous Leg Ulcers Have Difficulty Healing
  Presenter(s):Joseph D. Raffetto, MD  
6:19 PM - 6:24 PM Role Of Superficial Venous Therapies In Improving Venous Ulcer Healing: Choice Of Techniques And Use Of Adjunctive Strategies
  Presenter(s):Sung Yup Kim, MD  
6:25 PM - 6:30 PM Venous Ulcers: The Contributions Of Deep, Perforator, And Superficial Procedures On Wound Healing
  Presenter(s):Peter F. Lawrence, MD  
6:31 PM - 6:36 PM Skin Substitutes To Promote Venous Leg Ulcer Healing: What Is The Evidence
  Presenter(s):Yuri Casseres, MD  
6:37 PM - 6:42 PM Compression, Oxygen, And Humidification: Does It Improve Wound Healing
  Presenter(s):Anil P. Hingorani, MD  
6:43 PM - 6:48 PM Update On Pharmacological Treatment For Venous Ulcers
  Presenter(s):Monika L. Gloviczki, MD, PhD  
6:49 PM - 6:54 PM Non-Bandage Therapy For Venous Ulcers – Single Arm Study
  Presenter(s):Sundaram Ravikumar, MD  
6:55 PM - 7:00 PM Panel Discussion
End of Program I
END OF SESSION 73
 
SESSION 74 SCHEDULE
Thursday
SESSION 74: ADVANCES IN STROKE AND THE NEXT FRONTIER
x
7:30 AM - 7:40 AM Introduction
  Presenter(s):Allan L. Brook, MD  
7:41 AM - 7:48 AM Evidence Of Acute Stroke Care And What Gaps Are Left To Fill
  Presenter(s):Dan Antoniello, MD  
7:49 AM - 7:56 AM Stroke Imaging Triage: Pearls And Nuances Of Daily Practice
  Presenter(s):Raj Gupta, MD  
7:57 AM - 8:04 AM Should ELVO Patients Go Directly To The Angio Suite
 
8:05 AM - 8:12 AM Next Generation Thrombectomy Devices And How They Impact Clinical Outcomes
  Presenter(s):David Fiorella, MD, PhD  
8:13 AM - 8:20 AM

Power Point Presentation with Synched Audio
Tandem Occlusions: Should We Stent – Above, Below, Both, Or Neither
  Presenter(s):Adnan H. Siddiqui, MD, PhD  
8:21 AM - 8:28 AM Direct Carotid Access: Is It Time For This Time Saving Approach
  Presenter(s):Ajay K. Wakhloo, MD, PhD, FAHA, FSNIS   
8:29 AM - 8:36 AM Imaging Pearls That Save Time
  Presenter(s):Lawrence N. Tanenbaum, MD  
8:37 AM - 8:44 AM Aspirations In Aspiration Thrombectomy
  Presenter(s):James Milburn, MD  
8:45 AM - 8:52 AM Distal/Middle Intracranial Occlusion Can Lead To Significant Morbidity: Should They Be Treated
  Presenter(s):Charles Esenwa, MD, MS  
END OF SESSION 74
 
SESSION 75 SCHEDULE
Thursday
SESSION 75: INTRACRANIAL HEMORRHAGE, VESSEL WALL IMAGING AND NEW DEVELOPMENTS
Moderators:Deepak Khatri, MD / David Gordon, MD  
x
8:53 AM - 9:00 AM Radial And Ulnar Anatomy/Access; Complication Management
  Presenter(s):Sudhakar R. Satti, MD  
9:01 AM - 9:08 AM Literature That Has Changed Over The Last Year And How It Has Changed Our Practice
  Presenter(s):Chirag D. Gandhi, MD  
9:09 AM - 9:16 AM INTRASACCULAR DEVICES: For SAH, Or Only Elective Cases
  Presenter(s):Ansaar T. Rai, MD  
9:17 AM - 9:24 AM A Neiman Fellow Analyzes How The No Surprises Act Interests With MT 4 ELVO Stroke
  Presenter(s):Joshua A. Hirsch, MD  
9:25 AM - 9:32 AM Is There Any Imaging To Distinguish Intracranial Athero Versus Embolic Thrombus
  Presenter(s):Richard L. Zampolin, MD  
END OF SESSION 75
 
SESSION 76 SCHEDULE
Thursday
SESSION 76: CAROTID AND CEREBRAL ANEURYSMS LATER TRENDS AND POTPOURRI
x
9:33 AM - 9:40 AM Robots Are A Bust In The Brain, Or Are We Waiting For Next Generation Devices And Insights
  Presenter(s):Aquilla S. Turk, DO  
9:41 AM - 9:48 AM Intracranial Aneurysm Literature: What Has ARISEn
  Presenter(s):David S. Liebeskind, MD  
9:49 AM - 9:56 AM Basilar Artery Thrombectomy: Planning For Efficient Revascularization
  Presenter(s):Maksim Shapiro, MD  
9:57 AM - 10:04 AM SDH And MMA Embolization: What Is The Standard Of Care
 
10:05 AM - 10:12 AM MMA Embolization: Does The Embolic Material Really Matter And Why
  Presenter(s):J Mocco, MD, MS  
END OF SESSION 76
 
SESSION 77 SCHEDULE
Thursday
SESSION 77: PEDIATRIC STROKE AND LESSONS TO BE LEARNED IN UNIQUE CEREBROVASCULAR ARENAS
x
10:13 AM - 10:20 AM Pediatric Stroke, And Are Endovascular Methods The Same As For Adults
 
10:21 AM - 10:28 AM Great Pediatric Neurointerventional Cases
  Presenter(s):Amanda Baker, MD  
10:29 AM - 10:36 AM 70 Years Of NI Practice: My Most Interesting Case Pearls For All To Enjoy
  Presenter(s):Peter K. Nelson, MD  
10:37 AM - 10:44 AM Dural Sinus Stenosis: Is There A Standard Of Care
  Presenter(s):Athos Patsalides, MD, MPH  
10:45 AM - 10:52 AM Carotid Blowout: Evidence And Treatment Options
  Presenter(s):Guilherme Dabus, MD  
10:53 AM - 11:00 AM Artificial Intelligence: Relevance In Stroke And How It Will Impact Our Lives
  Presenter(s):Allan L. Brook, MD  
END OF SESSION 77
 
SESSION 78 SCHEDULE
Thursday
SESSION 78: CAROTID ARTERY THERAPY STARS AND LATEST TRENDS
Moderators:Thomas G. Brott, MD / Don Heck, MD  
x
11:01 AM - 11:08 AM Carotid Artery Disease: New Trials And Best Literature 2023
  Presenter(s):Thomas G. Brott, MD  
11:09 AM - 11:16 AM TCAR Is Better Than True Percutaneous Carotid Stenting: Myth Or Reality
  Presenter(s):Peter A. Schneider, MD  
11:17 AM - 11:24 AM CAS Versus TCAR Versus CEA: They Cannot Be Equal And Why
  Presenter(s):Don Heck, MD  
11:25 AM - 11:32 AM CEA Done Through A Microincision Versus TCAR: Why Do So Few Perform This
  Presenter(s):Enrico Ascher, MD  
11:33 AM - 11:40 AM Latest Stenting Technology For The Carotid Artery: Does It Match The Evidence
  Presenter(s):Michele Antonello, MD, PhD  
11:41 AM - 11:56 AM

Power Point Presentation with Synched Audio
Encore: Why Does Everybody Outside Of Australia Overtreat Carotids (15-Minute Presentation)
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
11:57 AM - 12:15 PM Panel Discussion
End Of Program J

END OF SESSION 78
 
SESSION 79 SCHEDULE
Friday
SESSION 79: PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH THE TREATMENT OF THORACIC, THORACOABDOMINAL AND COMPLEX ABDOMINAL ANEURYSMS
x
6:40 AM - 6:45 AM New Experimental Work In Avoiding SCI After TAAA Repair: How Can A Sheep Model Of TEVAR Be Helpful
  Presenter(s):Hamdy Awad, MD  
6:46 AM - 6:51 AM With Complex AAAs And Type IV TAAAs, The Incidence Of SCI Is 3 Times Greater With Endovascular Repairs Than Open Repairs: Why Is This A Controversial Finding And How Can It Be So
  Presenter(s):George Geroulakos, MD, PhD  
6:52 AM - 6:57 AM Prediction Of Spinal Cord Ischemia With AI After Aortic Procedures: Combinations Of Anatomic Features Accurately Predict Risk
  Presenter(s):Kak Khee Yeung, MD, PhD  
6:58 AM - 7:03 AM What Is The Muenster Strategy To Avoid SCI After F/B/EVAR For TAAA: What Is The Proof That It Works
  Presenter(s):Martin J. Austermann, MD  
7:04 AM - 7:09 AM How To Use Motor Evoked Potentials (MEPs) To Decrease The Incidence Of SCI After Open And Endo TAAA Repairs: What Else Is Important
  Presenter(s):James H. Black, III, MD  
7:10 AM - 7:15 AM Role Of Direct Segmental Artery Revascularization To Prevent SCI After Endovascular TAAA Repairs: When And How To Do It
  Presenter(s):Sukgu Han, MD  
7:16 AM - 7:21 AM Current Strategies To Minimize SCI With TAAA Repairs (Endo And Open) By Improving The Intraspinal Collateral Arterial Network: Status Of Intercostal Embolization As Preconditioning To Prevent Ischemia (MIS2ACE): Progress Of The PAPA-ARTIS RCT
  Presenter(s):Christian D. Etz, MD, PhD  
7:22 AM - 7:27 AM Extensive Single Center Clinical Experience With Intercostal Coil Embolization (MIS2ACE) To Prevent SCI With Endovascular TAAA Repair: How And When To Do It: Why We Still Need An RCT
  Presenter(s):Daniela Branzan, MD / Andrej Schmidt, MD  
7:28 AM - 7:33 AM Why Cerebrospinal Fluid (CSF) Drainage To Decrease SCI With TAAA Repair Is Not A Benign Procedure: When To Use It And When Not
  Presenter(s):Gustavo S. Oderich, MD, FACS  
7:34 AM - 7:39 AM Prevention Of SCI After Endovascular TAAA Repairs: Lessons Learned From The US Aortic Research Consortium (ARC)
  Presenter(s):Adam Beck, MD / Mark A. Farber, MD / Andres Schanzer, MD  
7:40 AM - 7:45 AM Shifts In Prevention Protocols For SCI During Open And Endovascular TAAA Repairs: What Is Agreed On And What Remains Controversial
  Presenter(s):Germano C.G. Melissano, MD / Roberto L.V. Chiesa, MD  
7:46 AM - 7:54 AM Panel Discussion
END OF SESSION 79
 
SESSION 80 SCHEDULE
Friday
SESSION 80: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS: UPDATE ON MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
x
7:54 AM - 7:59 AM Carotid Webs: An Important Etiology Of Devastating Strokes Especially In Young Women: How Should They Be Diagnosed And Treated
  Presenter(s):Bruce A. Perler, MD, MBA  
MESH COVERED STENTS
8:00 AM - 8:05 AM Long-Term Results Of Micromesh Stents Show Their Value In Carotid Artery Stenting (CAS): Are There Limitations: Do The Differences In The 3 Micromesh Stents Matter
  Presenter(s):Max Amor, MD / D. Christopher C. Metzger, MD   
8:06 AM - 8:11 AM

Power Point Presentation with Synched Audio
When You Can Do All, How To Decide Between CEA, TCAR And TFCAS: Will Mesh Covered Stents Like CGuard Make A Difference
  Presenter(s):Adnan H. Siddiqui, MD, PhD / L. Nelson Hopkins, MD  
8:12 AM - 8:17 AM Outcome Of TCAR Combined With A Mesh-Covered Stent (CGuard From InspireMD): The Best Of All Worlds: What Is The Proof
  Presenter(s):Ralf R. Kolvenbach, MD  
8:18 AM - 8:23 AM Update On All Trial Results With CGuard And CGuard Prime MicroMesh Covered Stents (InspireMD): Are They Making A Difference And Limitations With Transfemoral/Transradial CAS: Evidence Summary And Long-Term Outcomes
  Presenter(s):Piotr Musialek, MD, DPhil / D. Christopher C. Metzger, MD  / Stefan Mueller-Huelsbeck, MD  
8:24 AM - 8:29 AM US Studies And Status Of The CGuard And CGuard Prime MicroMesh Stents: Can They Be Used In TCAR And Are They Making A Difference
  Presenter(s):Patrick J. Geraghty, MD  
8:30 AM - 8:35 AM Latest Real-World Results Of >2,000 Patients Treated With The Roadsaver (Terumo) Dual-Layer Micromesh Carotid Stent
  Presenter(s):Stefan Mueller-Huelsbeck, MD  
8:36 AM - 8:42 AM Panel Discussion
TCAR RELATED TOPICS
8:42 AM - 8:47 AM Update On Comparative Performance And Risks Of TCAR, Transfemoral CAS (TFCAS) And CEA With > 50K TCAR, 25K TFCAS, And 100K CEA: This Population Based Study Shows That CEA Is Better Than TCAR Which Is Better Than TFCAS
  Presenter(s):Marc L. Schermerhorn, MD / Mahmoud B. Malas, MD, MHS  
8:48 AM - 8:53 AM Is TCAR Ready To Replace CEA: What About The Clinical Results To Date: What About The Impact Of Clever Marketing: How Will We Find Out
  Presenter(s):Bruce A. Perler, MD, MBA  
8:54 AM - 8:59 AM DEBATE: CEA Versus TCAR In A Single Center Propensity Matched Study: The Outcomes Of The Two Treatments Are Comparable At 30 Days But TCAR Has A Higher Mortality At 2 Years
  Presenter(s):Ali F. AbuRahma, MD / Zach AbuRahma, DO  
9:00 AM - 9:05 AM DEBATE: Not So: TCAR Like TFCAS Has Durable Effectiveness Without Increased Mortality At 2 Years And Beyond
  Presenter(s):Sumaira Macdonald, MD, PhD  
9:06 AM - 9:11 AM Favorable 30-Day Results Of TCAR In Good Risk Symptomatic And Asymptomatic Patients: Late Breaking Trial Results From ROADSTER 3 Shows That The Stroke, Death And MI Rates Are Lower Than In High Risk Patients
  Presenter(s):Marc L. Schermerhorn, MD  
9:12 AM - 9:17 AM TCAR Is Safe In Recently Symptomatic Patients And Those With Contralateral Carotid Occlusions: Why TCAR Should Be The Procedure Of Choice In These Conditions
  Presenter(s):Peter A. Schneider, MD  
9:18 AM - 9:23 AM Panel Discussion
9:24 AM - 9:34 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 80
 
SESSION 81 SCHEDULE
Friday
SESSION 81: MORE CAROTID HOT TOPICS RELATED TO TCAR, CAS AND EFFECTS OF INTERVENTIONS ON COGNITIVE FUNCTION
x
9:35 AM - 9:40 AM Comparative Cost Effectiveness Of TCAR, CEA, TFCAS: CEA Is More Cost Effective Than TCAR And TCAR Is More Cost Effective Than TFCAS
  Presenter(s):Mohammad H. Eslami, MD, MPH  
9:41 AM - 9:46 AM Intracranial Angiography During TCAR: Why It Can Be Valuable And How To Do It In View Of Flow Reversal
  Presenter(s):Peter L. Faries, MD, FACS  
9:47 AM - 9:52 AM Best Device Selection For CAS: What Stent Type And Design, What Type Of Cerebral Protection, What Approach And Delivery System: A Review Of The Evidence
  Presenter(s):Carlo Setacci, MD / Francesco Setacci, MD  
9:53 AM - 9:58 AM Comparison Of SVS Versus ESVS Carotid Guidelines For Treatment Of Asymptomatic Carotid Artery Stenosis: What Is Known For Sure And What Remains Controversial
  Presenter(s):Ali F. AbuRahma, MD  
9:59 AM - 10:04 AM Management Of Anticoagulants And Antiplatelet Therapy In TCAR Patients
  Presenter(s):Michael C. Stoner, MD  
CAROTID STENOSIS AND COGNITIVE FUNCTION
10:05 AM - 10:10 AM Preservation Of Cognition: The New Role For Carotid Artery Interventions For Asymptomatic Disease: Will CREST 2 Confirm Or Deny Its Importance: Findings To Date
  Presenter(s):Wesley S. Moore, MD / Brajesh K. Lal, MD / Thomas G. Brott, MD  
10:11 AM - 10:16 AM DEBATE: Carotid Intervention Improves Cognitive Function Of Patients With Severe Asymptomatic Carotid Stenosis (ACS): What About In Octogenarians: Should More Or Fewer ACS Patients Undergo Invasive Treatment
  Presenter(s):Wei Zhou, MD  
10:17 AM - 10:22 AM

Power Point Presentation with Synched Audio
DEBATE: Not So Fast: There Is Still Great Doubt That Eliminating ACS Improves Cognitive Function: It Should Not Be A Reason For Treating More ACS Patients
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
10:23 AM - 10:30 AM Panel Discussion
END OF SESSION 81
 
SESSION 82 SCHEDULE
Friday
SESSION 82: MORE CAROTID RELATED NEW DEVELOPMENT TOPICS RELATED TO TCAR, CAS AND CEA, NEW DEVICES, MESH COVERED STENTS, MINI-INCISION CEA, SIGNIFICANCE OF DW MRI DEFECTS, TIMING OF TREATMENT, MEDICAL TREATMENT AND DEALING WITH DISTAL (HIGH) CAROTID LESIONS
x
10:30 AM - 10:35 AM

Power Point Presentation with Synched Audio
Transradial CAS Using Novel Low-Profile Double-Mesh Stents (Roadsaver, Terumo): Results And Technical Tips
  Presenter(s):Andrea Kahlberg, MD  
10:36 AM - 10:41 AM Selecting Patients For Carotid Intervention Is Getting Harder: Candidates Are Older (And Sicker), Anatomic Imaging Is Not Standardized, Medical Therapy Is Improving, More Options For Intervention Exist And Cries For Non-Operative Management Are Getting Louder: Is Consensus Even Possible
  Presenter(s):Reese A. Wain, MD  
SIGNIFICANCE OF SMALL DW MRI DEFECTS AFTER CEA/CAS
10:42 AM - 10:47 AM DEBATE: Silent DWI MRI Brain Lesions (Small Infarcts) After CEA/CAS Don’t Matter
  Presenter(s):Thomas G. Brott, MD  
10:48 AM - 10:53 AM DEBATE: Not So: Silent Brain Infarcts (DW MRI Defects) After CEA/CAS Really Matter And Affect Cognitive Changes: The Size And Number Of DW MRI Defects Are Critical
  Presenter(s):Wei Zhou, MD  
10:54 AM - 10:59 AM Value Of Lithotripsy (Shockwave) For CAS In Heavily Calcified Lesions: How To Do It Safely And Technical Tips: Limitations And Precautions
  Presenter(s):Max Amor, MD  
11:00 AM - 11:05 AM Minimal Incision CEA (MICE) Versus TCAR: Technical Tips For MICE, Cost Effectiveness, Advantages And Limitations Of Both
  Presenter(s):Enrico Ascher, MD  
11:06 AM - 11:11 AM For Symptomatic Carotid Stenosis Invasive Treatment (TFCAS, CEA, TCAR) On Weekends Is More Risky: This Is Especially True For TFCAS Which Probably Should Not Be Performed On Weekends
  Presenter(s):Heepeel Chang, MD  
11:12 AM - 11:18 AM Panel Discussion
11:18 AM - 11:23 AM What Is The Best Medical Treatment For Patients With Carotid Stenosis (Asymptomatic And Symptomatic): Can High Risk Plaques Be Made Low Risk And Smaller: All Stroke Patients Should Be On Statins Because They Markedly Decrease Recurrent Stroke And Mortality Rates
  Presenter(s):J. David Spence, MD  
11:24 AM - 11:29 AM Technical Tips And Maneuvers To Make Treatment Of High Carotid Lesions Safe And Relatively Simple
  Presenter(s):Richard J. Powell, MD  
11:30 AM - 11:35 AM What Are The Real Risk Factors For CEA, TFCAS And TCAR: Why Has CMS Gotten Their Risk Factors Wrong And How Have They Messed Up Their Reimbursement Incentives
  Presenter(s):Mahmoud B. Malas, MD, MHS  
TIMING OF CAROTID INTERVENTIONS AFTER SYMPTOM ONSET
11:36 AM - 11:41 AM When Is Urgent (Within 48 Hours) CEA Or CAS Fairly Indicated After A Stroke: How Does Use Of tPA Influence Indications And Neurologic Outcomes In This Setting
  Presenter(s):Hernan A. Bazan, MD, DFSVS, FACS  
11:42 AM - 11:47 AM When Is It Reasonable To Perform CEA Within 48 Hours After Stroke Symptoms Starts: Under What Conditions And What Precautions Should Be Taken
  Presenter(s):R. Clement Darling III, MD  
11:48 AM - 11:53 AM With Crescendo TIAs And Thrombus Overlying A Plaque What Is The Best Invasive Treatment And When Should It Be Performed
  Presenter(s):Domenico Valenti, DMChir, PhD, FRCS, FRCS(Ed), FEBVS  
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 1:00 PM Lunch Break – Rhinelander Gallery, 2nd Floor
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 82
 
SESSION 83 SCHEDULE
Friday
SESSION 83: MORE HOT CAROTID AND SUBCLAVIAN TOPICS: UPDATES ON KEY CAROTID RCTs
x
1:00 PM - 1:05 PM Lipid Management For High Risk Carotid Lesions: Statins, Ezetimibe, PCSK9 And What Else: Should LDL-C Be Monitored
  Presenter(s):Christos D. Liapis, MD  
UPDATE ON CAROTID RCTs
1:06 PM - 1:11 PM Update On CREST 2: CEA Versus Best Medical Treatment (BMT) And CAS Versus BMT For Asymptomatic Carotid Stenosis (ACS): Recruitment And Findings To Date: Why Not Present The 30-Day And 1-Year Results: If BMT Showed No Difference In Stroke And Death Rates With Those Of CAS Or CEA, Wouldn’t This Remove Justification For Invasive Treatment Of ACS Until A Benefit Was Shown
  Presenter(s):Thomas G. Brott, MD / Brajesh K. Lal, MD  
1:12 PM - 1:17 PM Why The Carotid RCTs Fail To Support The Recent CMS Expansion Of Reimbursement For CAS To Treat Asymptomatic Disease (ACS): Do The 5-Year SPACE-2 Results Suggest That Such Expanded Reimbursement Be Delayed Until CREST-2 Data Is In
  Presenter(s):Caitlin W. Hicks, MD, MS  
1:18 PM - 1:23 PM Why CREST-2 May Not Provide Any Valid Answers: Because Of Bad Patient Selection In CREST-2, And Because BMT May Not Be Optimal Without GLP-1 Agonists Which Decrease Stroke Rates: What Is The Evidence
  Presenter(s):Sumaira Macdonald, MD, PhD  
1:24 PM - 1:29 PM Update On ACST-2: This RCT Found That CEA And CAS For ACS Had Comparable Adverse Event Rates Up To 10 Years And Implied That Both Invasive Treatments Were Superior To Now Obsolete BMT
  Presenter(s):Richard Bulbulia, MA, MD, FRCS / Alison Halliday, MS, FRCS  
1:30 PM - 1:35 PM Not So Fast! ACST-2 – Like CREST – Has Flaws That Invalidate Their Conclusions: Invasive Therapies May NOT Be Better Than BMT: What Are These Flaws
  Presenter(s):J. David Spence, MD  
1:36 PM - 1:41 PM What Is The Proof That CAS Is Ever Indicated For ACS: The Evidence Does Not Yet Support It
  Presenter(s):Franco Grego, MD  
1:42 PM - 1:47 PM Panel Discussion
1:48 PM - 1:53 PM Consecutive Monocenter Results With CAS For Asymptomatic Carotid Stenosis (ACS): We Should Not Need An RCT: But Why We Will Still Do
  Presenter(s):Klaus D. Mathias, MD / Anna Zeller, MD  
1:54 PM - 1:59 PM The 2nd European Carotid Surgery Trial (ECST-2): What Will It Tell Us About Best Medical Therapy Versus Invasive Therapy And Progress To Date
  Presenter(s):Gert J. de Borst, MD, PhD  
2:00 PM - 2:05 PM When A Duplex Scan Detects Subclavian Steal, Symptomatic Or Asymptomatic, What Is The Natural History And How Should It Be Managed
  Presenter(s):Ali F. AbuRahma, MD  
2:06 PM - 2:11 PM DEBATE: Completion Imaging After CEA Is Unnecessary And Potentially Harmful
  Presenter(s):Ali F. AbuRahma, MD  
2:12 PM - 2:17 PM DEBATE: Not So: Completion Imaging (Angiography Or Duplex) After CEA Is Necessary And Helpful
  Presenter(s):Keith D. Calligaro, MD  
2:18 PM - 2:23 PM Panel Discussion
END OF SESSION 83
 
SESSION 84 SCHEDULE
Friday
SESSION 84: MORE HOT CAROTID TOPICS: TREATMENT IN 2024 OF RECURRENT CAROTID STENOSIS; STROKES DURING CAROTID TREATMENT; CAROTID NEAR OCCLUSIONS; SILENT CORONARY ISCHEMIA IN CAROTID PATIENTS
x
2:24 PM - 2:29 PM Most Recurrent Carotid Stenosis Is Benign: When Is Intervention Justified And What Intervention Should Be Used
  Presenter(s):Ashraf Mansour, MD  
2:30 PM - 2:35 PM Current Best Treatment For Strokes Apparent During Or Right After CEA, CAS Or TCAR: Best Diagnostic Modalities And Treatments: Who Should Be Involved And What Skills Are Needed
  Presenter(s):Gert J. de Borst, MD, PhD  
2:36 PM - 2:41 PM Can TCAR Be Helpful In The Management Of Carotid String Sign Lesions Or Near Occlusions Of The Internal Carotid Artery: When Is Its Use Justified, Advantage And Technical Tips
  Presenter(s):Animesh Rathore, MD  
2:42 PM - 2:47 PM Advances In The Diagnosis And Treatment Of Near Total Occlusions And String Signs Of The Internal Carotid Artery (ICA) In Symptomatic And Asymptomatic Patients: How Are They Best Treated: What Do The Current Guidelines Say
  Presenter(s):Christos D. Liapis, MD  
2:48 PM - 2:53 PM Optical Coherence Tomography (OCT) Proves CAS Is Rendered Safer Because Mesh Covered Stents Decrease Emboli: The Imaging Evidence And What It Shows About The Interaction Between Stent And Plaque
  Presenter(s):Carlo Setacci, MD / Francesco Setacci, MD  
2:54 PM - 2:59 PM Silent Coronary Ischemia As Detected By FF+RCT Is Common In Carotid Stenosis Patients: Coronary Revascularization In Such Patients Decreases Mortality: When Should It Be Done – Before Or After Carotid Treatment
  Presenter(s):Christopher K. Zarins, MD / Dainis K. Krievins, MD  
3:00 PM - 3:05 PM Technical Tips To Enable TCAR In Difficult Anatomic Circumstances Including Use Of A Prosthetic Conduit
  Presenter(s):Ashraf Mansour, MD  
3:06 PM - 3:11 PM Compared To CEA, TCAR Improves Operating Room (OR) Throughout But Is More Costly: Tips To Improve OR Efficiency
  Presenter(s):Gregg S. Landis, MD  
3:12 PM - 3:19 PM Panel Discussion
3:19 PM - 3:30 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 84
 
SESSION 85 SCHEDULE
Friday
SESSION 85: UPDATED ENDOVASCULAR CONCEPT AND MORE HOT AND CONTROVERSIAL CAROTID TOPICS
x
3:30 PM - 3:35 PM Update On Transvenous Liver Biopsies: What Equipment Is Needed And How To Do Them
  Presenter(s):Jacob Cynamon, MD, FACR, FSIR  
3:36 PM - 3:41 PM Floating Clot At The Carotid Bifurcation Is A Prime Indication For Flow Reversal Technology During Treatment Of Carotid Stenosis: How Can Flow Reversal Best Be Achieved In This Setting
  Presenter(s):Juan C. Parodi, MD  
3:42 PM - 3:47 PM In Stent Stenosis After CAS: How Can It Be Predicted: When Is It Threatening And How Is It Best Managed
  Presenter(s):Jacques Busquet, MD  
3:48 PM - 3:53 PM Anatomic And Procedural Correlates Of Intra- And Postoperative Hypotension With CAS: What Should Be Done About It
  Presenter(s):Michael C. Stoner, MD  
3:54 PM - 3:59 PM DEBATE: CAS Is The Best Treatment For Young Healthy Patients With High Grade Asymptomatic Carotid Stenosis (ACS)
  Presenter(s):D. Christopher C. Metzger, MD   
4:00 PM - 4:05 PM

Power Point Presentation with Synched Audio
DEBATE:Not So: Even Young Patients With A High Grade ACS Should Not Be Treated By CAS Or CEA: BMT Should Suffice: Are There Any Exceptions
  Presenter(s):Anne L. Abbott, MD, PhD, FRACP  
4:06 PM - 4:11 PM Why We Need An RCT Comparing TCAR With TFCAS, Transradial CAS And Best Medical Treatment For ACS And Symptomatic Carotid Stenosis
  Presenter(s):Michael H. Wholey, MD, MBA  
4:12 PM - 4:17 PM New Technical Tips To Make Minimal Incision CEA (MICE) Easier And Better: Can Same Day Discharge Be Safe
  Presenter(s):Robert M. Proczka, MD, PhD  
4:18 PM - 4:23 PM Risks And Causes Of Non-Ipsilateral Stroke Complicating CEA And CAS: How To Decrease Them
  Presenter(s):Mark Conrad, MD, MMSc / W. Darrin Clouse, MD  
4:24 PM - 4:30 PM Panel Discussion
END OF SESSION 85
 
SESSION 86 SCHEDULE
Friday
SESSION 86: NEW CONCEPTS AND NEW DEVELOPMENTS IN PERCUTANEOUS ACCESS CLOSURE AND WOUND CARE
x
PROGRESS IN PERCUTANEOUS ACCESS AND CLOSURE
4:30 PM - 4:35 PM Update On Large Bore Percutaneous Access Closure: Current Status, New Devices, How To Avoid Complications And Where Do We Go From Here
  Presenter(s):Zvonimir Krajcer, MD, FACC  
4:36 PM - 4:41 PM Large Bore Percutaneous Arterial Closure: Which Device Is Best: Advantages And Disadvantages Of The Manta Device
  Presenter(s):Michael J. Singh, MD  
4:42 PM - 4:47 PM Current Approaches For Large Bore Device Arterial Closure After Percutaneous EVAR And TEVAR: Technical Tips And Causes Of Failure
  Presenter(s):Gianmarco de Donato, MD  
4:48 PM - 4:53 PM How To Use Fascial Suture Technique To Control Percutaneous Large Vessel Access: Technical Tips And When To Use
  Presenter(s):Tal M. Hoerer, MD, PhD / Thomas Larzon, MD, PhD  
4:54 PM - 4:59 PM Results And Benefits Of The CELT ACD Femoral Arteriotomy Closure Device In The Office-Based Laboratory And Hospital
  Presenter(s):Joseph J. Ricotta II, MD, MS, DFSVS, FACS  
PROGRESS IN WOUND CARE
5:00 PM - 5:05 PM Update/Review Of Recently Published AHA Guidelines For Treatment Of Diabetic Wounds In The Setting Of PAD
  Presenter(s):Katherine A. Gallagher, MD  
5:06 PM - 5:11 PM A Single Device (From AOTI) For Triple Therapy (Local Oxygen, Compression And Humidification) Enhances Healing Of Non-Healing Lower Extremity Wounds And Incisions
  Presenter(s):David J. Dexter, MD  
5:12 PM - 5:17 PM New Developments With The TAVITA System To Predict Wound And Amputation Healing And To Monitor The Effectiveness Of Revascularization Procedures: Hyperspectral Imaging Can Non-Invasively Determine Oxygenation And Perfusion: How Does It Work And Results
  Presenter(s):Jan-Willem Elshof, MD  
5:18 PM - 5:23 PM Optimal Treatment For Deep Groin Infection After Prosthetic Bypasses From The Common Femoral Artery: How To Save The Graft And The Leg
  Presenter(s):Hosam F. El Sayed, MD  
5:24 PM - 5:32 PM Panel Discussion
End of Program K

END OF SESSION 86
 
SESSION 87 SCHEDULE
Friday
SESSION 87: POPLITEAL DISEASE TOPICS RELATED TO ANEURYSM TREATMENT, ENTRAPMENTS, ADVENTITIAL CYSTIC DISEASE AND TRAUMA
x
POPLITEAL ANEURYSMS AND THEIR BEST CURRENT TREATMENTS
6:52 AM - 6:57 AM Endovascular Repair For Popliteal Artery Aneurysm: Pitfalls And Complications: When Is Open Surgery Best
  Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS  
6:58 AM - 7:03 AM Treatment Of Popliteal Aneurysms: When Conservative, When Open, When Endovascular: What Are The Hard Data
  Presenter(s):Martin Björck, MD, PhD  
7:04 AM - 7:09 AM Endovascular Versus Open Repair: Why After 20 Years Of Selective Endografting, I Now Favor Open Repair In Most Patients
  Presenter(s):Martin R. Back, MD  
7:10 AM - 7:15 AM Outpatient Endovascular Repair Of Popliteal Artery Aneurysms With Bare Metal Stents: It Shouldn’t Work, But Does: What Is The Evidence
  Presenter(s):Sam S. Ahn, MD, FACS, MBA  
7:16 AM - 7:21 AM Rescue Procedures For Failed Endovascular Repairs Of Popliteal Aneurysms: Observation May Be Enough: If Not, Hybrid Versus Open Repair: Technical Tips
  Presenter(s):Jose Fernandes e Fernandes, MD, PhD, FRCS (Eng), FACS, FESC, FEBVS  
ENTRAPMENTS, ADVENTITIAL CYSTIC DISEASE AND TRAUMA
7:22 AM - 7:29 AM Updates On The Diagnosis And Treatment Of Popliteal Entrapments: What Are Their Misleading (Doppelganger) Diagnoses
  Presenter(s):Katherine A. Gallagher, MD  
7:30 AM - 7:35 AM Management Of Functional Popliteal Artery Entrapment Syndrome In Athletes: What Is The Pathological Anatomy And What Symptoms Does It Cause: Technique Of Surgical Repair
  Presenter(s):Jason T. Lee, MD  
7:36 AM - 7:41 AM Adventitial Cystic Disease Of The Popliteal Artery: Pathogenesis, Symptoms And Optimal Treatment
  Presenter(s):Irwin V. Mohan, MBBS, MD, FRCS, FEBVS, FRACS  
7:42 AM - 7:47 AM What Is The Surgical Approach And Best Graft Usage For Popliteal Artery Injury From Posterior Knee Dislocation: How Can Associated Vein Injury Be Detected And What Should Its Treatment Be
  Presenter(s):Charles J. Fox, MD, FACS  
7:48 AM - 7:56 AM Panel Discussion
END OF SESSION 87
 
SESSION 88 SCHEDULE
Friday
SESSION 88: NEW DEVELOPMENTS IN TREATING ARTERIAL (INCLUDING AORTIC) GRAFT INFECTIONS
x
7:56 AM - 8:01 AM Update On The NAIS Procedure (Deep Vein Reconstruction) For Infected Aortic Grafts: How To Make The Operation Easier And Faster: When Is It Indicated
  Presenter(s):John F. Eidt, MD  
TREATMENT OF MYCOTIC ANEURYSMS
8:02 AM - 8:07 AM What Is The Best Treatment For Mycotic Aneurysms: Open, Endo, Or Hybrid: When Is EVAR Helpful
  Presenter(s):Yamume Tshomba, MD  
8:08 AM - 8:13 AM Rifampin Soaked Endografts To Treat Mycotic AAAs: How To Prepare Them And When To Use Them: Are They Stand-Alone Treatment Or Do They Need Adjunctive Techniques
  Presenter(s):Guillermo A. Escobar, MD  
TREATMENT OF AORTIC AND ARTERIAL GRAFT AND ENDOGRAFT INFECTIONS
8:14 AM - 8:19 AM For Many Infected Prosthetic Arterial/Aortic Grafts, Endografts And Mycotic Aneurysms Less Than The Current Standard Radical Graft Excisional Treatment Is Best: Details And Examples Of This Less Radical Treatment
  Presenter(s):Martin Malina, MD, PhD  
8:20 AM - 8:25 AM Support For The Graft Preservation Concept For Treating Prosthetic Aortic Graft Infections From A European Multicenter Study (VASGRA): All Or Part Of The Infected Graft May Be Preserved: Under What Circumstances
  Presenter(s):Zoran Rancic, MD, PhD, EMBA HSG  
8:26 AM - 8:31 AM Optimal Techniques In 2024 For Treating Infected Aortoiliac Prosthetic Grafts And Endografts (Including EVAR, TEVAR, F/B/EVAR): From A Large National Cohort And The GRANDPA Global Registry
  Presenter(s):Anders Wanhainen, MD, PhD  
8:32 AM - 8:37 AM Panel Discussion
8:38 AM - 8:43 AM With Aortic Graft Infection, How Can Inline (In Situ) Flow Be Reestablished: Indications: What Grafts: Technical Tips: Results
  Presenter(s):Peter F. Lawrence, MD  
8:44 AM - 8:49 AM Infected Endografts After EVAR: Etiological Factors, Diagnosis, Treatment: Does The Endograft Always Have To Be Removed
  Presenter(s):Mohammad H. Eslami, MD, MPH  
8:50 AM - 8:55 AM The Real Truth About Use Of Cryopreserved Conduits (CryoGraft-Artivion) To Treat Infected Aortic/Arterial Reconstructions: From A Large Single Center Experience: There Are Advantages And Limitations
  Presenter(s):Randall R. De Martino, MD / Manju Kalra, MBBS  
8:56 AM - 9:01 AM Update On Surgical Treatment For Infected Thoracic Aortic Grafts And Endografts, With Or Without Aorto-Esophageal Or Aorto-Bronchial Fistulas: Optimal Techniques And Results From A Committed Center
  Presenter(s):Germano C.G. Melissano, MD / Andrea Kahlberg, MD / Roberto L.V. Chiesa, MD  
9:02 AM - 9:07 AM TEVAR For The Treatment Of Aorto-Esophageal And Aorto-Bronchial Fistulas: Is It Only A Bridging Procedure Or Is It Ever A Definitive Treatment
  Presenter(s):Markus K. Furrer, MD  
9:08 AM - 9:13 AM Treatment Of Infected Aortic Grafts (Endo And Open): Explantation Or Preservation: Technical Tips
  Presenter(s):Javairiah Fatima, MD  
9:14 AM - 9:20 AM Panel Discussion
9:20 AM - 9:34 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 88
 
SESSION 89 SCHEDULE
Friday
SESSION 89: PROGRESS IN VASCULAR IMAGING AND GUIDANCE FOR ENDOVASCULAR TREATMENTS WITH LESS RADIATION EXPOSURE OR CONTRAST TOXICITY
x
9:34 AM - 9:39 AM Advantages And Disadvantages Of The Three Main Hybrid OR Suites (GE, Siemens, Philips): How To Pick The Best One For Your Institution
  Presenter(s):Bjoern D. Suckow, MD  
ADVANCED ENDOVASCULAR GUIDANCE WITH LESS RADIATION
9:40 AM - 9:45 AM 3-Dimensional Advanced Guidance Systems For Endovascular Procedures: How Do The IOPS (Centerline), FORS (Philips), And Cydar (Medtronic) Systems Work And Reduce The Need For Radiation
  Presenter(s):Mark A. Adelman, MD  
9:46 AM - 9:51 AM With F/B/EVAR For Complex AAAs, FORS Lumiguide Fiberoptic Guidance (Philips) Reduces Radiation Exposure Compared To Standard Imaging
  Presenter(s):Marc L. Schermerhorn, MD  
9:52 AM - 9:57 AM New Developments With The IOPS (Centerline) Guidance System For F/B/EVAR: How Effective Is It Proving To Be: Advantages And Limitations
  Presenter(s):Matthew J. Eagleton, MD  
9:58 AM - 10:03 AM What Is Redo Fusion And How Does It Help After Failed Endovascular Complex Aortic Procedures
  Presenter(s):Giovanni Tinelli, MD, PhD  
10:04 AM - 10:09 AM Panel Discussion
DUPLEX AND INTRAVASCULAR ULTRASOUND
10:10 AM - 10:15 AM Duplex Ultrasound Guidance: When Can It Replace Fluoroscopy For Endovascular Procedures: Requirements, Advantages, Limitations: Is Its Use Becoming Widespread
  Presenter(s):Enrico Ascher, MD / Natalie A. Marks, MD, RPVI, RVT, FSVM  
10:16 AM - 10:21 AM Intraprocedural Duplex Ultrasound Guidance May Be Better And Cheaper Than IVUS For Most Endovascular Cases: When Is It Not
  Presenter(s):Eric A. Secemsky, MD, MSc  
EKG-GATED CTA
10:22 AM - 10:27 AM EKG-Gated CTA And Its Added Value For Sizing EVAR And TEVAR Endografts: How It Decrease Failures
  Presenter(s):Frans L. Moll, MD, PhD  
VASCULAR HOLOGRAPHY
10:28 AM - 10:33 AM Update On The ARCUS System Of Augmented Reality (Derived From A Contrast CT) And Its Value In Vascular And Endovascular Procedures: How Does It Work And Experience To Date
  Presenter(s):Jan M.M. Heyligers, MD, PhD, FEBVS  
10:34 AM - 10:39 AM Update On Holographic Guidance Of Endovascular Procedures (With Augmented Reality Goggles And No Screen): How Does It Work And Clinical Experience: What Is Possible And What Is Not
  Presenter(s):Claude Mialhe, MD  
10:40 AM - 10:48 AM Panel Discussion
END OF SESSION 89
 
SESSION 90 SCHEDULE
Friday
SESSION 90: AUGMENTED REALITY (AR), MIXED REALITY AND ARTIFICIAL INTELLIGENCE (AI): HOW WILL THEY IMPROVE VASCULAR IMAGING AND ENDOVASCULAR DEVICE GUIDANCE WHILE MINIMIZING RADIATION
x
10:49 AM - 12:00 PM PROGRAM TO BE DETERMINED
12:00 PM - 1:00 PM Lunch Break – Rhinelander Gallery, 2nd Floor
Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 90
 
SESSION 91 SCHEDULE
Friday
SESSION 91: PRESENTATIONS AND CHALLENGING RECORDED LIVE CASES FROM MÜNSTER, GERMANY
x
1:00 PM - 1:37 PM PROGRAM TO BE DETERMINED
END OF SESSION 91
 
SESSION 92 SCHEDULE
Friday
SESSION 92: NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC OUTLET SYNDROMES (TOSs)
x
1:38 PM - 1:43 PM For Venous TOS An Anterior Infraclavicular Approach Permits Resection Of The Anterior Third Of The First Rib Which Is Sufficient: Technique, Limitations And Results
  Presenter(s):Keith D. Calligaro, MD / Matthew J. Dougherty, MD  
1:44 PM - 1:49 PM Minimal Invasive Transaxillary First Rib Resection Under Local And Regional Anesthesia For TOSs: How To Do It, Limitations And Precautions
  Presenter(s):Francesco Spinelli, MD  
1:50 PM - 1:55 PM To Treat Various Forms Of TOSs Resection Of The Middle Third Of The First Rib Is Sufficient: A 30-Year Experience: How To Do It And When Not To
  Presenter(s):Claude D. Vaislic, MD  
1:56 PM - 2:01 PM Robotic Approach To Thoracic Outlet Decompression: How To Do It: Limitations And Contraindications
  Presenter(s):Katherine A. Teter, MD  
2:02 PM - 2:07 PM Supraclavicular Approach To Arterial And Neurogenic TOSs (Video Presentation)
  Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS  
2:08 PM - 2:13 PM Botox Injections In The Treatment Of Neurogenic TOS: How Does It Work, When To Do It, How To Do It And Results
  Presenter(s):Jason T. Lee, MD  
2:14 PM - 2:19 PM Adolescent Neurogenic And Vascular TOSs: They Are Different And Uniquely Challenging: How To Diagnose Them And How Best To Treat Them In Athletes And Non-Athletes
  Presenter(s):Michael J. Singh, MD  
2:20 PM - 2:25 PM Subclavian Artery Aneurysms In Patients With Genetic Arteriopathy: How Should They Be Worked Up And Treated
  Presenter(s):Sherene Shalhub, MD, MPH  
2:26 PM - 2:32 PM Panel Discussion
2:32 PM - 2:42 PM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 92
 
SESSION 93 SCHEDULE
Friday
SESSION 93: BEST ANTIPLATELET REGIMENS UPDATE ON RARE VASCULAR DISEASES; NEW DEVELOPMENTS IN ANTIPLATELET AND ANTICOAGULATION REGIMENS AND MEDICAL AND DRUG TREATMENTS
x
UPDATE ON TREATMENT OF RARE VASCULAR DISEASES
2:42 PM - 2:47 PM Optimal Current Management Of Takayasu's Disease Involving The Supra-Aortic Branches: Technical Details For Open Surgical Management And What Is The Role For Endo Treatment With Bare Or Covered Stents
  Presenter(s):Kellie R. Brown, MD  
2:48 PM - 2:53 PM The Present Status Of Buerger’s Disease: Does It Still Exist; How To Diagnose And Treat It
  Presenter(s):Kamphol Laohapensang, MD  
2:54 PM - 2:59 PM How To Make Operations For Complications Of Vascular Ehlers Danlos Syndrome Go Well
  Presenter(s):James H. Black, III, MD  
3:00 PM - 3:05 PM

Power Point Presentation with Synched Audio
Medical Treatment Of Patients With Vascular Ehlers Danlos Syndrome: How Does Celiprolol Treatment Work And How Does It Help
  Presenter(s):Martin Björck, MD, PhD  
ANTIPLATELET AND ANTICOAGULATION TREATMENT
3:06 PM - 3:11 PM Current Optimal Antiplatelet And Anticoagulation Treatment For Various Vascular Procedures In Various Vascular Beds: What Newer Drugs And DOACs Are Useful And What Is The Optimal Timing Of Treatment
  Presenter(s):Peter Henke, MD  
3:12 PM - 3:17 PM Understanding The Barriers To Antiplatelet And Statin Adherence Following Vascular Interventions: What Should Be Done About It
  Presenter(s):Wei Zhou, MD  
3:18 PM - 3:23 PM Panel Discussion
3:24 PM - 3:29 PM Next Generation Antithrombotic Agents: What’s On The Horizon For Anticoagulant And Antithrombotic Drugs: How Will They Work And How Helpful Will They Be
  Presenter(s):Elliot L. Chaikof, MD, PhD  
3:30 PM - 3:35 PM Lowering LDL-C And Controlling Elevated Blood Pressure And Lipoprotein Little A [Lp(a)] Can Lower Cardiovascular Risk 80%: What To Do If Patients Can’t Tolerate A Statin Dose: Ezetimibe (Zetia), A PCSK9 Inhibitor, Inclisiran, Bempedoic Acid (Nexletol), Etc.
  Presenter(s):Richard Bulbulia, MA, MD, FRCS  
NEW DEVELOPMENTS IN MEDICAL MANAGEMENT
3:36 PM - 3:41 PM What Are The Best Medical Treatments After Carotid, Aortic And Lower Extremity Endovascular And Open Procedures
  Presenter(s):Maciej L. Dryjski, MD, PhD  
3:42 PM - 3:47 PM Value And Limitations Of Statins And Non-Statin Lipid Lowering Agents And Other Medical Treatments In Patients With Carotid Artery Stenosis: Should They Be The Same Or Different In Patients Undergoing Invasive Procedures
  Presenter(s):Kosmas I. Paraskevas, MD  
3:48 PM - 3:52 PM Panel Discussion
END OF SESSION 93
 
SESSION 94 SCHEDULE
Friday
SESSION 94: ADVANCES IN THE ENDO AND OPEN TREATMENT OF VASCULAR TRAUMA
x
3:52 PM - 3:57 PM Vascular Injuries After Blunt Abdominal Trauma: Diagnosis And Management: When Endo, When Open Treatment
  Presenter(s):Dittmar Boeckler, MD  
3:58 PM - 4:03 PM New Developments In The Endovascular Management Of Vascular Injuries: How Can A Hybrid Suite Be Helpful
  Presenter(s):Ravi R. Rajani, MD  
UPDATE ON BLUNT THORACIC AORTIC INJURY (BTAI)
4:04 PM - 4:09 PM How To Manage Heparin In TEVAR For BTAI When Head Or Other Injuries Are Also Present: Some, None Or Just Sheath Flushing
  Presenter(s):Charles J. Fox, MD, FACS  
4:10 PM - 4:15 PM Outcomes Of BTAI In >1,000 Patients: When Is Observation The Best Treatment; When Is TEVAR Best: When Is It Not: Technical Tips: From The Aortic Trauma Foundation Registry
  Presenter(s):Ali Azizzadeh, MD  
4:16 PM - 4:21 PM Acute Thoracic Aortic Pseudo-Coarctation After BTAI: What Is It: How Does It Produce Distal Organ Ischemia: How Should It Be Diagnosed And Treated Emergently By TEVAR: Technical Tips
  Presenter(s):Erica L. Mitchell, MD, MEd  
4:22 PM - 4:27 PM Classification Of BTAIs In Adults And Pediatric Patients: The Evidence Shows That Grade I And II Lesions Can Be Treated Conservatively Whereas Grades III And IV Should Be Treated Endovascularly: Recommendations For Graft Sizing In Children
  Presenter(s):Elina Quiroga, MD, MPH  
4:28 PM - 4:33 PM Update On The Retrievable Rescue Stent-Graft For Treating Aortic And Vena Cava Injuries: What Is It: How Does It Work And Current Status
  Presenter(s):Bryan W. Tillman, MD, PhD  
4:34 PM - 4:39 PM Update On Resuscitative Endovascular Balloon Occlusion Of The Aorta (REBOA): When Is It A Valuable Procedure And When Is It Not: Limitations And Precautions
  Presenter(s):Gilbert R. Upchurch, MD  
4:40 PM - 4:45 PM Evolving Techniques In Pediatric Vascular And Endovascular Trauma Surgery: What Special Precautions Are Needed: How To Deal With Arterial Spasm: When And How Can Endovascular Grafts Be Used
  Presenter(s):Michael C. Dalsing, MD  
4:46 PM - 4:56 PM Panel Discussion
End of Program L

END OF SESSION 94
 
SESSION 95 SCHEDULE
Friday
SESSION 95: DEEP VENOUS PHYSIOLOGY AND VENOUS STENT ISSUES
x
7:30 AM - 7:34 AM Introduction: Deep System
  Presenter(s):Lowell S. Kabnick, MD, FACS, FAVLS, DFAVF  
7:35 AM - 7:40 AM Why Do We Call It Venous Hypertension
  Presenter(s):Brajesh K. Lal, MD  
7:41 AM - 7:46 AM Appropriate Patient Selection For Iliac Vein Stenting
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
7:47 AM - 7:52 AM Is 50% Stenosis The Cutpoint For Stenting
  Presenter(s):Mark H. Meissner, MD  
7:53 AM - 7:58 AM Iliocaval Duplex Ultrasound With Image Optimization
  Presenter(s):Jan M. Sloves, RVT  
7:59 AM - 8:04 AM Physiologic Assessment Of The Severity Of Iliac Vein Obstruction
  Presenter(s):Fedor Lurie, MD, PhD  
8:05 AM - 8:10 AM Approaching The NIVL Patient: How To Ensure Success
  Presenter(s):Mahmood Razavi, MD  
8:11 AM - 8:16 AM An Ultrasound Imaging And Computational Fluid Dynamic Protocol To Assess Hemodynamics In Iliac Vein Compression Syndrome
  Presenter(s):Carlos Alberto Figueroa, PhD  
8:17 AM - 8:22 AM Panel Discussion
END OF SESSION 95
 
SESSION 96 SCHEDULE
Friday
SESSION 96: VENOUS STENT TRIALS
x
8:23 AM - 8:28 AM RCT: Venous Stenting Versus Conservative Treatment In Deep Venous Obstruction
  Presenter(s):Houman Jalaie, MD, PhD  
8:29 AM - 8:34 AM Early Experience With The Gore Viafort Venous Stent
  Presenter(s):Andrew Holden, MBChB  
8:35 AM - 8:40 AM The BEYOND Venous Stent Registry
  Presenter(s):Michael K.W. Lichtenberg, MD  
8:41 AM - 8:46 AM Criteria To Predict Mid-Term Outcome After Stenting Of Chronic Iliac Vein Obstructions (PROMISE Trial)
  Presenter(s):Iris Baumgartner, MD  
8:47 AM - 8:52 AM Will The BEST Trial Answer The Question On Iliac Stenting
  Presenter(s):Alun H. Davies, MA, DM, DSc, FRCS, FLSW, FMedSci, FEBVS  
8:53 AM - 8:58 AM A Look At Long-Term Venous Stent Data: ABRE Study 36-Month Clinical Outcome
  Presenter(s):Erin H. Murphy, MD  
8:59 AM - 9:04 AM Zilver Vena Stent Trial: 4-Year Outcomes
  Presenter(s):Anthony J. Comerota, MD, FACS, FACC  
9:05 AM - 9:10 AM Venovo Venous Registry: 36-Month Data Report From A Real World Registry
  Presenter(s):Michael K.W. Lichtenberg, MD  
9:11 AM - 9:16 AM Panel Discussion
END OF SESSION 96
 
SESSION 97 SCHEDULE
Friday
SESSION 97: FEMORO-ILIOCAVAL CHRONIC TOTAL OCCLUSIONS, RECANALIZATION TECHNIQUES AND OTHER CONSIDERATIONS
x
9:17 AM - 9:22 AM Steps To Minimize Complications During Central Venous Recanalization
  Presenter(s):Marcelo Guimaraes, MD, MBA, FSIR  
9:23 AM - 9:28 AM Ruptured IVC And Iliac Vein: Now What
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
9:29 AM - 9:34 AM Outcomes And Predictors Of Failure Of Iliac Vein Stenting
  Presenter(s):Rabih A. Chaer, MD  
9:35 AM - 9:40 AM Preclinical Data On Sirolimus Coated Balloons In Deep Veins: Results From The vSTRIDE Trial
  Presenter(s):Andrea T. Obi, MD  
9:41 AM - 9:46 AM Results Of Revcore For Use In Chronic Deep Vein Stent Occlusion
  Presenter(s):Steven D. Abramowitz, MD  
9:47 AM - 9:52 AM Hybrid Open And Endovascular Techniques For Complex Iliofemoral Disease
  Presenter(s):Erin H. Murphy, MD  
9:53 AM - 9:58 AM Endovascular Brachiocephalic And IVC Bypass Graft Creation: Changing What Is (Im)Possible
  Presenter(s):Marcelo Guimaraes, MD, MBA, FSIR  
9:59 AM - 10:04 AM Veins Aren’t Round – Stented Veins Don’t Need To Be Either
  Presenter(s):Lowell S. Kabnick, MD, FACS, FAVLS, DFAVF  
10:05 AM - 10:10 AM Panel Discussion
END OF SESSION 97
 
SESSION 98 SCHEDULE
Friday
SESSION 98: VENOUS THROMBOSIS SCIENCE AND TREATMENT STRATEGIES
x
10:11 AM - 10:16 AM Have Venous Trials Changed The Management Of The Ilio-Femoral DVT In 2024
  Presenter(s):Ali Amin, MD, RVT, FACS, FACC  
10:17 AM - 10:22 AM Update Of Post-Thrombotic Syndrome Prevention
  Presenter(s):Tomasz Urbanek, MD  
10:23 AM - 10:28 AM Update On Experimental DVT Vein Wall Injury
  Presenter(s):Peter Henke, MD  
10:29 AM - 10:34 AM Venous Thromboembolism In The Context Of Chronic Venous Disease
  Presenter(s):Thomas W. Wakefield, MD  
10:35 AM - 10:40 AM Inflow Assessment In PTS Patients
  Presenter(s):Jose I. Almeida, MD, FACS, RPVI, RVT  
10:41 AM - 10:46 AM Why Do VTE Risk Scores Fail To Prevent VTE
  Presenter(s):Peter Henke, MD  
10:47 AM - 10:52 AM Inflammation, Selectins And Venous Thrombosis
  Presenter(s):Thomas W. Wakefield, MD  
10:53 AM - 10:58 AM Predictive Modeling For Post-Thrombotic Syndrome In DVT Patients
  Presenter(s):Steven D. Abramowitz, MD  
10:59 AM - 11:04 AM Assessing Radiation Exposure To Patients During Recanalization Of Chronic Venous Obstruction
  Presenter(s):Houman Jalaie, MD, PhD  
11:05 AM - 11:10 AM Panel Discussion
END OF SESSION 98
 
SESSION 99 SCHEDULE
Friday
SESSION 99: THROMBUS REMOVAL THROMBECTOMY DEVICES AND OTHER ISSUES TO CONSIDER
x
11:11 AM - 11:16 AM P-Max Study: Mechanical Thrombectomy For Iliofemoral DVT With Aspirex – 24-Month Results
  Presenter(s):Michael K.W. Lichtenberg, MD  
11:17 AM - 11:22 AM Tips And Tricks With Lightning FLASH For PE And DVT Patients
  Presenter(s):Patrick E. Muck, MD, FACS  
11:23 AM - 11:28 AM New Percutaneous Thrombectomy Reperfusion System
  Presenter(s):Patrick E. Muck, MD, FACS  
11:29 AM - 11:34 AM CLOUT Registry For The Inari CloTriever
  Presenter(s):David J. Dexter, MD  
11:35 AM - 11:40 AM Management Of IVC Thrombus Using Large Bore Mechanical Thrombectomy
  Presenter(s):Constantino Pena, MD  
11:41 AM - 11:46 AM Venous Stent Thrombosis: Insights From The ABRE Study
  Presenter(s):Erin H. Murphy, MD  
11:47 AM - 11:52 AM Thrombolysis For Acute DVT: Guidance From Current Clinical Trials
  Presenter(s):Brian G. DeRubertis, MD  
11:53 AM - 11:58 AM Panel Discussion
11:59 AM - 1:03 PM Lunch Break – Rhinelander Gallery, 2nd Floor
Visit Exhibits And Pavilions (2nd and 3rd Floors)

END OF SESSION 99
 
SESSION 100 SCHEDULE
Friday
SESSION 100: PELVIC VEIN DISORDERS
x
1:04 PM - 1:09 PM The Role Of Conservative Pelvic Vein Management
  Presenter(s):Mark H. Meissner, MD  
1:10 PM - 1:15 PM Management Of Symptomatic Vulvar Varices With And Without Pelvic Symptoms
  Presenter(s):Steve Elias, MD  
1:16 PM - 1:21 PM Pelvic Venous Disease: New Terminology, New Treatment Approach, Still No Level 1 Data
  Presenter(s):Lindsay Machan, MD  
1:22 PM - 1:27 PM Ovarian Vein Embolization: Which Patients Benefit